Gil Dan Rabinovici

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$4,683,715

FY 2026

Project Title

New Approaches to Dementia Heterogeneity

Grant Number:

5P30AG062422-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/1/2019

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

ABSTRACT The University of California San Francisco Alzheimer’s Disease Research Center (UCSF ADRC) is a major catalyst for a broad spectrum of research in Alzheimer’s Disease and Related Dementias (AD/ADRD) conducted at UCSF and has served as a cornerstone for national and international multi-site ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAMES B BREWER

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

High-opportunity lead · 88/100

Likely hiring

Large award

Very recent

Active award

$4,584,783

FY 2026

Project Title

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30

Grant Number:

5P30AG062429-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/1/2019

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Alzheimer’s disease and related dementias (ADRD) are a growing public health issue with tremendous cost and unfathomable aggregate suffering. Unless the diseases can be effectively treated or prevented, increasing prevalence in an aging population will escalate costs that the country will struggle t...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Xin Zhang

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

High-opportunity lead · 82/100

Likely hiring

Above-average budget

Very recent

Active award

$808,380

FY 2026

Project Title

Core Facilities for Vision Research

Grant Number:

5P30EY019007-15

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2010

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary/Abstract Columbia University has a large and vibrant vision research community supported by the National Eye Institute, with 25 qualifying R01 grants and 48 vision scientists in all. Vision research at Columbia ranges across a gamut of topics, from genetic studies of retinal and visu...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Samuel M Wu

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

High-opportunity lead · 82/100

Likely hiring

Above-average budget

Very recent

Active award

$631,149

FY 2026

Project Title

P30 - Core Grant for Vision Research

Grant Number:

2P30EY002520-46

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/1997

End Date:

4/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

ABSTRACT Overall The objective of the Core Grant for Vision Research is to provide support and facilities, which are not available and cannot be obtained through individual grants, exclusively for vision research and NEI-funded projects at Baylor College of Medicine (BCM). The Core also provides spa...

Research Terms

<2-dimensional><3-D Imaging><3D imaging><Age related macular degeneration><Age-Related Maculopathy><Amblyopia><Animal Model><Animal Models and Related Studies><Animals><Area><Biochemical><Biochemistry><Bioinformatics><Biological Chemistry><Body Tissues><Cell Body><Cells><Chromium><Collaborations><Common Rat Strains><Complex><Computer software><Computers><Confocal Microscopy><Core Facility><Core Grant><Cornea><Cr element><Custom><DNA mutation><Dedications><Developmental Biology><Devices><Discipline><Disease><Disorder><Domestic Rabbit><Dysfunction><Electron Microscope><Electron Microscopy><Electronics><Electrophysiology><Electrophysiology (science)><Eligibility><Eligibility Determination><Environment><Equipment><Equipment Design><Eye><Eyeball><Fluorescence Agents><Fluorescent Agents><Fluorescent Dyes><Fostering><Functional disorder><Funding><Generations><Genes><Genetic Change><Genetic defect><Genetic mutation><Genomics><Glaucoma><Grant><HPLC><High Performance Liquid Chromatography><High Pressure Liquid Chromatography><High Speed Liquid Chromatography><Histologic><Histologically><Histology><Human Resources><Image><Individual><Industrialization><Institution><Investigators><Joints><Label><Laboratory Research><Light Microscope><Manpower><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mechanics><Medicine><Mice><Mice Mammals><Microscope><Microscopy><Molecular><Molecular Genetics><Murine><Mus><Mutation><NIH><National Institutes of Health><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Neurophysiology / Electrophysiology><Nucleic Acids><Ophthalmology><Optics><Oryctolagus cuniculus><Paper><Pathogenesis><Phorias><Physiologic><Physiological><Physiopathology><Pigmentary Retinopathy><Postdoc><Postdoctoral Fellow><Process><Productivity><Proteins><Protocol Screening><Psychophysics><Publications><Publishing><R-Series Research Projects><R01 Mechanism><R01 Program><Rabbits><Rabbits Mammals><Rat><Rats Mammals><Rattus><Reporting><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Training><Researchers><Resources><Retina><Retinitis Pigmentosa><Scanning><Scientific Publication><Services><Sight><Software><Squint><Strabismus><Structure><Students><Synapses><Synaptic><System><Systems Analyses><Systems Analysis><Tapetoretinal Degeneration><Technology><Thick><Thickness><Three-Dimensional Imaging><Tissue imaging><Tissues><Training><Transmission><United States National Institutes of Health><Vision><Vision research><Visual><Visual System><age dependent macular degeneration><age induced macular degeneration><age related macular disease><age related macular dystrophy><behavior test><behavioral test><college><collegiate><computer imaging><computerized><corneal><customs><design><design and construct><design and construction><designing><digital imaging><electronic><electronic device><electrophysiological><experience><fabrication><flexibility><flexible><fluorescence imaging><fluorescent dye/probe><fluorescent imaging><genome mutation><genome profiling><genomic profiling><glaucomatous><high definition><high-resolution><human genome sequencing><imaging><improved><innovate><innovation><innovative><instrumentation><lens><lenses><mechanic><mechanical><member><model of animal><neural><neuronal><optical><patch clamp><pathophysiology><personnel><post-doc><post-doctoral><post-doctoral trainee><programs><psychophysical><recruit><research associates><research facility><research faculty><rod and cone dystrophy><rod-cone dystrophy><senile macular disease><single cell genomics><sq. ft><square foot><synapse><transmission process><two-dimensional><visual function><visual neuroscience><water maze>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Xingjun Fan

AUGUSTA UNIVERSITY, AUGUSTA, GA

High-opportunity lead · 82/100

Likely hiring

Above-average budget

Very recent

Active award

$615,995

FY 2026

Project Title

Center Core Grant for Vision Research

Grant Number:

2P30EY031631-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary (Overall) This renewal application seeks continuing P30 funding for another five years to support the vision science research at the James and Jean Culver Vision Discovery Institute (VDI), Medical College of Georgia (MCG) of Augusta University (AU). Vision scientists at VDI engage in...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JONATHAN W FRIEDBERG

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Recent

Active award

$2,075,744

FY 2026

Project Title

University of Rochester Wilmot Cancer Institute Support Grant

Grant Number:

5P30CA272302-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/15/2025

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The mission of the Wilmot Cancer Institute (Wilmot) at the University of Rochester (UR) is to provide the highest quality treatment and care, through expert and innovative medicine, science, and education, for any patient burdened by any cancer within Central and Western New York, and beyond. Wilmot...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Denes V. Agoston

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LISA D COLES

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dominique Duncan

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Aristea S Galanopoulou

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDREY M MAZARATI

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Terence John O'Brien

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Staba

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

High-opportunity lead · 80/100

Likely hiring

Large award

Very recent

Active award

$1,898,729

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

5R01NS127524-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Judy Lieberman

BOSTON CHILDREN'S HOSPITAL, BOSTON, MA

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$733,069

FY 2026

Project Title

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

Grant Number:

5R01CA287076-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/4/2024

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Cancer immunotherapy using checkpoint blockade (CPB) has revolutionized cancer treatment, providing durable cures with acceptable toxicity in some cancer patients. However, only a few cancer types respond and even in responding tumor types, response is often limited to a minority of these cancers, w...

Research Terms

<3-D><3-Dimensional><3D><Adaptive Immune System><Agonist><Alkynes><Amphoterin><Amphoterin Gene><Anti-Cancer Agents><Antigen Presentation><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Apoptosis><Apoptosis Pathway><Apoptosis-Related Cysteine Protease Caspase 1><Azides><Beta Proprotein Interleukin 1><Binding Proteins><Biochemical><Biotinylation><Breast Cancer><Breast Cancer Model><Breast tumor model><CAR T cell therapy><CAR T therapy><CASP-1><CASP1><CASP1 gene><Cancer Drug><Cancer Induction><Cancer Patient><Cancer Treatment><Cancers><Caspase><Caspase Gene><Caspase-1><Caspase-1 Gene><Cell Body><Cell Communication and Signaling><Cell Death><Cell Signaling><Cell membrane><Cell-Death Protease><Cells><Chemistry><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Colorectal Cancer><Combined Modality Therapy><Complex><Cryo-electron Microscopy><Cryoelectron Microscopy><Cysteine Endopeptidases><Cysteine Protease><Cysteine Proteinases><Cytoplasmic Membrane><Data><Drugs><Electron Cryomicroscopy><Engineering><FM1 Gene Product><Family><GEM model><GEMM model><Genetically Engineered Mouse><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Human><ICE Protease><ICE-like protease><IL-1><IL-1 beta><IL-1 beta Convertase><IL-1 beta-Converting Enzyme><IL-1 β><IL-1-b><IL-1BC><IL-1b Converting Enzyme><IL-1β><IL1><IL1-Beta><IL1-β><IL1B Protein><IL1B-Convertase><IL1BC><IL1BCE><IL1F2><IL1β><Immune><Immune Regulators><Immune Surveillance><Immune response><Immune system><Immunes><Immunity><Immunocompetent><Immunocompromised><Immunocompromised Host><Immunocompromised Patient><Immunologic Surveillance><Immunomodulators><Immunosuppressed Host><Immunosurveillance><Implant><Inflammasome><Inflammation><Inflammation Mediators><Inflammatory><Innate Immunity><Interleukin 1-B Converting Enzyme><Interleukin 1-Beta Convertase><Interleukin 1beta><Interleukin I><Interleukin-1><Interleukin-1 Beta Converting Enzyme><Interleukin-1 Converting Enzyme><Interleukin-1 beta><Interleukin-1β><Intracellular Communication and Signaling><Knock-out><Knockout><Laboratories><Ligand Binding Protein><Ligand Binding Protein Gene><Lymphocyte-Stimulating Hormone><Macrophage Cell Factor><Malignant Breast Neoplasm><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Medication><Medicinal Chemistry><Mice><Mice Mammals><Microfluidics><Minority><Modeling><Modern Man><Multimodal Therapy><Multimodal Treatment><Murine><Mus><N-terminal><NH2-terminal><Native Immunity><Natural Immunity><Neoplastic Disease Chemotherapeutic Agents><Non-Specific Immunity><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nonspecific Immunity><Normal Tissue><Normal tissue morphology><Outcome><PD-1 antibody><PD1 antibody><Pharmaceutic Chemistry><Pharmaceutical Chemistry><Pharmaceutical Preparations><Physiologic pulse><Plasma Membrane><Preinterleukin 1 Beta><Process><Programmed Cell Death><Property><Propidium Diiodide><Propidium Iodide><Protein Binding><Pulse><SBP-1><SBP-1 Gene><Sampling><Sepsis><Series><Signal Transduction><Signal Transduction Systems><Signaling><Staining method><Stains><Strepavidin><Streptavidin><Structure><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><System><T Helper Factor><T cell response><T-Cells><T-Lymphocyte><Testing><Therapeutic><Toxic effect><Toxicities><Tumor Cell><Tumor Immunity><Tumor-Infiltrating Lymphocytes><Tumor-Specific Treatment Agents><Vaccination><aPD-1><aPD1><acquired immune system><adaptive immunity><analog><anti programmed cell death 1><anti-PD-1><anti-PD-1 Ab><anti-PD-1 antibodies><anti-PD-1 monoclonal antibodies><anti-PD1><anti-PD1 Ab><anti-PD1 antibodies><anti-PD1 monoclonal antibodies><anti-cancer drug><anti-cancer immunotherapy><anti-cancer therapy><anti-programmed cell death protein 1><anti-programmed cell death protein 1 antibodies><anti-programmed death-1 antibody><anti-tumor immunity><antiPD-1><anticancer immunotherapy><antitumor immunity><biological signal transduction><bound protein><cancer cell><cancer immunity><cancer immunotherapy><cancer microenvironment><cancer therapy><cancer type><cancer-directed therapy><carcinogenesis><cell imaging><cell killing><cellular imaging><check point blockade><checkpoint blockade><chimeric antigen receptor (CAR) T cell therapy><chimeric antigen receptor T cell therapy><chimeric antigen receptor T therapy><combination therapy><combined modality treatment><combined treatment><cryo-EM><cryoEM><cryogenic electron microscopy><cystein protease><cystein proteinase><cysteine endopeptidase><cytokine><drug/agent><genetically engineered mouse model><genetically engineered murine model><host response><human disease><immune check point blockade><immune checkpoint blockade><immune competent><immune modulators><immune system response><immune-based cancer therapies><immunogenic><immunogenic apoptosis><immunogenic cell death><immunomodulatory molecules><immunoregulator><immunoregulatory molecules><immunoresponse><immunosuppressed patient><immunotherapy for cancer><immunotherapy of cancer><in vivo><inflammatory mediator><lymphocyte activating factor><malignancy><malignant breast tumor><mammary cancer model><mammary tumor model><meter><mouse model><multi-modal therapy><multi-modal treatment><murine model><necrocytosis><neoplasm/cancer><neoplastic cell><pathogen><plasmalemma><response><screening><screenings><spheroids><subcutaneous><subdermal><synergism><three dimensional><thymus derived lymphocyte><tool><tumor><tumor growth><tumor microenvironment><µfluidic><αPD-1><αPD1>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hao Wu

BOSTON CHILDREN'S HOSPITAL, BOSTON, MA

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$733,069

FY 2026

Project Title

Activating gasdermin pores to induce pyroptosis and stimulate anti-tumor immunity

Grant Number:

5R01CA287076-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/4/2024

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Cancer immunotherapy using checkpoint blockade (CPB) has revolutionized cancer treatment, providing durable cures with acceptable toxicity in some cancer patients. However, only a few cancer types respond and even in responding tumor types, response is often limited to a minority of these cancers, w...

Research Terms

<3-D><3-Dimensional><3D><Adaptive Immune System><Agonist><Alkynes><Amphoterin><Amphoterin Gene><Anti-Cancer Agents><Antigen Presentation><Antineoplastic Agents><Antineoplastic Drugs><Antineoplastics><Apoptosis><Apoptosis Pathway><Apoptosis-Related Cysteine Protease Caspase 1><Azides><Beta Proprotein Interleukin 1><Binding Proteins><Biochemical><Biotinylation><Breast Cancer><Breast Cancer Model><Breast tumor model><CAR T cell therapy><CAR T therapy><CASP-1><CASP1><CASP1 gene><Cancer Drug><Cancer Induction><Cancer Patient><Cancer Treatment><Cancers><Caspase><Caspase Gene><Caspase-1><Caspase-1 Gene><Cell Body><Cell Communication and Signaling><Cell Death><Cell Signaling><Cell membrane><Cell-Death Protease><Cells><Chemistry><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Colorectal Cancer><Combined Modality Therapy><Complex><Cryo-electron Microscopy><Cryoelectron Microscopy><Cysteine Endopeptidases><Cysteine Protease><Cysteine Proteinases><Cytoplasmic Membrane><Data><Drugs><Electron Cryomicroscopy><Engineering><FM1 Gene Product><Family><GEM model><GEMM model><Genetically Engineered Mouse><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Human><ICE Protease><ICE-like protease><IL-1><IL-1 beta><IL-1 beta Convertase><IL-1 beta-Converting Enzyme><IL-1 β><IL-1-b><IL-1BC><IL-1b Converting Enzyme><IL-1β><IL1><IL1-Beta><IL1-β><IL1B Protein><IL1B-Convertase><IL1BC><IL1BCE><IL1F2><IL1β><Immune><Immune Regulators><Immune Surveillance><Immune response><Immune system><Immunes><Immunity><Immunocompetent><Immunocompromised><Immunocompromised Host><Immunocompromised Patient><Immunologic Surveillance><Immunomodulators><Immunosuppressed Host><Immunosurveillance><Implant><Inflammasome><Inflammation><Inflammation Mediators><Inflammatory><Innate Immunity><Interleukin 1-B Converting Enzyme><Interleukin 1-Beta Convertase><Interleukin 1beta><Interleukin I><Interleukin-1><Interleukin-1 Beta Converting Enzyme><Interleukin-1 Converting Enzyme><Interleukin-1 beta><Interleukin-1β><Intracellular Communication and Signaling><Knock-out><Knockout><Laboratories><Ligand Binding Protein><Ligand Binding Protein Gene><Lymphocyte-Stimulating Hormone><Macrophage Cell Factor><Malignant Breast Neoplasm><Malignant Cell><Malignant Neoplasm Therapy><Malignant Neoplasm Treatment><Malignant Neoplasms><Malignant Tumor><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Medication><Medicinal Chemistry><Mice><Mice Mammals><Microfluidics><Minority><Modeling><Modern Man><Multimodal Therapy><Multimodal Treatment><Murine><Mus><N-terminal><NH2-terminal><Native Immunity><Natural Immunity><Neoplastic Disease Chemotherapeutic Agents><Non-Specific Immunity><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nonspecific Immunity><Normal Tissue><Normal tissue morphology><Outcome><PD-1 antibody><PD1 antibody><Pharmaceutic Chemistry><Pharmaceutical Chemistry><Pharmaceutical Preparations><Physiologic pulse><Plasma Membrane><Preinterleukin 1 Beta><Process><Programmed Cell Death><Property><Propidium Diiodide><Propidium Iodide><Protein Binding><Pulse><SBP-1><SBP-1 Gene><Sampling><Sepsis><Series><Signal Transduction><Signal Transduction Systems><Signaling><Staining method><Stains><Strepavidin><Streptavidin><Structure><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><System><T Helper Factor><T cell response><T-Cells><T-Lymphocyte><Testing><Therapeutic><Toxic effect><Toxicities><Tumor Cell><Tumor Immunity><Tumor-Infiltrating Lymphocytes><Tumor-Specific Treatment Agents><Vaccination><aPD-1><aPD1><acquired immune system><adaptive immunity><analog><anti programmed cell death 1><anti-PD-1><anti-PD-1 Ab><anti-PD-1 antibodies><anti-PD-1 monoclonal antibodies><anti-PD1><anti-PD1 Ab><anti-PD1 antibodies><anti-PD1 monoclonal antibodies><anti-cancer drug><anti-cancer immunotherapy><anti-cancer therapy><anti-programmed cell death protein 1><anti-programmed cell death protein 1 antibodies><anti-programmed death-1 antibody><anti-tumor immunity><antiPD-1><anticancer immunotherapy><antitumor immunity><biological signal transduction><bound protein><cancer cell><cancer immunity><cancer immunotherapy><cancer microenvironment><cancer therapy><cancer type><cancer-directed therapy><carcinogenesis><cell imaging><cell killing><cellular imaging><check point blockade><checkpoint blockade><chimeric antigen receptor (CAR) T cell therapy><chimeric antigen receptor T cell therapy><chimeric antigen receptor T therapy><combination therapy><combined modality treatment><combined treatment><cryo-EM><cryoEM><cryogenic electron microscopy><cystein protease><cystein proteinase><cysteine endopeptidase><cytokine><drug/agent><genetically engineered mouse model><genetically engineered murine model><host response><human disease><immune check point blockade><immune checkpoint blockade><immune competent><immune modulators><immune system response><immune-based cancer therapies><immunogenic><immunogenic apoptosis><immunogenic cell death><immunomodulatory molecules><immunoregulator><immunoregulatory molecules><immunoresponse><immunosuppressed patient><immunotherapy for cancer><immunotherapy of cancer><in vivo><inflammatory mediator><lymphocyte activating factor><malignancy><malignant breast tumor><mammary cancer model><mammary tumor model><meter><mouse model><multi-modal therapy><multi-modal treatment><murine model><necrocytosis><neoplasm/cancer><neoplastic cell><pathogen><plasmalemma><response><screening><screenings><spheroids><subcutaneous><subdermal><synergism><three dimensional><thymus derived lymphocyte><tool><tumor><tumor growth><tumor microenvironment><µfluidic><αPD-1><αPD1>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ryan Peter Vetreno

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$653,214

FY 2026

Project Title

Proinflammatory HMGB1 Contributions to Adolescent Alcohol-induced Reversible Epigenetic Suppression of Cholinergic Neuron Phenotype and Cognitive Deficits in Adulthood

Grant Number:

1R01AA032804-01

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2026

End Date:

1/31/2031

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT ABSTRACT. Human adolescent binge drinking is associated with lasting deleterious effects on the brain, including induction of proinflammatory HMGB1 signaling, degeneration of basal forebrain cholinergic neurons (BFCNs), and impaired adult cognitive flexibility, increasing risk for later AUD ...

Research Terms

<12-20 years old><21+ years old><7S Gamma Globulin><Absolute ethanol><Acetylcholine><Adolescence><Adolescent><Adolescent Youth><Adult><Adult Human><Alcohol Chemical Class><Alcohols><Amentia><Amides><Ammon Horn><Amphoterin><Amphoterin Gene><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Behavioral><Brain><Brain Nervous System><Brain region><CNS plasticity><Cell Communication and Signaling><Cell Death><Cell Signaling><Chromatin><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive deficits><Cognitive function abnormal><Cornu Ammonis><Data><Dementia><Development><Disease><Disorder><Disturbance in cognition><EC 2.1.1><ETOH><Electrophysiology><Electrophysiology (science)><Encephalon><Enzyme Gene><Enzymes><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Ethanol><Ethyl Alcohol><FM1 Gene Product><Female><Gene Inactivation><Gene Silencing><Genes><Genotype><Glycyrrhizic Acid><Glycyrrhizin><Glycyrrhizinic Acid><Grain Alcohol><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Hippocampus><Human><IgG><Immunoglobulin G><Impaired cognition><Impairment><Inflammatory><Injections><Intracellular Communication and Signaling><Learning><Link><Maintenance><Mediating><Methylcarbinol><Methyltransferase><Mice><Mice Mammals><Microbeads><Microspheres><Modeling><Modern Man><Murine><Mus><Nerve Cells><Nerve Degeneration><Nerve Unit><Neural Cell><Neurocyte><Neuron Degeneration><Neuronal Plasticity><Neurons><Neuropathy><Neurophysiology / Electrophysiology><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Phenotype><Physiologic><Physiological><Pre-Clinical Model><Preclinical Models><Risk><Role><SBP-1><SBP-1 Gene><Signal Transduction><Signal Transduction Systems><Signaling><Single-Nucleus Sequencing><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Testing><Therapeutic><Transgenic Organisms><Viral Vector><adolescence (12-20)><adolescent alcohol binge exposure><adolescent binge alcohol drinking><adolescent binge drinking><adolescent onset binge drinking><adulthood><alcohol use disorder><basal forebrain><basal forebrain cholinergic neurons><biological signal transduction><central nervous system plasticity><cholinergic><cholinergic neuron><cognitive defects><cognitive dysfunction><cognitive loss><developmental><electrophysiological><epigenetic regulation><epigenetically><ethanol use disorder><executive control><executive function><flexibility><flexible><global gene expression><global transcription profile><hippocampal><human model><inhibitor><innovate><innovation><innovative><juvenile><juvenile human><male><manufacture><methylase><mimetics><model of human><morris water maze><morris watermaze><multiomics><multiple omics><necrocytosis><nerve cell death><nerve cell loss><neural degeneration><neural inflammation><neural plasticity><neurodegeneration><neurodegenerative><neuroinflammation><neuroinflammatory><neurological degeneration><neuron cell death><neuron cell loss><neuron death><neuron loss><neuronal><neuronal cell death><neuronal cell loss><neuronal death><neuronal degeneration><neuronal loss><neuropathic><neuropathologic><neuropathological><neuropathology><neuroplastic><neuroplasticity><novel><panomics><pharmacologic><phenotypic biomarker><phenotypic marker><post intervention><promoter><promotor><sNuc-Seq><shRNA><short hairpin RNA><single nucleus RNA-sequencing><single nucleus seq><single-nucleus RNA-seq><snRNA sequencing><snRNA-seq><social role><transcriptional silencing><transcriptome><transcriptomics><transgenic><transmethylase><♀><♂>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ju Chen

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$528,589

FY 2026

Project Title

ATF4 a Novel Regulator of Cardiac Development

Grant Number:

5R01HL164549-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2023

End Date:

4/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Activating Transcription Factor 4 (ATF4), also known as cAMP-Response Element Binding Protein 2 (CREB2), belongs to the ATF/cAMP responsive element-binding (CREB) protein family of transcription factors. As a well- characterized stress-response transcription factor, ATF4 is constitut...

Research Terms

<21+ years old><ATF><ATF-4><Ablation><Address><Adult><Adult Human><Antioncogene Protein p53><Appearance><Atrial Fibrillation><Auricular Fibrillation><Basal Transcription Factor><Basal transcription factor genes><Binding><Binding Sites><Biological Function><Biological Process><Body Tissues><CRE Binding Protein><CREB Protein><Cancers><Cardiac><Cardiac Diseases><Cardiac Disorders><Cardiac Malformation><Cardiac Muscle Cells><Cardiac Myocytes><Cardiac defect><Cardiac development><Cardiocyte><Cell Cycle><Cell Cycle Arrest><Cell Cycle Progression><Cell Division Cycle><Cellular Stress><Cellular Stress Response><Cellular Tumor Antigen P53><Cessation of life><ChIP Sequencing><ChIP-seq><ChIPseq><Combining Site><Complex><Congestive Cardiomyopathy><Cyclic AMP Response Element-Binding Protein><Cyclic AMP Responsive Element Binding Protein><Cyclic AMP-Responsive DNA-Binding Protein><DNA><Data><Death><Defect><Deoxyribonucleic Acid><Development><Dilated Cardiomyopathy><Dimensions><Disease><Disorder><Down-Regulation><Embryo><Embryonic><Exhibits><Family><Family member><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic Transcription><Heart><Heart Diseases><Heart Malformation><Heart Muscle Cells><Heart failure><Heart myocyte><KO mice><Knock-out><Knock-out Mice><Knockout><Knockout Mice><Knowledge><Leanness><Left><Leucine Zippers><MLC2 gene product><Maintenance><Malignant Neoplasms><Malignant Tumor><Mediating><Mediator><Messenger RNA><Mice><Mice Mammals><Modeling><Molecular><Molecular Interaction><Morphogenesis><Morphology><Murine><Mus><Neonatal><Null Mouse><Oncoprotein p53><P53><Pathologic><Pathway interactions><Patients><Perinatal Mortalities><Perinatal lethality><Perinatal mortality demographics><Pharmaceutical Agent><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Phenotype><Phosphoprotein P53><Phosphoprotein pp53><Physiologic><Physiological><Physiology><Platanna><Play><Proliferating><Protein Family><Protein TP53><Proteins><RNA Expression><RNA Seq><RNA sequencing><RNAseq><Reactive Site><Regulation><Regulator Genes><Reporting><Role><Series><TP53><TP53 gene><TRP53><Tamoxifen><Therapeutic><Thick><Thickness><Thinness><Tissues><Transcription><Transcription Factor Proto-Oncogene><Transcription factor genes><Transcriptional Regulatory Elements><Transgenic Mice><Troponin T><Tumor Protein p53><Tumor Protein p53 Gene><Upregulation><Ventricular><Xenopus laevis><abnormal heart development><activating transcription factor><activating transcription factor 4><adulthood><biological adaptation to stress><cAMP Response Element-Binding Protein><cAMP Responsive Element Binding Protein><cardiac MLC2><cardiac failure><cardiac function><cardiogenesis><cardiomyocyte><cell stress><cell type><chromatin immunoprecipitation coupled with sequencing><chromatin immunoprecipitation followed by sequencing><chromatin immunoprecipitation with sequencing><chromatin immunoprecipitation-seq><chromatin immunoprecipitation-sequencing><congenital cardiac abnormality><congenital cardiac anomalies><congenital cardiac disease><congenital cardiac disorder><congenital cardiac malformation><congenital heart abnormality><congenital heart anomaly><congenital heart disease><congenital heart disorder><congenital heart malformation><developmental><function of the heart><genetic trans acting element><genome scale><genome-wide><genomewide><heart defect><heart development><heart disorder><heart formation><heart function><in vivo><inhibitor><mRNA><malignancy><morphogenetic process><mouse model><murine model><myosin light chain 2><myosin light chain 2 gene product><neoplasm/cancer><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><perinatal deaths><pharmaceutical><pharmacologic><postnatal><programs><protein p53><reactioncrisis><regulatory gene><side effect><social role><stress response><stressreaction><trans acting element><transcription factor><transcriptome sequencing><transcriptomic sequencing><tropomyosin binding protein troponin T>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MICHELE CARBONE

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$525,368

FY 2026

Project Title

Novel strategies to improve mesothelioma therapy

Grant Number:

5R01CA290173-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Exposure to asbestos fibers is the major risk factor for the development of malignant mesothelioma (MM). We demonstrated that asbestos fibers induce HMGB1 translocation from the nucleus to the cytoplasm, inducing autophagy, a protective mechanism for mesothelial cells survival after ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert Taylor Ripley

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$525,368

FY 2026

Project Title

Novel strategies to improve mesothelioma therapy

Grant Number:

5R01CA290173-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Exposure to asbestos fibers is the major risk factor for the development of malignant mesothelioma (MM). We demonstrated that asbestos fibers induce HMGB1 translocation from the nucleus to the cytoplasm, inducing autophagy, a protective mechanism for mesothelial cells survival after ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Haining Yang

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

High-opportunity lead · 74/100

Likely hiring

Above-average budget

Very recent

Active award

$525,368

FY 2026

Project Title

Novel strategies to improve mesothelioma therapy

Grant Number:

5R01CA290173-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

5/1/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY Exposure to asbestos fibers is the major risk factor for the development of malignant mesothelioma (MM). We demonstrated that asbestos fibers induce HMGB1 translocation from the nucleus to the cytoplasm, inducing autophagy, a protective mechanism for mesothelial cells survival after ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SCOTT A SMALL

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,750,237

FY 2025

Project Title

Alzheimer's Disease Research Center

Grant Number:

2P30AG066462-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/15/2020

End Date:

4/30/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY In this application to renew Columbia University’s Alzheimer’s Disease Research Center (ADRC), we propose to continue our Center’s tradition that has existed at Columbia since 1989, originally as a P50 that then transitioned to a P30 in 2020. Building off our prior accomplis...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Aina E. Cohen

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,401,660

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

2P30GM133894-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KEITH O HODGSON

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,401,660

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

2P30GM133894-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ritimukta Sarangi

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,401,660

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

2P30GM133894-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Erik D Roberson

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$4,274,956

FY 2025

Project Title

UAB Alzheimer's Disease Research Center

Grant Number:

5P30AG086401-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/15/2024

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL The thematic focus of the UAB Alzheimer’s Disease Research Center (ADRC) is Deep South disparities in dementia. Individuals born in the Deep South (traditionally defined as the five-state region spanning LA, MS, AL, GA, and SC) have high rates of Alzheimer’s disease (AD) and relate...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Peter M. Abadir

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,947,726

FY 2025

Project Title

Utilizing Technology and AI Approaches to Facilitate Independence and Resilience in Older Adults

Grant Number:

5P30AG073104-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of this application is to build an Artificial Intelligence (AI) and Technology Collaboratory (AITC) ecosystem that will serve as a national resource to promote the development and implementation of novel AI and technology approaches to improve care and health outcomes for older ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexis Battle

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,947,726

FY 2025

Project Title

Utilizing Technology and AI Approaches to Facilitate Independence and Resilience in Older Adults

Grant Number:

5P30AG073104-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of this application is to build an Artificial Intelligence (AI) and Technology Collaboratory (AITC) ecosystem that will serve as a national resource to promote the development and implementation of novel AI and technology approaches to improve care and health outcomes for older ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rama Chellappa

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,947,726

FY 2025

Project Title

Utilizing Technology and AI Approaches to Facilitate Independence and Resilience in Older Adults

Grant Number:

5P30AG073104-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of this application is to build an Artificial Intelligence (AI) and Technology Collaboratory (AITC) ecosystem that will serve as a national resource to promote the development and implementation of novel AI and technology approaches to improve care and health outcomes for older ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Phillip Phan

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,947,726

FY 2025

Project Title

Utilizing Technology and AI Approaches to Facilitate Independence and Resilience in Older Adults

Grant Number:

5P30AG073104-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2021

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching goal of this application is to build an Artificial Intelligence (AI) and Technology Collaboratory (AITC) ecosystem that will serve as a national resource to promote the development and implementation of novel AI and technology approaches to improve care and health outcomes for older ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PRIMO N. LARA

UNIVERSITY OF CALIFORNIA AT DAVIS, DAVIS, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,572,269

FY 2025

Project Title

Cancer Center Support Grant P30

Grant Number:

5P30CA093373-23

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2002

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The UC Davis Comprehensive Cancer Center (UCDCCC) is a matrix organization under the aegis of the UC Davis Health and University of California, Davis. It received NCI-designation in 2002 and comprehensive status in 2012. Primo N. Lara, Jr., MD was appointed Cancer Center Director in 2018, overseeing...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RUSSELL H. SWERDLOW

UNIVERSITY OF KANSAS MEDICAL CENTER, KANSAS CITY, KS

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$3,042,560

FY 2025

Project Title

University of Kansas Alzheimer's Disease Research Center (KU ADRC)

Grant Number:

5P30AG072973-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/15/2021

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT: OVERALL The University of Kansas Alzheimer's Disease Research Center (KU ADRC) promotes Alzheimer's Disease and Related Disorders (ADRD) research at local, national, and international levels. Our strengths in basic and translational mitochondria, lifestyle modification, and prevention res...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Seung K Kim

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,967,401

FY 2025

Project Title

Stanford Diabetes Research Center

Grant Number:

5P30DK116074-09

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/15/2017

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

CENTER OVERVIEW: PROJECT SUMMARY/ABSTRACT The Stanford Diabetes Research Center (SDRC) embodies the culmination of a strategic plan by the Stanford University School of Medicine to create a premier program founded on a base of superb, collaborative investigators studying basic, clinical and translat...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert O Wright

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,647,750

FY 2025

Project Title

Mount Sinai Center for Health and Environment Across the LifeSpan (HEALS)

Grant Number:

5P30ES023515-12

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/18/2014

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

In just 8 years of existence, our Health Effects Across the LifeSPan (HEALS) P30 Core Center has accelerated remarkable environmental health research growth. Using a life stage approach and the underlying philosophy that environment is important for all diseases, we have formed new transdisciplinary...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tracey J. Woodruff

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,613,018

FY 2025

Project Title

UCSF Environmental Research and Translation for Health Center (EaRTH Center)

Grant Number:

2P30ES030284-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/22/2020

End Date:

3/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

ABSTRACT - OVERALL Established in 2020 with a goal to accelerate the pace of discovery and translation of the environmental impacts on health and susceptible populations, the UCSF Environmental Research and Translation for Health (EaRTH) Center produces ground-breaking research, innovations and enga...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gokhan M. Mutlu

UNIVERSITY OF CHICAGO, CHICAGO, IL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,605,109

FY 2025

Project Title

ChicAgo Center for Health and EnvironmenT (CACHET)

Grant Number:

5P30ES027792-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2017

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY – Overall This is the revised submission of the first competing renewal proposal for the “ChicAgo Center for Health and EnvironmenT (CACHET)” – the first NIH P30 Environmental Health Sciences (EHS) Core Center in the Chicago area established in 2017 with an equal partnership betwee...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gail S Prins

UNIVERSITY OF CHICAGO, CHICAGO, IL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,605,109

FY 2025

Project Title

ChicAgo Center for Health and EnvironmenT (CACHET)

Grant Number:

5P30ES027792-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2017

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY – Overall This is the revised submission of the first competing renewal proposal for the “ChicAgo Center for Health and EnvironmenT (CACHET)” – the first NIH P30 Environmental Health Sciences (EHS) Core Center in the Chicago area established in 2017 with an equal partnership betwee...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Charles Chavkin

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,598,795

FY 2025

Project Title

University of Washington Center of Excellence in Opioid Addiction Research

Grant Number:

5P30DA048736-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2019

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The “University of Washington Center of Excellence in Opioid Addiction Research” is designed to provide shared resources that would continue to enhance efficiency and facilitate collaborative research for the study of the effects of opioids on neural circuits with the goal of understanding opioid ad...

Research Terms

<2-photon><2-photon microscopy><Actiq><Address><Affect><Animals><Anxiety Disorders><Award><Behavior><Behavioral><Brain><Brain Nervous System><Brain imaging><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><Calcium Ion Signaling><Calcium Signaling><Cas nuclease technology><Cell Body><Cells><Cessation of life><Chemical Dependence><Chronic><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Collaborations><Communities><Community Outreach><Complex><Computer Analysis><Confocal Microscopy><Coupled><Death><Development><Diacetylmorphine><Diamorphine><Disease><Disease remission><Disorder><Drug Addiction><Drug Dependence><Drug Dependency><Drug usage><Duragesic><Education and Outreach><Educational workshop><Encephalon><Endoscopy><Ensure><Equipment><Faculty><Fentanest><Fentanyl><Fentyl><Fiber><Fostering><Funding><Gene Expression><Generations><Genetic><Genetic Technics><Genetic Techniques><Goals><Heroin><History><Image><Imaging Device><Imaging Instrument><Imaging Procedures><Imaging Technics><Imaging Techniques><Imaging Tool><Imaging in rodent><Infrastructure><Institution><Instruction and Outreach><Investigation><Investigators><Laboratories><Light><Link><Mental Depression><Mice><Mice Mammals><Minority><Modernization><Molecular><Molecular Genetics><Monitor><Murine><Mus><NIDA><National Institute of Drug Abuse><National Institute on Drug Abuse><Nerve Cells><Nerve Unit><Neural Cell><Neurobiology><Neurocyte><Neurons><Neurosciences><North Carolina><Opiate Addiction><Opiate Dependence><Opiates><Opioid><Pain><Painful><Participant><Pharmacology><Phentanyl><Photometry><Photons><Photoradiation><Pilot Projects><Postdoc><Postdoctoral Fellow><Productivity><Professional Organizations><Qualifying><Reagent><Receptor Signaling><Recording of previous events><Relapse><Remission><Reproducibility><Research><Research Associate><Research Personnel><Research Resources><Research Training><Researchers><Resolution><Resource Sharing><Resources><Risk><Rodent><Rodent Control><Rodentia><Rodents Mammals><Science><Scientist><Self Administered><Self Administration><Techniques><Training><Training Programs><Training and Outreach><Translations><Tutoring and Outreach><Universities><Viral><Viral Genes><Visit><Visualization><Washington><Workshop><addiction><addictive disorder><archive data><archiving data><awake><brain visualization><co-morbid><co-morbidity><comorbidity><computational analyses><computational analysis><computational neuroscience><computer analyses><data analysis pipeline><data processing pipeline><depression><design><design and construct><design and construction><designing><developmental><drug abstinence><drug use><dysphoria><endoscopic imaging><gene manipulation><genetic manipulation><genetic resource><genetically manipulate><genetically perturb><graduate student><high risk><histories><imaging><imaging approach><imaging based approach><imaging studies in rodent><imaging studies of rodent><in vivo><innovate><innovation><innovative><insight><interest><meeting><meetings><motivated behavior><neural circuit><neural circuitry><neural imaging><neuro-imaging><neurobiological><neurocircuitry><neuroimaging><neurological imaging><neuronal><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><open data><open science><open-source data><opiate consumption><opiate drug use><opiate intake><opiate overdose><opiate related overdose><opiate use><opiate use disorder><opioid addiction><opioid consumption><opioid dependence><opioid dependent><opioid drug overdose><opioid drug use><opioid induced overdose><opioid intake><opioid intoxication><opioid medication overdose><opioid overdose><opioid poisoning><opioid related overdose><opioid toxicity><opioid use><opioid use disorder><optogenetics><overdose risk><pilot study><post-doc><post-doctoral><post-doctoral trainee><post-doctoral training><professional association><professional membership><professional society><programs><recruit><relapse risk><research associates><research study><resolutions><rodent imaging><sensor><spatial and temporal><spatial temporal><spatiotemporal><summer research><summer undergraduate training><synaptic circuit><synaptic circuitry><tool><translation><two photon excitation microscopy><two photon microscopy><two-photon><undergrad><undergraduate><undergraduate research experience><undergraduate research opportunities><undergraduate research programs><undergraduate student><undergraduate summer program><undergraduate summer research><vector><virtual><web site><website>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RONALD J. ELLIS

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,499,994

FY 2025

Project Title

HIV Neurobehavioral Research Center

Grant Number:

5P30MH062512-25

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/24/2001

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY/ABSTRACT For over two decades, the NIMH P30 HIV Neurobehavioral Research Center (HNRC) has been a leader in the neuroHIV field, supporting research that has greatly advanced our understanding of the central nervous system (CNS) consequences of HIV disease, as well as their pr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID J MOORE

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,499,994

FY 2025

Project Title

HIV Neurobehavioral Research Center

Grant Number:

5P30MH062512-25

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/24/2001

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL PROJECT SUMMARY/ABSTRACT For over two decades, the NIMH P30 HIV Neurobehavioral Research Center (HNRC) has been a leader in the neuroHIV field, supporting research that has greatly advanced our understanding of the central nervous system (CNS) consequences of HIV disease, as well as their pr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lisa A. Marsch

DARTMOUTH COLLEGE, HANOVER, NH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,441,869

FY 2025

Project Title

Technology-based Treatments for Substance Use Disorders

Grant Number:

5P30DA029926-15

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2011

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL CORE CENTER PROJECT SUMMARY Digital therapeutics that deliver science-based, behavior change interventions targeting substance use disorders (SUDs) and related issues (including HIV risk behavior and mental health disorders) can markedly improve access to care, quality of care, and treatment...

Research Terms

<21+ years old><Acceleration><Access to Care><Achievement><Achievement Attainment><Address><Adolescent><Adolescent Youth><Adult><Adult Human><Area><Authorization><Authorization documentation><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><Caring><Clinical><Computer software><Conditioning Therapy><Congresses><Data Analytics><Development><Discipline><Disease><Disorder><Dissemination and Implementation><Education><Educational aspects><Effectiveness><Emergent Technologies><Emerging Technologies><Ensure><Ethics><Evaluation><Funding><Future><Grant><HIV risk><Health Care><Health Services Accessibility><Improve Access><Industry><Infrastructure><International><Intervention><Investigators><Leadership><Link><Measurement><Medical><Mental Health><Mental Hygiene><Mental disorders><Mental health disorders><Mentorship><Methodology><Modeling><NIDA><National Institute of Drug Abuse><National Institute on Drug Abuse><Permission><Phase><Pilot Projects><Population><Psychiatric Disease><Psychiatric Disorder><Psychological Health><Publications><QOC><Quality of Care><R-Series Research Projects><R01 Mechanism><R01 Program><Research><Research Grants><Research Methodology><Research Methods><Research Personnel><Research Priority><Research Project Grants><Research Projects><Research Resources><Researchers><Resource Sharing><Resources><Risk Behaviors><Risky Behavior><SAMHSA><Science><Scientific Publication><Software><Substance Abuse and Mental Health Services Administration><Substance Use Disorder><System><Technology><Testing><Therapeutic><Training><Treatment outcome><Underrepresented Ethnic Minority><Underrepresented Minority><United States Substance Abuse and Mental Health Services Administration><Work><access to health services><access to services><access to treatment><accessibility to health services><adulthood><at risk behavior><authority><availability of services><behavior change><behavior intervention><behavioral health><behavioral intervention><care access><care outcomes><co-occurring disorders><conference><convention><cost><cost effectiveness><data analysis core><data analysis research core><data analytics core><data analytics research core><develop therapy><developmental><digital><digital delivery><digital diagnostic><digital health><digital intervention><digital phenotyping><digital platform><digital therapeutics><digital therapy><digital treatment><digitally deliver><disparities in treatment><diversity and inclusion><diversity and inclusivity><dual diagnosis><ethical><health assessment><health care outcomes><health care settings><health service access><health services availability><implementation efforts><inequality in treatment><innovate><innovation><innovative><intervention development><juvenile><juvenile human><mental illness><mobile sensing><next generation><novel><physical conditioning><physical health><pilot study><prevent><preventing><psychiatric illness><psychological disorder><research and methods><scale up><service availability><substance use and disorder><substance use treatment><summit><symposia><symposium><synergism><therapeutic target><therapy development><treatment access><treatment development><treatment disparity><treatment inequality><treatment inequity><under-representation of minorities><under-represented minority><underrepresentation of minorities>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Abraham A. Palmer

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,387,925

FY 2025

Project Title

Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats

Grant Number:

5P30DA060810-02

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2024

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary (Overall) The goal of this P30 application is to support the community of scientists who use outbred heterogeneous stock (HS) rats to understand the genetic basis of individual differences in vulnerability to substance use disorders (SUDs). Although this is a new grant, one of its m...

Research Terms

<0-4 weeks old><Address><Alcohol Chemical Class><Alcohols><Alleles><Allelomorphs><Attention><Behavior><Behavioral><Breeding><California><Cell Body><Cells><Cessation of life><Chromosomes><Common Rat Strains><Communities><Complex><Criminal Justice><DNA Recombination><Data><Data Bases><Databases><Death><Diacetylmorphine><Diamorphine><Dihydrohydroxycodeinone><Education><Educational aspects><Electrophysiology><Electrophysiology (science)><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Europe><FAIR data><FAIR guiding principles><FAIR principles><Findable, Accessible, Interoperable and Re-usable><Findable, Accessible, Interoperable, and Reusable><Funding><GWA study><GWAS><Gene Expression><Generations><Genes><Genetic><Genetic Predisposition><Genetic Predisposition to Disease><Genetic Recombination><Genetic Susceptibility><Genetic Technics><Genetic Techniques><Genetic propensity><Genetic study><Genomics><Genotype><Goals><Grant><Health Care Costs><Health Costs><Heroin><Human><Impulsivity><Inbred Strains Rats><Individual Differences><Inherited Predisposition><Inherited Susceptibility><Investigators><Learning><Machine Learning><Maps><Measures><Mental disorders><Mental health disorders><Methodology><Mice><Mice Mammals><Modern Man><Murine><Mus><NIDA><NIDDK><National Institute of Diabetes and Digestive and Kidney Diseases><National Institute of Drug Abuse><National Institute on Drug Abuse><Neurophysiology / Electrophysiology><Newborn Infant><Newborns><Nicotine><Oxycodeinon><Oxycodone><Oxycodone SR><Oxycontin><Pathway interactions><Phenotype><Pilot Projects><Population><Productivity><Psychiatric Disease><Psychiatric Disorder><QTL><Quantitative Genetics><Quantitative Trait Loci><Rat><Rats Mammals><Rattus><Recombination><Research Personnel><Researchers><Roxicodone><Scientist><Services><Slice><Substance Use Disorder><Techniques><Time><Universities><addiction><addictive disorder><cocaine self-administration><comparator group><comparison group><cost><data base><data management><data sharing><design><designing><distributed data><effective therapy><effective treatment><electrophysiological><epigenetically><epigenomics><genetic approach><genetic etiology><genetic mechanism of disease><genetic strategy><genetic vulnerability><genetically predisposed><genome wide association><genome wide association scan><genome wide association study><genomewide association scan><genomewide association study><global gene expression><global transcription profile><high school><innovate><innovation><innovative><machine based learning><mental illness><multidisciplinary><newborn child><newborn children><novel><pathway><pilot study><premature><prematurity><psychiatric illness><psychological disorder><rat genome><self-administer cocaine><substance use and disorder><therapeutic target><trait><transcriptome><transcriptomics><undergrad><undergraduate><undergraduate student><virtual><web site><website><whole genome association analysis><whole genome association study>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard H Fortinsky

UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, FARMINGTON, CT

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,333,352

FY 2025

Project Title

Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)

Grant Number:

5P30AG067988-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/15/2021

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY OVERALL This proposal seeks to establish the Claude D Pepper Older Americans Independence Center at UConn (UConn OAIC) with the overarching goal of developing clinical strategies for enhancing function and independence in older adults that are more precise, personalized, and effectiv...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GEORGE A KUCHEL

UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, FARMINGTON, CT

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,333,352

FY 2025

Project Title

Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)

Grant Number:

5P30AG067988-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/15/2021

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY OVERALL This proposal seeks to establish the Claude D Pepper Older Americans Independence Center at UConn (UConn OAIC) with the overarching goal of developing clinical strategies for enhancing function and independence in older adults that are more precise, personalized, and effectiv...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Terri R. Fried

YALE UNIVERSITY, NEW HAVEN, CT

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,323,421

FY 2025

Project Title

Claude D. Pepper Older Americans Independence Center at Yale

Grant Number:

5P30AG021342-23

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2002

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching objective of the Yale Older Americans Independence Center (OAIC), established in 1992, is to provide intellectual leadership and innovation for aging research that is directed at enhancing the inde- pendence of older persons. The unifying theme of the Yale OAIC remains the investigat...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Thomas Michael Gill

YALE UNIVERSITY, NEW HAVEN, CT

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,323,421

FY 2025

Project Title

Claude D. Pepper Older Americans Independence Center at Yale

Grant Number:

5P30AG021342-23

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2002

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The overarching objective of the Yale Older Americans Independence Center (OAIC), established in 1992, is to provide intellectual leadership and innovation for aging research that is directed at enhancing the inde- pendence of older persons. The unifying theme of the Yale OAIC remains the investigat...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Christopher Hooper Goss

SEATTLE CHILDREN'S HOSPITAL, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,313,622

FY 2025

Project Title

Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

Grant Number:

2P30DK089507-16

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/7/2010

End Date:

5/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

This P30 Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) is located at the University of Washington School of Medicine (UWSOM) and its affiliated institution, Seattle Children’s Research Institute (SCRI). This proposal updates our already robust P30 center program, with a large b...

Research Terms

<0-11 years old><21+ years old><Adult><Adult Human><Aging><Area><B9 endocrine pancreas><Back><Basic Research><Basic Science><Biological><Biometrics><Biometry><Biostatistics><CF mice><CF mouse model><CF patients><CF related diabetes><CFTR><CFTR Protein><Caring><Center for Translational Science Activities><Child><Child Youth><Children (0-21)><Chronic><Clinical><Clinical Research><Clinical Study><Collaborations><Country><Creativeness><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><Data><Development><Disease><Disorder><Doctor of Philosophy><Dorsum><Dysfunction><Endocrine Pancreas><Exocrine pancreas><FDA approved><Functional disorder><Funding><Future><GI microbiome><Generalized Growth><Genetic><Genomics><Genotype><Germ-Free><Goals><Grant><Growth><Health><History><Industry><Infant><Inflammation><Informatics><Infrastructure><Institution><International><Intestinal Diseases><Intestinal Disorder><Investigators><Islands of Langerhans><Islets of Langerhans><Kidney><Kidney Diseases><Kidney Urinary System><Laboratories><Leadership><Liver><Measures><Medicine><Mentors><Metabolic><Methods><Microbiology><Mucoviscidosis><NIDDK><National Institute of Diabetes and Digestive and Kidney Diseases><Nephropathy><Nesidioblasts><Nutrition><Nutritional><Observation research><Observation study><Observational Study><Observational research><Organ><Outcome Measure><Pancreatic Islets><Pars endocrina pancreatis><Pathogenesis><Patients><Pediatrics><Persons><Ph.D.><PhD><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Play><Population><Process><Recording of previous events><Renal Disease><Research><Research Design><Research Institute><Research Personnel><Research Resources><Research Specimen><Researchers><Resources><Scholars Program><Schools><Science><Scientist><Sight><Specimen><Statistical Methods><Strategic vision><Study Type><Symptoms><Testing><Tissue Growth><Toddler><Training><Translational Research><Translational Science><Universities><Update><Vision><Washington><Work><adulthood><associate faculty><associate professor><base><bases><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><biologic><care burden><clinical effect><clinical implementation><clinical phenotype><clinical translation><clinically translatable><colon carcinogenesis><colorectal cancer risk><colorectal carcinogenesis><comparative><creativity><cystic fibrosis mouse><cystic fibrosis mouse model><cystic fibrosis patients><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><design><designing><developmental><digestive tract microbiome><disease risk><disorder risk><dissemination research><drug development><enteric microbiome><exocrine pancreatic><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><hepatic body system><hepatic organ system><histories><improved><individuals with CF><individuals with cystic fibrosis><infancy><infantile><innovate><innovation><innovative><interest><intestinal biome><intestinal microbiome><intestine disease><intestine disorder><kidney disorder><kids><life span><lifespan><measurable outcome><medical college><medical schools><member><mid-career faculty><midcareer faculty><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutics><new therapy><new therapy approaches><new treatment approach><new treatment strategy><next generation><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutics><novel therapy><novel therapy approach><nutritious><ontogeny><outcome measurement><pathophysiology><patients with CF><patients with cystic fibrosis><placebo group><professor><programs><renal><renal disorder><school of medicine><sham group><statistic methods><study design><success><translation research><translational investigation><translational pipeline><translational research center><translational sciences center><translational spectrum><treatment effect><visual function><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lucas R Hoffman

SEATTLE CHILDREN'S HOSPITAL, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,313,622

FY 2025

Project Title

Center for Cystic Fibrosis Translational Research in the Post-CFTR modulator Era

Grant Number:

2P30DK089507-16

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/7/2010

End Date:

5/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

This P30 Cystic Fibrosis (CF) Research and Translational Core Center (CFRTC) is located at the University of Washington School of Medicine (UWSOM) and its affiliated institution, Seattle Children’s Research Institute (SCRI). This proposal updates our already robust P30 center program, with a large b...

Research Terms

<0-11 years old><21+ years old><Adult><Adult Human><Aging><Area><B9 endocrine pancreas><Back><Basic Research><Basic Science><Biological><Biometrics><Biometry><Biostatistics><CF mice><CF mouse model><CF patients><CF related diabetes><CFTR><CFTR Protein><Caring><Center for Translational Science Activities><Child><Child Youth><Children (0-21)><Chronic><Clinical><Clinical Research><Clinical Study><Collaborations><Country><Creativeness><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><Data><Development><Disease><Disorder><Doctor of Philosophy><Dorsum><Dysfunction><Endocrine Pancreas><Exocrine pancreas><FDA approved><Functional disorder><Funding><Future><GI microbiome><Generalized Growth><Genetic><Genomics><Genotype><Germ-Free><Goals><Grant><Growth><Health><History><Industry><Infant><Inflammation><Informatics><Infrastructure><Institution><International><Intestinal Diseases><Intestinal Disorder><Investigators><Islands of Langerhans><Islets of Langerhans><Kidney><Kidney Diseases><Kidney Urinary System><Laboratories><Leadership><Liver><Measures><Medicine><Mentors><Metabolic><Methods><Microbiology><Mucoviscidosis><NIDDK><National Institute of Diabetes and Digestive and Kidney Diseases><Nephropathy><Nesidioblasts><Nutrition><Nutritional><Observation research><Observation study><Observational Study><Observational research><Organ><Outcome Measure><Pancreatic Islets><Pars endocrina pancreatis><Pathogenesis><Patients><Pediatrics><Persons><Ph.D.><PhD><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Play><Population><Process><Recording of previous events><Renal Disease><Research><Research Design><Research Institute><Research Personnel><Research Resources><Research Specimen><Researchers><Resources><Scholars Program><Schools><Science><Scientist><Sight><Specimen><Statistical Methods><Strategic vision><Study Type><Symptoms><Testing><Tissue Growth><Toddler><Training><Translational Research><Translational Science><Universities><Update><Vision><Washington><Work><adulthood><associate faculty><associate professor><base><bases><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><biologic><care burden><clinical effect><clinical implementation><clinical phenotype><clinical translation><clinically translatable><colon carcinogenesis><colorectal cancer risk><colorectal carcinogenesis><comparative><creativity><cystic fibrosis mouse><cystic fibrosis mouse model><cystic fibrosis patients><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><design><designing><developmental><digestive tract microbiome><disease risk><disorder risk><dissemination research><drug development><enteric microbiome><exocrine pancreatic><gastrointestinal microbiome><gut microbiome><gut-associated microbiome><hepatic body system><hepatic organ system><histories><improved><individuals with CF><individuals with cystic fibrosis><infancy><infantile><innovate><innovation><innovative><interest><intestinal biome><intestinal microbiome><intestine disease><intestine disorder><kidney disorder><kids><life span><lifespan><measurable outcome><medical college><medical schools><member><mid-career faculty><midcareer faculty><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutic approach><new therapeutic intervention><new therapeutic strategies><new therapeutics><new therapy><new therapy approaches><new treatment approach><new treatment strategy><next generation><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutic approach><novel therapeutic intervention><novel therapeutic strategies><novel therapeutics><novel therapy><novel therapy approach><nutritious><ontogeny><outcome measurement><pathophysiology><patients with CF><patients with cystic fibrosis><placebo group><professor><programs><renal><renal disorder><school of medicine><sham group><statistic methods><study design><success><translation research><translational investigation><translational pipeline><translational research center><translational sciences center><translational spectrum><treatment effect><visual function><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David J. Marcinek

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,294,617

FY 2025

Project Title

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)

Grant Number:

2P30AG013280-31

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/15/1997

End Date:

5/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – PROJECT SUMMARY We propose this renewal application for the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (UW NSC). The UW NSC has been a leader in providing innovative resources and expertise to the geroscience community for over 30 years. The pr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jessica Elaine Young

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,294,617

FY 2025

Project Title

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)

Grant Number:

2P30AG013280-31

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/15/1997

End Date:

5/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

OVERALL – PROJECT SUMMARY We propose this renewal application for the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging (UW NSC). The UW NSC has been a leader in providing innovative resources and expertise to the geroscience community for over 30 years. The pr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DEAN R MADDEN

DARTMOUTH COLLEGE, HANOVER, NH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,291,515

FY 2025

Project Title

DartCF: The Dartmouth Cystic Fibrosis Research Center

Grant Number:

2P30DK117469-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2018

End Date:

8/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

In cystic fibrosis (CF), mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) unleash a cascade of clinical disorders, including chronic airway infections, systemic inflammation, microbial virulence, diabetes, malnutrition, and kidney and liver disease. Great progress has been...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SARAH J BLOSSOM

UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, ALBUQUERQUE, NM

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,276,227

FY 2025

Project Title

New Mexico Integrative Science Program Incorporating Research in Environmental Sciences (NM-INSPIRES)

Grant Number:

5P30ES032755-04

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/25/2022

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

This NIEHS P30 Core Center will support basic and translational research pertaining to environmentally induced diseases. NM-INSPIRES will engage populations through multi-directional communication and programs. The Center’s theme is Metals, Mining, and Mixtures, and it will support numerous mechanis...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Raouf S. Amin

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,248,906

FY 2025

Project Title

Personalized Cystic Fibrosis Therapy and Research Center

Grant Number:

2P30DK117467-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2018

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

A key component of this P30 application is the ‘Personalized Cystic Fibrosis Model System Core’. The models will include the patient-specific cultures derived from intestinal epithelia (enteroids) and the induced pluripotent stem cells (iPSCs) from myofibroblasts. These patient-specific cultures wil...

Research Terms

<0-11 years old><3-D structure><3-dimensional structure><3D structure><Address><Affect><Applications Grants><Assay><Bedside Testings><Bioassay><Biologic Models><Biological><Biological Assay><Biological Models><Biology><Body System><Body Tissues><CF patients><CFTR><CFTR Protein><California><Cell Culture Techniques><Cell Line><CellLine><Center Core Grants><Child><Child Youth><Childhood><Children (0-21)><Chloride Channels><Chloride Ion Channels><Clinical><Clinical Trials><Complement><Complement Proteins><Complex><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Death Rate><Dedications><Defect><Delta F508 mutation><Development><Disease><Disorder><Dose><Duct><Duct (organ) structure><Embryo><Embryonic><Endoderm><Enteric Nervous System><Epithelium><F508 deletion><F508 mutation><F508-del><F508del><Fluid Balance><Fluid Homeostasis><Fluids and Secretions><Freezing><Funding><GI Stem cell><Gastrointestinal Diseases><Genetic Change><Genetic Diversity><Genetic Variation><Genetic defect><Genetic mutation><Genotype><Goals><Grant Proposals><Health><Human><IRB><IRBs><In Vitro><Individual><Institutional Review Boards><Interdisciplinary Research><Interdisciplinary Study><International><Intestinal><Intestines><Investigators><Medical center><Medicine><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methodology><Methods><Microscopy><Model System><Modeling><Modern Man><Morbidity><Morbidity - disease rate><Motility><Mucoviscidosis><Multidisciplinary Collaboration><Multidisciplinary Research><Mutation><Myofibroblast><NIDDK><Names><Nasal><Nasal Passages Nose><National Institute of Diabetes and Digestive and Kidney Diseases><Nose><Onset of illness><Organ><Organ System><Organogenesis><Organoids><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pancreas><Pancreatic><Pancreatic duct><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pattern><Persons><Phenotype><Predisposition><Progenitor Cells><Regulator Genes><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Respiratory System, Nose, Nasal Passages><Role><Services><Strains Cell Lines><Subgroup><Surface Proteins><Susceptibility><Techniques><Testing><Therapeutic><Therapeutic Intervention><Tissue Engineering><Tissues><Training><Transcriptional Regulatory Elements><Translating><Translational Research><Translational Science><Universities><Wirsung canal><adult progenitor><adult stem cell><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><bioengineered tissue><biologic><bowel><cell culture><cell cultures><clinical investigation><clinical translation><clinically translatable><complementation><cultured cell line><customized therapy><customized treatment><cystic fibrosis patients><cystic fibrosis transmembrane regulator><database of Genotypes and Phenotypes><dbGaP><developmental><directed differentiation><disease onset><disorder onset><early onset><engineered tissue><gastrointestinal><gastrointestinal disorder><gastrointestinal stem cell><gastrointestinal transplantation><genetic trans acting element><genome mutation><gut progenitor><gut stem cell><human derived pluripotent stem cell><human disease><human model><human pluripotent stem cell><human progenitor><human stem cells><iPS><iPSC><iPSC technology><iPSCs><implantation><improved><in vivo><in vivo Model><individual patient><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><individuals with CF><individuals with cystic fibrosis><induced pluripotent cell><induced pluripotent stem cell><induced pluripotent stem cell technology><induced pluripotent stem cells derived from patients><induced pluripotent stem cells from patients><inducible pluripotent cell><inducible pluripotent stem cell><innovate><innovation><innovative><interest><intervention therapy><intestinal epithelium><intestinal progenitor><intestinal stem cells><intestine surgery><intestine transplant><kids><low-frequency mutation><model of human><mortality rate><mortality ratio><mutant><name><named><naming><next generation><novel><patient derived human iPS><patient derived human iPSC><patient derived human induced pluripotent stem cell><patient derived iPS><patient derived iPSC><patient derived induced pluripotent cells><patient derived induced pluripotent stem cells><patient oriented outcomes><patient population><patient specific therapies><patient specific treatment><patient-derived pluripotent stem cells><patients with CF><patients with cystic fibrosis><pediatric><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><rare allele><rare mutation><rare variant><regulatory gene><social role><somatic progenitor><somatic stem cell><sound><spheroids><stem cell derived tissues><stem cells><tailored medical treatment><tailored therapy><tailored treatment><three dimensional structure><trans acting element><translation research><translational investigation><unique treatment><youngster><ΔF508>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MICHAEL A. HELMRATH

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,248,906

FY 2025

Project Title

Personalized Cystic Fibrosis Therapy and Research Center

Grant Number:

2P30DK117467-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2018

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

A key component of this P30 application is the ‘Personalized Cystic Fibrosis Model System Core’. The models will include the patient-specific cultures derived from intestinal epithelia (enteroids) and the induced pluripotent stem cells (iPSCs) from myofibroblasts. These patient-specific cultures wil...

Research Terms

<0-11 years old><3-D structure><3-dimensional structure><3D structure><Address><Affect><Applications Grants><Assay><Bedside Testings><Bioassay><Biologic Models><Biological><Biological Assay><Biological Models><Biology><Body System><Body Tissues><CF patients><CFTR><CFTR Protein><California><Cell Culture Techniques><Cell Line><CellLine><Center Core Grants><Child><Child Youth><Childhood><Children (0-21)><Chloride Channels><Chloride Ion Channels><Clinical><Clinical Trials><Complement><Complement Proteins><Complex><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Death Rate><Dedications><Defect><Delta F508 mutation><Development><Disease><Disorder><Dose><Duct><Duct (organ) structure><Embryo><Embryonic><Endoderm><Enteric Nervous System><Epithelium><F508 deletion><F508 mutation><F508-del><F508del><Fluid Balance><Fluid Homeostasis><Fluids and Secretions><Freezing><Funding><GI Stem cell><Gastrointestinal Diseases><Genetic Change><Genetic Diversity><Genetic Variation><Genetic defect><Genetic mutation><Genotype><Goals><Grant Proposals><Health><Human><IRB><IRBs><In Vitro><Individual><Institutional Review Boards><Interdisciplinary Research><Interdisciplinary Study><International><Intestinal><Intestines><Investigators><Medical center><Medicine><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methodology><Methods><Microscopy><Model System><Modeling><Modern Man><Morbidity><Morbidity - disease rate><Motility><Mucoviscidosis><Multidisciplinary Collaboration><Multidisciplinary Research><Mutation><Myofibroblast><NIDDK><Names><Nasal><Nasal Passages Nose><National Institute of Diabetes and Digestive and Kidney Diseases><Nose><Onset of illness><Organ><Organ System><Organogenesis><Organoids><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pancreas><Pancreatic><Pancreatic duct><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pattern><Persons><Phenotype><Predisposition><Progenitor Cells><Regulator Genes><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Respiratory System, Nose, Nasal Passages><Role><Services><Strains Cell Lines><Subgroup><Surface Proteins><Susceptibility><Techniques><Testing><Therapeutic><Therapeutic Intervention><Tissue Engineering><Tissues><Training><Transcriptional Regulatory Elements><Translating><Translational Research><Translational Science><Universities><Wirsung canal><adult progenitor><adult stem cell><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><bioengineered tissue><biologic><bowel><cell culture><cell cultures><clinical investigation><clinical translation><clinically translatable><complementation><cultured cell line><customized therapy><customized treatment><cystic fibrosis patients><cystic fibrosis transmembrane regulator><database of Genotypes and Phenotypes><dbGaP><developmental><directed differentiation><disease onset><disorder onset><early onset><engineered tissue><gastrointestinal><gastrointestinal disorder><gastrointestinal stem cell><gastrointestinal transplantation><genetic trans acting element><genome mutation><gut progenitor><gut stem cell><human derived pluripotent stem cell><human disease><human model><human pluripotent stem cell><human progenitor><human stem cells><iPS><iPSC><iPSC technology><iPSCs><implantation><improved><in vivo><in vivo Model><individual patient><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><individuals with CF><individuals with cystic fibrosis><induced pluripotent cell><induced pluripotent stem cell><induced pluripotent stem cell technology><induced pluripotent stem cells derived from patients><induced pluripotent stem cells from patients><inducible pluripotent cell><inducible pluripotent stem cell><innovate><innovation><innovative><interest><intervention therapy><intestinal epithelium><intestinal progenitor><intestinal stem cells><intestine surgery><intestine transplant><kids><low-frequency mutation><model of human><mortality rate><mortality ratio><mutant><name><named><naming><next generation><novel><patient derived human iPS><patient derived human iPSC><patient derived human induced pluripotent stem cell><patient derived iPS><patient derived iPSC><patient derived induced pluripotent cells><patient derived induced pluripotent stem cells><patient oriented outcomes><patient population><patient specific therapies><patient specific treatment><patient-derived pluripotent stem cells><patients with CF><patients with cystic fibrosis><pediatric><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><rare allele><rare mutation><rare variant><regulatory gene><social role><somatic progenitor><somatic stem cell><sound><spheroids><stem cell derived tissues><stem cells><tailored medical treatment><tailored therapy><tailored treatment><three dimensional structure><trans acting element><translation research><translational investigation><unique treatment><youngster><ΔF508>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anjaparavanda P Naren

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,248,906

FY 2025

Project Title

Personalized Cystic Fibrosis Therapy and Research Center

Grant Number:

2P30DK117467-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2018

End Date:

8/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

A key component of this P30 application is the ‘Personalized Cystic Fibrosis Model System Core’. The models will include the patient-specific cultures derived from intestinal epithelia (enteroids) and the induced pluripotent stem cells (iPSCs) from myofibroblasts. These patient-specific cultures wil...

Research Terms

<0-11 years old><3-D structure><3-dimensional structure><3D structure><Address><Affect><Applications Grants><Assay><Bedside Testings><Bioassay><Biologic Models><Biological><Biological Assay><Biological Models><Biology><Body System><Body Tissues><CF patients><CFTR><CFTR Protein><California><Cell Culture Techniques><Cell Line><CellLine><Center Core Grants><Child><Child Youth><Childhood><Children (0-21)><Chloride Channels><Chloride Ion Channels><Clinical><Clinical Trials><Complement><Complement Proteins><Complex><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Death Rate><Dedications><Defect><Delta F508 mutation><Development><Disease><Disorder><Dose><Duct><Duct (organ) structure><Embryo><Embryonic><Endoderm><Enteric Nervous System><Epithelium><F508 deletion><F508 mutation><F508-del><F508del><Fluid Balance><Fluid Homeostasis><Fluids and Secretions><Freezing><Funding><GI Stem cell><Gastrointestinal Diseases><Genetic Change><Genetic Diversity><Genetic Variation><Genetic defect><Genetic mutation><Genotype><Goals><Grant Proposals><Health><Human><IRB><IRBs><In Vitro><Individual><Institutional Review Boards><Interdisciplinary Research><Interdisciplinary Study><International><Intestinal><Intestines><Investigators><Medical center><Medicine><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methodology><Methods><Microscopy><Model System><Modeling><Modern Man><Morbidity><Morbidity - disease rate><Motility><Mucoviscidosis><Multidisciplinary Collaboration><Multidisciplinary Research><Mutation><Myofibroblast><NIDDK><Names><Nasal><Nasal Passages Nose><National Institute of Diabetes and Digestive and Kidney Diseases><Nose><Onset of illness><Organ><Organ System><Organogenesis><Organoids><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pancreas><Pancreatic><Pancreatic duct><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pattern><Persons><Phenotype><Predisposition><Progenitor Cells><Regulator Genes><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Respiratory System, Nose, Nasal Passages><Role><Services><Strains Cell Lines><Subgroup><Surface Proteins><Susceptibility><Techniques><Testing><Therapeutic><Therapeutic Intervention><Tissue Engineering><Tissues><Training><Transcriptional Regulatory Elements><Translating><Translational Research><Translational Science><Universities><Wirsung canal><adult progenitor><adult stem cell><bench bed side><bench bedside><bench to bed side><bench to bedside><bench to clinic><bench to clinical practice><bioengineered tissue><biologic><bowel><cell culture><cell cultures><clinical investigation><clinical translation><clinically translatable><complementation><cultured cell line><customized therapy><customized treatment><cystic fibrosis patients><cystic fibrosis transmembrane regulator><database of Genotypes and Phenotypes><dbGaP><developmental><directed differentiation><disease onset><disorder onset><early onset><engineered tissue><gastrointestinal><gastrointestinal disorder><gastrointestinal stem cell><gastrointestinal transplantation><genetic trans acting element><genome mutation><gut progenitor><gut stem cell><human derived pluripotent stem cell><human disease><human model><human pluripotent stem cell><human progenitor><human stem cells><iPS><iPSC><iPSC technology><iPSCs><implantation><improved><in vivo><in vivo Model><individual patient><individualized medicine><individualized patient treatment><individualized therapeutic strategy><individualized therapy><individualized treatment><individuals with CF><individuals with cystic fibrosis><induced pluripotent cell><induced pluripotent stem cell><induced pluripotent stem cell technology><induced pluripotent stem cells derived from patients><induced pluripotent stem cells from patients><inducible pluripotent cell><inducible pluripotent stem cell><innovate><innovation><innovative><interest><intervention therapy><intestinal epithelium><intestinal progenitor><intestinal stem cells><intestine surgery><intestine transplant><kids><low-frequency mutation><model of human><mortality rate><mortality ratio><mutant><name><named><naming><next generation><novel><patient derived human iPS><patient derived human iPSC><patient derived human induced pluripotent stem cell><patient derived iPS><patient derived iPSC><patient derived induced pluripotent cells><patient derived induced pluripotent stem cells><patient oriented outcomes><patient population><patient specific therapies><patient specific treatment><patient-derived pluripotent stem cells><patients with CF><patients with cystic fibrosis><pediatric><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><rare allele><rare mutation><rare variant><regulatory gene><social role><somatic progenitor><somatic stem cell><sound><spheroids><stem cell derived tissues><stem cells><tailored medical treatment><tailored therapy><tailored treatment><three dimensional structure><trans acting element><translation research><translational investigation><unique treatment><youngster><ΔF508>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anthony W Ferrante

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,221,081

FY 2025

Project Title

New York Obesity Research Center

Grant Number:

5P30DK026687-45

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

12/1/1996

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The New York Obesity Nutrition Research Center (NYNORC) has as its primary aim to convene and support - by its Core Services, Pilot & Feasibility and Enrichment programs - funded investigators at Columbia University and the Albert Einstein College of Medicine studying obesity. The themes for this Ce...

Research Terms

<0-4 weeks old><Achievement><Achievement Attainment><Advisory Committees><Ally><Animals><Approaches to prevention><Area><Award><Back><Basic Research><Basic Science><Behavior><Behavioral><Bile Acids><Biology><Biomedical Research><Body Composition><Causality><Cell Therapy><Center Core Grants><Clinical><Clinical Evaluation><Clinical Investigator><Clinical Testing><Collaborations><Communities><Core Facility><Creativeness><DNA Molecular Biology><Defense Mechanisms><Development><Diabetes Mellitus><Direct Costs><Disease><Disorder><Dorsum><Dysfunction><Eating><Elements><Environment><Etiology><Fatty Liver><Food Intake><Food Intake Regulation><Fostering><Foundations><Functional disorder><Funding><Funding Agency><Funding Source><Genes><Goals><Grant><History><Human><Individual><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigation><Investigators><Laboratories><Liver Steatosis><Manuscripts><Mediation><Medical center><Medicine><Mentors><Metabolic><Modern Man><Molecular Biology><Molecular Genetics><Monitor><Multidisciplinary Collaboration><Multidisciplinary Research><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Negotiating><Negotiation><Nerve Cells><Nerve Unit><Neural Cell><Neurobiology><Neurocyte><Neurons><Neurosciences><New York><Newborn Infant><Newborns><Nutrient><Nutrition><Nutrition Research><Nutritional><Nutritional Study><Obesity><P30 Award><P30 Grant><P30 Mechanism><P30 Program><P50 Mechanism><P50 Program><Pathogenesis><Pathology><Patients><Peer Review><Pharmaceutical Agent><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Pilot Projects><Preventative strategy><Prevention><Prevention approach><Prevention strategy><Preventive strategy><Productivity><Progenitor Cells><Publishing><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Regulation><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Risk-associated variant><Role><Science><Scientist><Series><Services><Specialized Center><Task Forces><Techniques><Training><Translational Research><Translational Research Enterprise><Translational Science><United States National Institutes of Health><Universities><Weight><Weight Gain><Weight Increase><adiposity><advisory team><application in practice><base><bases><body weight gain><body weight increase><causation><cell based intervention><cell mediated intervention><cell mediated therapies><cell-based therapeutic><cell-based therapy><cellular therapeutic><cellular therapy><child adiposity><child obesity><childhood adiposity><childhood obesity><clinical care><clinical test><co-morbid><co-morbidity><college><collegiate><comorbidity><corpulence><creativity><design><designing><developmental><diabetes><disease causation><dosage><hepatic steatosis><hepatosteatosis><histories><innovate><innovation><innovative><insight><instrument><interdisciplinary collaboration><interest><investigator training><knowledge base><member><neurobiological><neuronal><newborn child><newborn children><next generation><novel><nutritious><obese children><obesity development><obesity during childhood><obesity in children><obesity intervention><obesity therapy><obesity treatment><pathophysiology><pediatric obesity><pharmaceutical><pilot study><practical application><preference><programs><psychological defense mechanism><research clinical testing><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><skills><social role><stem cells><sugar><tool><transdisciplinary collaboration><translation research><translation research enterprise><translational investigation><translational research program><treatment strategy><weights><wt gain>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DYMPNA GALLAGHER

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,221,081

FY 2025

Project Title

New York Obesity Research Center

Grant Number:

5P30DK026687-45

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

12/1/1996

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

The New York Obesity Nutrition Research Center (NYNORC) has as its primary aim to convene and support - by its Core Services, Pilot & Feasibility and Enrichment programs - funded investigators at Columbia University and the Albert Einstein College of Medicine studying obesity. The themes for this Ce...

Research Terms

<0-4 weeks old><Achievement><Achievement Attainment><Advisory Committees><Ally><Animals><Approaches to prevention><Area><Award><Back><Basic Research><Basic Science><Behavior><Behavioral><Bile Acids><Biology><Biomedical Research><Body Composition><Causality><Cell Therapy><Center Core Grants><Clinical><Clinical Evaluation><Clinical Investigator><Clinical Testing><Collaborations><Communities><Core Facility><Creativeness><DNA Molecular Biology><Defense Mechanisms><Development><Diabetes Mellitus><Direct Costs><Disease><Disorder><Dorsum><Dysfunction><Eating><Elements><Environment><Etiology><Fatty Liver><Food Intake><Food Intake Regulation><Fostering><Foundations><Functional disorder><Funding><Funding Agency><Funding Source><Genes><Goals><Grant><History><Human><Individual><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigation><Investigators><Laboratories><Liver Steatosis><Manuscripts><Mediation><Medical center><Medicine><Mentors><Metabolic><Modern Man><Molecular Biology><Molecular Genetics><Monitor><Multidisciplinary Collaboration><Multidisciplinary Research><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Negotiating><Negotiation><Nerve Cells><Nerve Unit><Neural Cell><Neurobiology><Neurocyte><Neurons><Neurosciences><New York><Newborn Infant><Newborns><Nutrient><Nutrition><Nutrition Research><Nutritional><Nutritional Study><Obesity><P30 Award><P30 Grant><P30 Mechanism><P30 Program><P50 Mechanism><P50 Program><Pathogenesis><Pathology><Patients><Peer Review><Pharmaceutical Agent><Pharmaceuticals><Pharmacologic Substance><Pharmacological Substance><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Pilot Projects><Preventative strategy><Prevention><Prevention approach><Prevention strategy><Preventive strategy><Productivity><Progenitor Cells><Publishing><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Regulation><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Risk-associated variant><Role><Science><Scientist><Series><Services><Specialized Center><Task Forces><Techniques><Training><Translational Research><Translational Research Enterprise><Translational Science><United States National Institutes of Health><Universities><Weight><Weight Gain><Weight Increase><adiposity><advisory team><application in practice><base><bases><body weight gain><body weight increase><causation><cell based intervention><cell mediated intervention><cell mediated therapies><cell-based therapeutic><cell-based therapy><cellular therapeutic><cellular therapy><child adiposity><child obesity><childhood adiposity><childhood obesity><clinical care><clinical test><co-morbid><co-morbidity><college><collegiate><comorbidity><corpulence><creativity><design><designing><developmental><diabetes><disease causation><dosage><hepatic steatosis><hepatosteatosis><histories><innovate><innovation><innovative><insight><instrument><interdisciplinary collaboration><interest><investigator training><knowledge base><member><neurobiological><neuronal><newborn child><newborn children><next generation><novel><nutritious><obese children><obesity development><obesity during childhood><obesity in children><obesity intervention><obesity therapy><obesity treatment><pathophysiology><pediatric obesity><pharmaceutical><pilot study><practical application><preference><programs><psychological defense mechanism><research clinical testing><risk allele><risk gene><risk genotype><risk loci><risk locus><risk variant><skills><social role><stem cells><sugar><tool><transdisciplinary collaboration><translation research><translation research enterprise><translational investigation><translational research program><treatment strategy><weights><wt gain>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tanvi Bhatt

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,189,610

FY 2025

Project Title

Midwest Roybal Center for Health Promotion and Translation

Grant Number:

5P30AG022849-22

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2003

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Our proposed UIC Midwest Roybal Center for Health Promotion and Translation seeks to accelerate the translation of behavioral research interventions into practical outcomes to improve the functioning (cognitive and physical) and quality of life of older adults at risk of Alzheimer’s Disease and Alzh...

Research Terms

<21+ years old><AD dementia><AD related dementia><ADRD><Acceleration><Acute><Address><Adult><Adult Human><Advisory Committees><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimers Dementia><Area><Behavior><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Mechanisms><Behavioral Modification><Behavioral Research><Behavioral Therapy><Behavioral Treatment><Center Core Grants><Clinical Trials><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive aging><Cognitive decline><Cognitive function abnormal><Collaborations><Committee Members><Communities><Conditioning Therapy><Development><Diet><Disturbance in cognition><Evaluation><Faculty><Family><Fostering><Funding><Goals><Grant><Health><Health Care Systems><Health Promotion><Health behavior><Illinois><Image><Impaired cognition><Individual><Infrastructure><Intervention><Investigators><Knowledge><Life Style><Lifestyle><Maintenance><Mechanisms of Behavior and Behavior Change><Memory><Methodology><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Modeling><Monitor><NIH><National Institutes of Health><Neighborhoods><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Performance><Phase><Physical activity><Population><Primary Senile Degenerative Dementia><Process><Program Development><Provider><Public Health><QOL><Qualifying><Quality of life><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Risk><Risk Factors><Risk Reduction><Salutogenesis><Science><Sedentary behavior><Sedentary life-style><Specific qualifier value><Specified><Task Forces><Technology><Testing><Translations><United States National Institutes of Health><Universities><Work><adulthood><advisory team><alzheimer risk><behavior change><behavior intervention><behavior mechanism><behavioral intervention><brain health><cognitive dysfunction><cognitive enhancement><cognitive function><cognitive loss><design><designing><develop therapy><developmental><diets><disability><ethnic minority><experience><functional improvement><health related behavior><imaging><implementation research><implementation science><improve function><improved><improved functional outcomes><intervention delivery><intervention design><intervention development><multi-modality><multimodality><older adult><older adulthood><operation><operations><phase 2 study><phase II study><physical conditioning><physical health><practical implementation><pragmatic implementation><primary degenerative dementia><programs><promoting health><racial minority><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and methods><risk-reducing><sedentary lifestyle><senile dementia of the Alzheimer type><sound><statistics><stress reduction><theories><therapy design><therapy development><translation><translational progress><translational progression><treatment design><treatment development>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID X MARQUEZ

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,189,610

FY 2025

Project Title

Midwest Roybal Center for Health Promotion and Translation

Grant Number:

5P30AG022849-22

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2003

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Our proposed UIC Midwest Roybal Center for Health Promotion and Translation seeks to accelerate the translation of behavioral research interventions into practical outcomes to improve the functioning (cognitive and physical) and quality of life of older adults at risk of Alzheimer’s Disease and Alzh...

Research Terms

<21+ years old><AD dementia><AD related dementia><ADRD><Acceleration><Acute><Address><Adult><Adult Human><Advisory Committees><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer risk factor><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimer's disease risk><Alzheimers Dementia><Area><Behavior><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Mechanisms><Behavioral Modification><Behavioral Research><Behavioral Therapy><Behavioral Treatment><Center Core Grants><Clinical Trials><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive aging><Cognitive decline><Cognitive function abnormal><Collaborations><Committee Members><Communities><Conditioning Therapy><Development><Diet><Disturbance in cognition><Evaluation><Faculty><Family><Fostering><Funding><Goals><Grant><Health><Health Care Systems><Health Promotion><Health behavior><Illinois><Image><Impaired cognition><Individual><Infrastructure><Intervention><Investigators><Knowledge><Life Style><Lifestyle><Maintenance><Mechanisms of Behavior and Behavior Change><Memory><Methodology><Midwest><Midwest U.S.><Midwest US><Midwestern United States><Minority><Mission><Modeling><Monitor><NIH><National Institutes of Health><Neighborhoods><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Performance><Phase><Physical activity><Population><Primary Senile Degenerative Dementia><Process><Program Development><Provider><Public Health><QOL><Qualifying><Quality of life><Research><Research Methodology><Research Methods><Research Personnel><Researchers><Risk><Risk Factors><Risk Reduction><Salutogenesis><Science><Sedentary behavior><Sedentary life-style><Specific qualifier value><Specified><Task Forces><Technology><Testing><Translations><United States National Institutes of Health><Universities><Work><adulthood><advisory team><alzheimer risk><behavior change><behavior intervention><behavior mechanism><behavioral intervention><brain health><cognitive dysfunction><cognitive enhancement><cognitive function><cognitive loss><design><designing><develop therapy><developmental><diets><disability><ethnic minority><experience><functional improvement><health related behavior><imaging><implementation research><implementation science><improve function><improved><improved functional outcomes><intervention delivery><intervention design><intervention development><multi-modality><multimodality><older adult><older adulthood><operation><operations><phase 2 study><phase II study><physical conditioning><physical health><practical implementation><pragmatic implementation><primary degenerative dementia><programs><promoting health><racial minority><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><research and methods><risk-reducing><sedentary lifestyle><senile dementia of the Alzheimer type><sound><statistics><stress reduction><theories><therapy design><therapy development><translation><translational progress><translational progression><treatment design><treatment development>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Amy Leanne Ryan

UNIVERSITY OF IOWA, IOWA CITY, IA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,166,250

FY 2025

Project Title

Precision Medicine Center for Cystic Fibrosis

Grant Number:

2P30DK054759-26

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/1998

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT (PRECISION MEDICINE CENTER FOR CF – OVERALL) For the past 25 years, the P30 Center for Gene Therapy of CF has concentrated on advancing CF treatments through enhanced understanding of disease mechanisms, identifying key targets for gene and cell manipulation, and developing ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Brian R. Davis

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,113,750

FY 2025

Project Title

UAB CF Research and Translation Core Center

Grant Number:

5P30DK072482-19

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/2007

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT The UAB P30 Research and Translation Core Center consolidates a large number of externally funded cystic fibrosis (CF) research programs on our campus, building an innovative environment to pursue, advance, and train in CF-related science. During the last funding period, the...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Aina E. Cohen

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,001,289

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

3P30GM133894-06S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary/Abstract - P30GM133894 Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchrotron Structural Biology Resource" at the Stanford Synchrotron Radiation Lightsource (SSRL) is to prov...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KEITH O HODGSON

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,001,289

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

3P30GM133894-06S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary/Abstract - P30GM133894 Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchrotron Structural Biology Resource" at the Stanford Synchrotron Radiation Lightsource (SSRL) is to prov...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Ritimukta Sarangi

STANFORD UNIVERSITY, STANFORD, CA

Good lead · 68/100

Likely hiring

Large award

Active award

Team-scale grant

$1,001,289

FY 2025

Project Title

A Synchrotron Radiation Structural Biology Resource

Grant Number:

3P30GM133894-06S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/2020

End Date:

2/28/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Large budget suggests more room for personnel or project growth.

Project Abstract

Summary/Abstract - P30GM133894 Synchrotron radiation (SR) is an extremely bright and tunable x-ray source that enables forefront research in structural molecular biology (SMB). The goal of “A Synchrotron Structural Biology Resource" at the Stanford Synchrotron Radiation Lightsource (SSRL) is to prov...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kate E Keller

OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, OR

Good lead · 68/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$624,000

FY 2026

Project Title

Ophthalmology Core Facility

Grant Number:

5P30EY010572-32

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/1/1997

End Date:

1/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL CORE PROJECT SUMMARY This P30 Ophthalmology Core Facility provides ongoing support for NEI-funded Oregon Health and Science University (OHSU) and Casey Eye Institute vision researchers. The four resource cores are: Bioimaging & Confocal Microscopy; Gene Expression & Manipulation; Proteomics;...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LAURA J. FRISHMAN

UNIVERSITY OF HOUSTON, HOUSTON, TX

Good lead · 68/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$620,000

FY 2026

Project Title

Center Core Grant for Vision Research

Grant Number:

5P30EY007551-39

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/1/1997

End Date:

12/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The NEI P30 Center Core Grant for Vision Research at the University of Houston (UH) provides ongoing and stable funding for four high quality and productive vision research resource/service Modules: Instrument Design, Research Computer Programming, Biostatistics Support, and Biological Imaging. Thes...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bradley Pearce Ander

UNIVERSITY OF CALIFORNIA AT DAVIS, DAVIS, CA

Good lead · 66/100

Likely hiring

Above-average budget

Recent

Active award

$642,100

FY 2026

Project Title

Whole Transcriptome Studies of Blood to Predict Stroke Outcome

Grant Number:

5R01NS127976-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2023

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Abstract Several clinical variables are associated with outcomes following ischemic stroke (IS). However, clinical and demographic parameters account only for a portion of the outcome variance, thus it is difficult for clinicians to reliably predict long-term IS outcome. Hence, new biomarkers are n...

Research Terms

<(TNF)-α><3-D><3-Dimensional><3D><AMPA Receptors><Age><Amphoterin><Amphoterin Gene><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Apoplexy><Atrial Fibrillation><Auricular Fibrillation><B-Cell Differentiation Factor Gene><B-Cell Stimulatory Factor 2 Gene><BDNF><BSF-2 Gene><BSF2 Gene><Beta-2 Gene Interferon><Biological Markers><Biology><Blood><Blood Neutrophil><Blood Platelet Count><Blood Platelet Number><Blood Platelets><Blood Polymorphonuclear Neutrophil><Blood Pressure><Blood Reticuloendothelial System><Blood leukocyte><Blood monocyte><Brain><Brain Nervous System><Brain Vascular Accident><Brain-Derived Neurotrophic Factor><C-reactive protein><CD61><CD61 Antigens><COX-2><COX2><CSIF><CSIF-10><Cachectin><Causality><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Clinical><Clinical Trials><Clotting><Coagulation><Coagulation Process><Cytochrome P-450><Cytochrome P-450 Enzyme System><Cytochrome P450><Cytochrome P450 Family Gene><Cytokine Synthesis Inhibitory Factor><D-Glucose><Data><Derivation><Derivation procedure><Dextrose><Diabetes Mellitus><Encephalon><Engineering><Environment><Etiology><Expression Signature><FM1 Gene Product><Future><GP IIIa><GP3A><GPIIIa><Gene Expression><Gene Expression Profile><Genes><Genetic Markers><Genetic predisposing factor><Genome><Glucose><Growth Agents><Growth Factor><Growth Substances><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HSF Gene><Heat shock proteins><Hemoglobin concentration result><Heparin-Binding Protein p30><Hepatocyte Stimulatory Factor Gene><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Human><Hybridoma Growth Factor Gene><Hyperlipemia><Hyperlipidemia><IFNB2 Gene><IL-1><IL-10><IL-6 Gene><IL1><IL10><IL10A><IL6><IL6 gene><ITGB3><ITGB3 gene><Immune><Immunes><Infection><Inflammatory><Integrin Beta 3><Integrin beta3><Integrin β3><Interleukin 10 Precursor><Interleukin 6 (Interferon, Beta 2) Gene><Interleukin I><Interleukin-1><Interleukin-10><Interleukin-6 Gene><Ischemic Stroke><Knowledge><Leukocytes><Leukocytes Reticuloendothelial System><Life Style><Lifestyle><Light><Location><Logistic Regressions><Lymphocyte Count><Lymphocyte Number><Lymphocyte-Stimulating Hormone><Machine Learning><Macrophage Cell Factor><Macrophage-Derived TNF><Marrow Neutrophil><Marrow leukocyte><Marrow monocyte><Marrow platelet><Measures><Modern Man><Molecular><Monocyte-Derived TNF><NAIT><NIH><National Institutes of Health><Network Analysis><Neurologic><Neurological><Neutrophilic Granulocyte><Neutrophilic Leukocyte><Non-Polyadenylated RNA><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Outcome><Outcome Measure><P450><PARK2><PARK2 gene><PGHS-2><PHS-2><PTGS2><PTGS2 gene><PTP gene><Parkinson disease 2 gene><Pathway Analysis><Pathway interactions><Patients><Pattern><Phosphatases><Phosphohydrolases><Phosphomonoesterases><Phosphoric Monoester Hydrolases><Photoradiation><Platelet Count><Platelet Count measurement><Platelet Fibrinogen Receptor, Beta Subunit><Platelet GPIIIa><Platelet Glycoprotein IIIa><Platelet Membrane Glycoprotein IIIa><Platelet Number><Platelets><Polymorphonuclear Cell><Polymorphonuclear Leukocytes><Polymorphonuclear Neutrophils><Prognosis><Proteins><Proteins Growth Factors><Proteins, specific or class, C-reactive><RNA><RNA Gene Products><RNA Seq><RNA sequencing><RNAseq><Recovery><Regulator Genes><Ribonucleic Acid><SBP-1><SBP-1 Gene><Sensitivity and Specificity><Severities><Stroke><Stroke Volume><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><System><T Helper Factor><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Thrombocytes><Total Lymphocyte Count><Transcriptional Regulatory Elements><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><United States National Institutes of Health><Validation><White Blood Cells><White Cell><after stroke><ages><bio-markers><biologic marker><biomarker><brain attack><causation><cerebral vascular accident><cerebrovascular accident><cohort><cytokine><diabetes><disease causation><entire genome><full genome><functional outcomes><gene biomarker><gene expression biomarker><gene expression pattern><gene expression signature><gene marker><gene network><gene signature biomarker><genetic biomarker><genetic risk factor><genetic trans acting element><global gene expression><global transcription profile><hCOX-2><hemoglobin level><improved><indexing><inherited factor><kidney dysfunction><lymphocyte activating factor><machine based learning><machine learned algorithm><machine learning algorithm><machine learning based algorithm><machine learning based prediction model><machine learning based predictive model><machine learning prediction><machine learning prediction model><measurable outcome><molecular biomarker><molecular marker><monocyte><neurofilament><neuronal excitability><neutrophil><outcome measurement><outcome prediction><pathway><patient stratification><peripheral blood><post stroke><poststroke><presynaptic><regulatory gene><renal dysfunction><repair><repaired><response><sex><statistics><stratified patient><stress protein><stroke outcome><stroke patient><stroked><strokes><success><support vector machine><three dimensional><trans acting element><transcriptional profile><transcriptional signature><transcriptome><transcriptome sequencing><transcriptomic sequencing><validations><vascular risk factor><white blood cell><white blood corpuscle><whole genome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Boryana Stamova

UNIVERSITY OF CALIFORNIA AT DAVIS, DAVIS, CA

Good lead · 66/100

Likely hiring

Above-average budget

Recent

Active award

$642,100

FY 2026

Project Title

Whole Transcriptome Studies of Blood to Predict Stroke Outcome

Grant Number:

5R01NS127976-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2023

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Abstract Several clinical variables are associated with outcomes following ischemic stroke (IS). However, clinical and demographic parameters account only for a portion of the outcome variance, thus it is difficult for clinicians to reliably predict long-term IS outcome. Hence, new biomarkers are n...

Research Terms

<(TNF)-α><3-D><3-Dimensional><3D><AMPA Receptors><Age><Amphoterin><Amphoterin Gene><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Apoplexy><Atrial Fibrillation><Auricular Fibrillation><B-Cell Differentiation Factor Gene><B-Cell Stimulatory Factor 2 Gene><BDNF><BSF-2 Gene><BSF2 Gene><Beta-2 Gene Interferon><Biological Markers><Biology><Blood><Blood Neutrophil><Blood Platelet Count><Blood Platelet Number><Blood Platelets><Blood Polymorphonuclear Neutrophil><Blood Pressure><Blood Reticuloendothelial System><Blood leukocyte><Blood monocyte><Brain><Brain Nervous System><Brain Vascular Accident><Brain-Derived Neurotrophic Factor><C-reactive protein><CD61><CD61 Antigens><COX-2><COX2><CSIF><CSIF-10><Cachectin><Causality><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Clinical><Clinical Trials><Clotting><Coagulation><Coagulation Process><Cytochrome P-450><Cytochrome P-450 Enzyme System><Cytochrome P450><Cytochrome P450 Family Gene><Cytokine Synthesis Inhibitory Factor><D-Glucose><Data><Derivation><Derivation procedure><Dextrose><Diabetes Mellitus><Encephalon><Engineering><Environment><Etiology><Expression Signature><FM1 Gene Product><Future><GP IIIa><GP3A><GPIIIa><Gene Expression><Gene Expression Profile><Genes><Genetic Markers><Genetic predisposing factor><Genome><Glucose><Growth Agents><Growth Factor><Growth Substances><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HSF Gene><Heat shock proteins><Hemoglobin concentration result><Heparin-Binding Protein p30><Hepatocyte Stimulatory Factor Gene><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Human><Hybridoma Growth Factor Gene><Hyperlipemia><Hyperlipidemia><IFNB2 Gene><IL-1><IL-10><IL-6 Gene><IL1><IL10><IL10A><IL6><IL6 gene><ITGB3><ITGB3 gene><Immune><Immunes><Infection><Inflammatory><Integrin Beta 3><Integrin beta3><Integrin β3><Interleukin 10 Precursor><Interleukin 6 (Interferon, Beta 2) Gene><Interleukin I><Interleukin-1><Interleukin-10><Interleukin-6 Gene><Ischemic Stroke><Knowledge><Leukocytes><Leukocytes Reticuloendothelial System><Life Style><Lifestyle><Light><Location><Logistic Regressions><Lymphocyte Count><Lymphocyte Number><Lymphocyte-Stimulating Hormone><Machine Learning><Macrophage Cell Factor><Macrophage-Derived TNF><Marrow Neutrophil><Marrow leukocyte><Marrow monocyte><Marrow platelet><Measures><Modern Man><Molecular><Monocyte-Derived TNF><NAIT><NIH><National Institutes of Health><Network Analysis><Neurologic><Neurological><Neutrophilic Granulocyte><Neutrophilic Leukocyte><Non-Polyadenylated RNA><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Outcome><Outcome Measure><P450><PARK2><PARK2 gene><PGHS-2><PHS-2><PTGS2><PTGS2 gene><PTP gene><Parkinson disease 2 gene><Pathway Analysis><Pathway interactions><Patients><Pattern><Phosphatases><Phosphohydrolases><Phosphomonoesterases><Phosphoric Monoester Hydrolases><Photoradiation><Platelet Count><Platelet Count measurement><Platelet Fibrinogen Receptor, Beta Subunit><Platelet GPIIIa><Platelet Glycoprotein IIIa><Platelet Membrane Glycoprotein IIIa><Platelet Number><Platelets><Polymorphonuclear Cell><Polymorphonuclear Leukocytes><Polymorphonuclear Neutrophils><Prognosis><Proteins><Proteins Growth Factors><Proteins, specific or class, C-reactive><RNA><RNA Gene Products><RNA Seq><RNA sequencing><RNAseq><Recovery><Regulator Genes><Ribonucleic Acid><SBP-1><SBP-1 Gene><Sensitivity and Specificity><Severities><Stroke><Stroke Volume><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><System><T Helper Factor><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Thrombocytes><Total Lymphocyte Count><Transcriptional Regulatory Elements><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><United States National Institutes of Health><Validation><White Blood Cells><White Cell><after stroke><ages><bio-markers><biologic marker><biomarker><brain attack><causation><cerebral vascular accident><cerebrovascular accident><cohort><cytokine><diabetes><disease causation><entire genome><full genome><functional outcomes><gene biomarker><gene expression biomarker><gene expression pattern><gene expression signature><gene marker><gene network><gene signature biomarker><genetic biomarker><genetic risk factor><genetic trans acting element><global gene expression><global transcription profile><hCOX-2><hemoglobin level><improved><indexing><inherited factor><kidney dysfunction><lymphocyte activating factor><machine based learning><machine learned algorithm><machine learning algorithm><machine learning based algorithm><machine learning based prediction model><machine learning based predictive model><machine learning prediction><machine learning prediction model><measurable outcome><molecular biomarker><molecular marker><monocyte><neurofilament><neuronal excitability><neutrophil><outcome measurement><outcome prediction><pathway><patient stratification><peripheral blood><post stroke><poststroke><presynaptic><regulatory gene><renal dysfunction><repair><repaired><response><sex><statistics><stratified patient><stress protein><stroke outcome><stroke patient><stroked><strokes><success><support vector machine><three dimensional><trans acting element><transcriptional profile><transcriptional signature><transcriptome><transcriptome sequencing><transcriptomic sequencing><validations><vascular risk factor><white blood cell><white blood corpuscle><whole genome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SURENDRA SHARMA

UNIVERSITY OF TEXAS MED BR GALVESTON, GALVESTON, TX

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$485,838

FY 2026

Project Title

Targeting proteinopathy/tauopathy and impaired autophagy for mechanistic understanding and therapeutic intervention of preeclampsia

Grant Number:

5R01HD110408-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2024

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

SUMMARY Preeclampsia (PE) is a leading cause of maternal and fetal morbidity and mortality and complicates 3-8% of all pregnancies. This pregnancy complication is defined by de novo hypertension arising after 20 weeks of gestation and near term with proteinuria or other signs of end-organ damage. PE...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Edward M. Schwarz

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Good lead · 66/100

Likely hiring

Solid budget

Recent

Active award

$461,978

FY 2026

Project Title

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)

Grant Number:

5P30AR069655-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

1/1/2022

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

This is a proposal to sustain the University of Rochester Resource-based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) Program. ROCSTARR is comprised of an Administrative Core that will run the Enrichment Program, and will coordinate and integrate the Histology, Biochemistry and Molecu...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Denes V. Agoston

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LISA D COLES

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dominique Duncan

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Aristea S Galanopoulou

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ANDREY M MAZARATI

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Terence John O'Brien

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Richard Staba

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Good lead · 66/100

Likely hiring

Solid budget

Very recent

Active award

$312,762

FY 2026

Project Title

Translational Platform for Epilepsy Therapy and Biomarker Discovery

Grant Number:

3R01NS127524-05S1

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2022

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY There is currently no validated treatment to prevent the development of acquired epilepsies, such as post- traumatic epilepsy. The availability of biomarker that predicts, at an early stage, people at risk to develop epilepsy and benefit from treatment interventions would significant...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Luciano C. Greig

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 66/100

Training-friendly

Solid budget

Very recent

Active award

$255,340

FY 2026

Project Title

Development and regeneration of retinal ganglion cells in the vertebrate retina

Grant Number:

1K08EY038342-01

Activity Code:

K08

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/1/2026

End Date:

4/30/2031

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary/Abstract Vision loss is a devastating medical problem as it can lead to reduced productivity, lower quality of life, and loss of independence. Glaucoma affects over four million Americans and 76.0 million people worldwide, making it the second leading cause of irreversible blindness ...

Research Terms

<21+ years old><Adult><Adult Human><Advisory Committees><Affect><Alleles><Allelomorphs><Amacrine Cells><American><Axon><Basal Transcription Factor><Basal transcription factor genes><Blindness><Brachydanio rerio><Brain><Brain Nervous System><CNS Nervous System><Candidate Disease Gene><Candidate Gene><Cell Body><Cell Differentiation><Cell Differentiation process><Cell Survival><Cell Viability><Cells><Cellular Morphology><Central Nervous System><Chemotactic Cytokines><Collaborations><Communities><Cone><Core Facility><Cranial Nerve II><Cranial Nerve II Diseases><Cranial Nerve II Disorder><Danio rerio><Data><Dedications><Degenerative Neurologic Disorders><Development><Diminished Vision><Disease><Disease Progression><Disorder><Drug Therapy><Elderly><Electrophysiology><Electrophysiology (science)><Electroporation><Encephalon><Eye><Eyeball><Funding><Gene Abnormality><Gene Deletion><Gene Expression><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Generations><Genetic Transcription><Genome><Glaucoma><Goals><Grant><High Prevalence><High Throughput Assay><Homologous Chemotactic Cytokines><Human><Inflammatory><Injury><Intercrines><Intraocular Pressure><KO mice><Knock-out Mice><Knockout Mice><Knowledge><Label><Laboratories><Laser Electromagnetic><Laser Radiation><Lasers><Learning><Low Vision><Mediating><Medical><Mentors><Mice><Mice Mammals><Mitotic Activity><Modeling><Modern Man><Monitor><Morphology><Muller glia><Muller's cell><Murine><Mus><Müller cell><Müller glia><Natural regeneration><Nerve Cells><Nerve Degeneration><Nerve Unit><Nervous System Degenerative Diseases><Neural Cell><Neural Degenerative Diseases><Neural Inhibition><Neural degenerative Disorders><Neural-Optical Lesion><Neuraxis><Neurites><Neurocyte><Neurodegenerative Diseases><Neurodegenerative Disorders><Neurologic Degenerative Conditions><Neuron Degeneration><Neurons><Neurophysiology / Electrophysiology><Neurosciences><Null Mouse><Ocular Tension><Operative Procedures><Operative Surgical Procedures><Ophthalmology><Optic Nerve><Optic Nerve Diseases><Optic Neuropathy><Partial Sight><Pathway interactions><Patients><Persons><Pharmacological Treatment><Pharmacotherapy><Physiologic Intraocular Pressure><Position><Positioning Attribute><Process><Production><Productivity><Progenitor Cells><QOL><Quality of life><RNA Expression><Reduced Vision><Regeneration><Regenerative capacity><Reporter><Research><Research Resources><Resources><Retina><Retinal Ganglion Cells><Role><SIS cytokines><Second Cranial Nerve><Second Cranial Nerve Diseases><Secondary to><Stem Cell Research><Subnormal Vision><Surgical><Surgical Interventions><Surgical Procedure><Synapses><Synaptic><Task Forces><Techniques><Therapeutic Intervention><Training><Transcription><Transcription Factor Proto-Oncogene><Transcription factor genes><Transfection><Universities><Vertebrate Animals><Vertebrates><Visual impairment><Work><Zebra Danio><Zebra Fish><Zebrafish><adaptive optics><adulthood><advanced age><advisory team><axon regeneration><axonal regeneration><candidate selection><career><career development><cell morphology><cell type><cellular differentiation><chemoattractant cytokine><chemokine><degenerative diseases of motor and sensory neurons><degenerative neurological diseases><developmental><drug intervention><drug treatment><electrophysiological><electroporative delivery><experience><experiment><experimental research><experimental study><experiments><gain of function><gene deletion mutation><gene electrotransfer><gene regulatory network><geriatric><glaucoma surgery><glaucomatous><high throughput screening><in vivo><injuries><innovate><innovation><innovative><insight><intervention therapy><intra-ocular pressure><longitudinal imaging><loss of function><medical attention><member><mouse model><multipotency><multipotent><murine model><nerve cell death><nerve cell loss><neural degeneration><neurodegeneration><neurodegenerative><neurodegenerative illness><neurogenesis><neurological degeneration><neuron cell death><neuron cell loss><neuron death><neuron loss><neuronal><neuronal cell death><neuronal cell loss><neuronal circuit><neuronal circuitry><neuronal death><neuronal degeneration><neuronal loss><optic nerve disorder><pathway><pharmaceutical intervention><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><plasmid DNA><postmitotic><postnatal><prevent><preventing><progenitor><progenitor cell based therapy><progenitor cell proliferation><progenitor cell therapy><progenitor cell treatment><progenitor proliferation><progenitor therapy><progenitor treatment><programs><recruit><regenerate><regeneration ability><regeneration capacity><regenerative><retinal ganglion><retinal ganglion cell degeneration><retinal ganglion cell regeneration><retinal progenitor><retinal progenitor cell><retinal regeneration><retinal stem cell><scRNA sequencing><scRNA-seq><screening><screenings><second cranial nerve disorder><senior citizen><serial imaging><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><stem and progenitor cell proliferation><stem and progenitor cell therapy><stem cell based therapy><stem cell mediated therapy><stem cell proliferation><stem cell study><stem cell therapeutics><stem cell therapy><stem cell treatment><stem cell-based therapeutic><stem cell-based treatment><stem cells><success><surgery><synapse><transcription factor><vertebrata><vision impairment><vision loss><vision science><visual loss><visual science><visually impaired>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NAEL A MCCARTY

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$969,135

FY 2025

Project Title

Georgia Cystic Fibrosis Research and Translation Core Center

Grant Number:

5P30DK125013-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2020

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

– Overall Component This proposal seeks to continue the Georgia Cystic Fibrosis Research and Translation Core Center (the Georgia CF Core Center) at Emory University, Children’s Healthcare of Atlanta, Augusta University, and the Georgia Institute of Technology. Funded with partial budget in 2020, th...

Research Terms

<0-11 years old><Address><Aging><American><Autoregulation><Basic Research><Basic Science><Behavior><Behavioral><Biomedical Research><Bone Diseases><Budgets><CF related diabetes><CFTR><CFTR Protein><Center Core Grants><Child><Child Youth><Children (0-21)><Clinical><Clinical Informatics><Clinical Research><Clinical Study><Collaborations><Communities><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><Data><Development><Diabetes Mellitus><Diet><Disease><Disease Progression><Disorder><Dysfunction><Endocrinology><Ensure><Environment><Ethnic Origin><Ethnicity><European><Exercise><Functional disorder><Funding><Genetic Diseases><Goals><Health><Hepatic Disorder><Hepatology><Homeostasis><Informatics><Institution><Investigators><Knowledge><Length of Life><Life Style><Lifestyle><Link><Liver diseases><Longevity><Longitudinal Studies><Metabolic><Metabolism and Endocrinology><Mission><Molecular><Mucoviscidosis><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Nutrition><Nutritional><Nutritional status><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Patients><Persons><Phenotype><Physiological Homeostasis><Physiopathology><Population><Preventative intervention><R-Series Research Projects><R01 Mechanism><R01 Program><Ramp><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resources><Science><Scientist><Sleep><Technology><Therapeutic><Toddler><Translations><United States National Institutes of Health><Universities><base><bases><bone disorder><child health care><co-morbid><co-morbidity><comorbidity><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><data integration><data warehouse><developmental><diabetes><diets><gastrointestinal><genetic condition><genetic disorder><glucose metabolism><hepatic disease><hepatopathy><innovate><innovation><innovative><intervention for prevention><kids><liver disorder><long-term study><longitudinal outcome studies><member><mutant><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><nutritious><pandemic><pandemic disease><pathophysiology><pediatric care><pediatric health care><prevention intervention><preventional intervention strategy><preventive intervention><programs><success><translation><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Arlene A Stecenko

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$969,135

FY 2025

Project Title

Georgia Cystic Fibrosis Research and Translation Core Center

Grant Number:

5P30DK125013-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2020

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

– Overall Component This proposal seeks to continue the Georgia Cystic Fibrosis Research and Translation Core Center (the Georgia CF Core Center) at Emory University, Children’s Healthcare of Atlanta, Augusta University, and the Georgia Institute of Technology. Funded with partial budget in 2020, th...

Research Terms

<0-11 years old><Address><Aging><American><Autoregulation><Basic Research><Basic Science><Behavior><Behavioral><Biomedical Research><Bone Diseases><Budgets><CF related diabetes><CFTR><CFTR Protein><Center Core Grants><Child><Child Youth><Children (0-21)><Clinical><Clinical Informatics><Clinical Research><Clinical Study><Collaborations><Communities><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><Data><Development><Diabetes Mellitus><Diet><Disease><Disease Progression><Disorder><Dysfunction><Endocrinology><Ensure><Environment><Ethnic Origin><Ethnicity><European><Exercise><Functional disorder><Funding><Genetic Diseases><Goals><Health><Hepatic Disorder><Hepatology><Homeostasis><Informatics><Institution><Investigators><Knowledge><Length of Life><Life Style><Lifestyle><Link><Liver diseases><Longevity><Longitudinal Studies><Metabolic><Metabolism and Endocrinology><Mission><Molecular><Mucoviscidosis><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Nutrition><Nutritional><Nutritional status><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Patients><Persons><Phenotype><Physiological Homeostasis><Physiopathology><Population><Preventative intervention><R-Series Research Projects><R01 Mechanism><R01 Program><Ramp><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resources><Science><Scientist><Sleep><Technology><Therapeutic><Toddler><Translations><United States National Institutes of Health><Universities><base><bases><bone disorder><child health care><co-morbid><co-morbidity><comorbidity><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><data integration><data warehouse><developmental><diabetes><diets><gastrointestinal><genetic condition><genetic disorder><glucose metabolism><hepatic disease><hepatopathy><innovate><innovation><innovative><intervention for prevention><kids><liver disorder><long-term study><longitudinal outcome studies><member><mutant><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><nutritious><pandemic><pandemic disease><pathophysiology><pediatric care><pediatric health care><prevention intervention><preventional intervention strategy><preventive intervention><programs><success><translation><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LOUIS J SOSLOWSKY

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$805,757

FY 2025

Project Title

Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)

Grant Number:

5P30AR069619-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/2016

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Penn Center for Musculoskeletal Disorders (PCMD) will continue to provide critical resources and programs to, and enhance research productivity of, investigators to address multidisciplinary research strategies for musculoskeletal problems. The overall goal of this Center is to promote cooperati...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vadim Y Arshavsky

DUKE UNIVERSITY, DURHAM, NC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$805,000

FY 2025

Project Title

Center Core Grant for Vision Research

Grant Number:

5P30EY005722-40

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/1/1997

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Component Abstract NEI-supported investigators from Duke University request continuing support for a Center Core Grant for Vision Research. Research areas covered by this group range from basic mechanisms of cellular function to functional organization of neuronal circuits, with particular i...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Patricia Ann D'Amore

SCHEPENS EYE RESEARCH INSTITUTE, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$803,878

FY 2025

Project Title

Core Grant for Vision Research

Grant Number:

5P30EY003790-44

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/1997

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Core Project Summary/Abstract Funds are requested to support four modules that facilitate the research of and and enhance interaction among the investigators of at least 20 NEI-funded R01 grants. The modules will expand and enrich the activities of individual research programs by providing t...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Peter A Nigrovic

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$803,723

FY 2025

Project Title

Joint Biology Consortium Resource-based Center

Grant Number:

5P30AR070253-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/11/2016

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Breaking down barriers to translational research is the key to finding new approaches to inflammatory arthritis and related diseases in adults and children. Four years ago, with P30 support, we built the Joint Biology Consortium (JBC), a shared infrastructure based at the Brigham and Women’s Hospita...

Research Terms

<0-11 years old><21+ years old><ATAC sequencing><ATAC-seq><ATACseq><Acceleration><Adult><Adult Human><Ally><Antigens><Archives><Arthritis><Assay for Transposase-Accessible Chromatin using sequencing><Award><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biology><Biometrics><Biometry><Biostatistics><Body Tissues><Boston><CITE sequencing><CITE-seq><CITEseq><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><Cellular Indexing of Transcriptomes and Epitopes by Sequencing><Child><Child Youth><Childhood><Children (0-21)><Children's Hospital><Communities><Consent><Consultations><Country><Custom><Cytometry><Data><Dedications><Disease><Disorder><Education><Educational aspects><Electronic Health Record><Environment><Feasibility Studies><Fostering><Genotype><Grant><Health><Heart><Hospitals><Human><Individual><Inflammatory Arthritis><Infrastructure><Investigators><Investments><Joints><Leadership><Link><Lupus Erythematosus Disseminatus><Medicine><Mentors><Methodology><Methods><Modeling><Modern Man><NGS Method><NGS system><NIAMS><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><Orthopedic><Orthopedic Surgical Profession><Orthopedics><Patients><Pediatric Hospitals><PhIP-seq><Phage ImmunoPrecipitation Sequencing><Phenotype><Pilot Projects><Position><Positioning Attribute><Program Evaluation><Proteins><Publications><Research><Research Personnel><Research Resources><Researchers><Resources><Review Committee><Rheumatology><SLE><Sampling><Scanning><Scientific Publication><Services><Source><System><Systemic Lupus Erythematosus><Systemic Lupus Erythematous><Systemic Lupus Erythmatosus><Techniques><Technology><Tissues><Translational Research><Translational Science><United States><Update><Visit><Woman><Work><adulthood><analytical tool><arthritic><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><barrier to translation><biobank><biorepository><career><cellular indexing of transcriptomes and epitopes by single cell sequencing><clinical investigation><clustered regularly interspaced short palindromic repeats screen><cohort><consultation><customs><design><designing><disseminated lupus erythematosus><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><immunogen><innovate><innovation><innovative><interest><internet portal><kids><life span><lifespan><meeting><meetings><member><new approaches><next gen sequencing><next generation sequencing><nextgen sequencing><novel approaches><novel strategies><novel strategy><obstacle to translation><on-line portal><online portal><operation><operations><pediatric><pilot study><professor><programs><prospective><recruit><sample collection><scRNA sequencing><scRNA-seq><service delivery><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><specimen collection><statistical service><success><synergism><systemic lupus erythematosis><tool><translation barrier><translation obstacle><translation research><translational barrier><translational investigation><translational investigator><translational obstacle><translational researcher><translational scientist><web portal><web-based portal><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jeffrey Andrew Sparks

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$803,723

FY 2025

Project Title

Joint Biology Consortium Resource-based Center

Grant Number:

5P30AR070253-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/11/2016

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Breaking down barriers to translational research is the key to finding new approaches to inflammatory arthritis and related diseases in adults and children. Four years ago, with P30 support, we built the Joint Biology Consortium (JBC), a shared infrastructure based at the Brigham and Women’s Hospita...

Research Terms

<0-11 years old><21+ years old><ATAC sequencing><ATAC-seq><ATACseq><Acceleration><Adult><Adult Human><Ally><Antigens><Archives><Arthritis><Assay for Transposase-Accessible Chromatin using sequencing><Award><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biology><Biometrics><Biometry><Biostatistics><Body Tissues><Boston><CITE sequencing><CITE-seq><CITEseq><CRISPR editing screen><CRISPR screen><CRISPR-based screen><CRISPR/Cas9 screen><Cellular Indexing of Transcriptomes and Epitopes by Sequencing><Child><Child Youth><Childhood><Children (0-21)><Children's Hospital><Communities><Consent><Consultations><Country><Custom><Cytometry><Data><Dedications><Disease><Disorder><Education><Educational aspects><Electronic Health Record><Environment><Feasibility Studies><Fostering><Genotype><Grant><Health><Heart><Hospitals><Human><Individual><Inflammatory Arthritis><Infrastructure><Investigators><Investments><Joints><Leadership><Link><Lupus Erythematosus Disseminatus><Medicine><Mentors><Methodology><Methods><Modeling><Modern Man><NGS Method><NGS system><NIAMS><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><Orthopedic><Orthopedic Surgical Profession><Orthopedics><Patients><Pediatric Hospitals><PhIP-seq><Phage ImmunoPrecipitation Sequencing><Phenotype><Pilot Projects><Position><Positioning Attribute><Program Evaluation><Proteins><Publications><Research><Research Personnel><Research Resources><Researchers><Resources><Review Committee><Rheumatology><SLE><Sampling><Scanning><Scientific Publication><Services><Source><System><Systemic Lupus Erythematosus><Systemic Lupus Erythematous><Systemic Lupus Erythmatosus><Techniques><Technology><Tissues><Translational Research><Translational Science><United States><Update><Visit><Woman><Work><adulthood><analytical tool><arthritic><assay for transposase accessible chromatin followed by sequencing><assay for transposase accessible chromatin seq><assay for transposase accessible chromatin sequencing><assay for transposase-accessible chromatin with sequencing><barrier to translation><biobank><biorepository><career><cellular indexing of transcriptomes and epitopes by single cell sequencing><clinical investigation><clustered regularly interspaced short palindromic repeats screen><cohort><consultation><customs><design><designing><disseminated lupus erythematosus><electronic health care record><electronic health medical record><electronic health plan record><electronic health registry><electronic medical health record><immunogen><innovate><innovation><innovative><interest><internet portal><kids><life span><lifespan><meeting><meetings><member><new approaches><next gen sequencing><next generation sequencing><nextgen sequencing><novel approaches><novel strategies><novel strategy><obstacle to translation><on-line portal><online portal><operation><operations><pediatric><pilot study><professor><programs><prospective><recruit><sample collection><scRNA sequencing><scRNA-seq><service delivery><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><specimen collection><statistical service><success><synergism><systemic lupus erythematosis><tool><translation barrier><translation obstacle><translation research><translational barrier><translational investigation><translational investigator><translational obstacle><translational researcher><translational scientist><web portal><web-based portal><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SCOTT M. LYNCH

DUKE UNIVERSITY, DURHAM, NC

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$790,488

FY 2025

Project Title

Center for Population Health and Aging

Grant Number:

2P30AG034424-16

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

7/15/2009

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall PROJECT SUMMARY/ABSTRACT The Duke Center for Population Health and Aging (CPHA) will continue to support an interdisciplinary environment to develop faculty in aging research and to foster important scientific scholarship within our three themes, which include (1) the biodemography and bioso...

Research Terms

<0-11 years old><21+ years old><Acceleration><Address><Administrator><Adult><Adult Children><Adult Daughters><Adult Human><Adult Offspring><Adult Sons><Affect><Age><Aging><Area><Attention><Award><Behavioral><Biologic Factor><Biological><Biological Factors><Biological Markers><Biosocial><Business-Friendly Atmosphere><Centers for Population Health><Cessation of life><Child><Child Youth><Childhood><Children (0-21)><Chronic><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Communication><Communities><Data><Data Collection><Death><Demographer><Demography><Development><Discipline><Disease><Disorder><Disparate><Disparities><Disparity><Disturbance in cognition><E-Mail><EXTMR><Economics><Educational workshop><Electronic Mail><Email><Encapsulated><Ensure><Event><Exposure to><Extramural><Extramural Activities><Faculty><Faculty Recruitment><Feedback><Fostering><Funding><Generalized Growth><Generations><Genetic><Genomics><Goals><Grant><Growth><Health><Health Disparities Research><Health Inequity><Health disparities related research><Human><Impaired cognition><Individual><Inequalities in Health><Inequality><Inequities in Health><Infrastructure><Institution><Investigators><Knowledge><Length of Life><Life><Life Cycle><Life Cycle Stages><Longevity><Math><Mathematics><Medical><Mentors><Mentorship><Modern Man><North Carolina><Parents><Peer Review><Personal Satisfaction><Pilot Projects><Play><Policies><Population><Postdoc><Postdoctoral Fellow><Professional Organizations><Reporting><Research><Research Associate><Research Personnel><Research Resources><Research Support><Researchers><Resources><Role><Rural><SES disparity><Scholarship><Science><Series><Services><Sociology><Statistical Methods><Students><Tissue Growth><Training><Transmission><Universities><Work><Workshop><adulthood><aged group><aged groups><aged individual><aged individuals><aged people><aged person><aged persons><aged population><aged populations><ages><aging associated><aging demography><aging population><aging related><bio-markers><biodemography><biologic><biologic marker><biomarker><business-friendly environment><care giving><caregiving><cognitive dysfunction><cognitive loss><collaborative atmosphere><collaborative environment><design><designing><developmental><disparity in health><economic><electronic communication><graduate student><health disparities science><health disparity><health inequalities><healthy aging><healthy human aging><improved><in utero><innovate><innovation><innovative><inter-institutional><interactive atmosphere><interactive environment><interdisciplinary atmosphere><interdisciplinary environment><intergenerational><kids><life course><life span><lifespan><news><next generation><non-human primate><nonhuman primate><offspring><ontogeny><parent><pediatric><peer-group atmosphere><peer-group environment><pilot study><podcast><population aging><population health><post-doc><post-doctoral><post-doctoral trainee><professional association><professional membership><professional society><programs><psychologic><psychological><recruit><recruit teachers><research associates><research into practice><research to practice><rural health disparities><social><social disadvantage><social disparities><social factors><social inequality><social media><social role><socio-economic disparity><socio-economic inequality><socio-economic inequity><socioeconomic disparity><socioeconomic inequality><socioeconomic inequity><statistic methods><teacher recruitment><transmission process><web site><website><well-being><wellbeing><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jennifer Michelle Davis

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$788,834

FY 2025

Project Title

UW Center for Translational Muscle Research

Grant Number:

5P30AR074990-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/5/2019

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT - OVERALL The University of Washington (UW) Center for Translational Muscle Research (CTMR) will continue to provide critical resources and programs to enhance productivity of investigators to address multi-scale and multidisciplinary research of muscle disease and treatment strategies. Ou...

Research Terms

<0-11 years old><Acceleration><Address><Advocate><Affect><Aging><Animal Model><Animal Models and Related Studies><Applications Grants><Area><Assay><Award><Basic Research><Basic Science><Bioassay><Biological Assay><Biology><Biomechanics><Body Tissues><Canada><Cancer Center><Cancers><Cell Body><Cell Respiration><Cells><Cellular Respiration><Center for Cancer Research><Child><Child Youth><Children (0-21)><Children's Hospital><Clinic><Clinical><Clinical Faculty><Clinical Investigator><Clinical Nurse Educator><Clinical Research><Clinical Study><Collaborations><Communities><Computational toolkit><Connective Tissue><Core Facility><Data><Development><Development and Research><Device or Instrument Development><Devices><Diabetes Mellitus><Discipline><Disease><Disorder><Dysfunction><EXTMR><Education><Education and Training><Educational aspects><Educational workshop><Engineering><Environment><Europe><Exercise><Extramural><Extramural Activities><Faculty><Functional disorder><Funding><Genetic Diseases><Genomics><Goals><Grant Proposals><Health Status><History><Home><Hospitals><Human><Image><Individual><Infrastructure><Injury><Institution><Interdisciplinary Research><Interdisciplinary Study><Intermediary Metabolism><International><Investigators><Length><Level of Health><Malignant Neoplasms><Malignant Tumor><Measurement><Measures><Mechanics><Mentorship><Metabolic><Metabolic Processes><Metabolism><Mission><Mitochondria><Modeling><Modern Man><Movement><Multidisciplinary Collaboration><Multidisciplinary Research><Multiscale Mechanics><Muscle><Muscle Disease><Muscle Disorders><Muscle Tissue><Muscular Diseases><Muscular Dystrophies><Myodystrophica><Myodystrophy><Myopathic Conditions><Myopathic Diseases and Syndromes><Myopathic disease or syndrome><Myopathy><NCI Center for Cancer Research><Neuromuscular research><Nurse Educator><Nursing Faculty><Nursing Staff Developer><Nursing Staff Development Specialist><Organ><Organelles><Pathologic><Pathology><Patient-Centered Care><Pediatric Hospitals><Peripheral><Physicians><Physiopathology><Population><Productivity><Proteins><Proteomics><Public Health><QOL><Quality of life><R & D><R&D><Recording of previous events><Research><Research Personnel><Research Resources><Research Training><Researchers><Resources><Scientist><Series><Services><Skeletal Muscle><Speed><Striated Muscles><Structure><Techniques><Technology><Testing><Therapeutic Agents><Time><Tissues><Training><Training and Education><Translational Research><Translational Science><United States><Universities><Viral Vector><Voluntary Muscle><Washington><Work><Workshop><aerobic metabolism><aerobic respiration><age associated><age correlated><age dependent><age linked><age related><age specific><aged muscle><aging of muscle><analytical tool><biomechanical><body movement><bone><computational toolbox><computational tools><computational toolset><computerized tools><conference><convention><cost effective><developmental><device development><diabetes><disease mechanisms study><early-career faculty><experience><genetic condition><genetic disorder><health level><high reward><high risk><histories><homes><human progenitor><human stem cells><imaging><improved><injuries><innovate><innovation><innovative><insight><instrument development><instrumentation><interdisciplinary approach><interest><kids><malignancy><mechanic><mechanical><metabolism measurement><metabolomics><metabonomics><mitochondrial><model of animal><multi-scale mechanics><multidisciplinary><multidisciplinary approach><muscle aging><muscle dystrophy><muscle system><muscular><muscular disorder><muscular system><neoplasm/cancer><neuromuscular plasticity><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><news><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><outreach><oxidative metabolism><pathophysiology><progenitor biology><progenitor cell biology><progenitor cell model><progenitor model><programs><recruit><research and development><research faculty><sarcopenia><sarcopenic><skill acquisition><skill development><skills training><stem and progenitor biology><stem and progenitor cell model><stem cell based model><stem cell biology><stem cell derived model><stem cell model><success><summit><symposia><symposium><therapeutic agent development><therapeutic development><therapeutic target><tool><tool development><translation research><translational investigation><treatment research><treatment strategy><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DANIEL RAFTERY

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$788,834

FY 2025

Project Title

UW Center for Translational Muscle Research

Grant Number:

5P30AR074990-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/5/2019

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT - OVERALL The University of Washington (UW) Center for Translational Muscle Research (CTMR) will continue to provide critical resources and programs to enhance productivity of investigators to address multi-scale and multidisciplinary research of muscle disease and treatment strategies. Ou...

Research Terms

<0-11 years old><Acceleration><Address><Advocate><Affect><Aging><Animal Model><Animal Models and Related Studies><Applications Grants><Area><Assay><Award><Basic Research><Basic Science><Bioassay><Biological Assay><Biology><Biomechanics><Body Tissues><Canada><Cancer Center><Cancers><Cell Body><Cell Respiration><Cells><Cellular Respiration><Center for Cancer Research><Child><Child Youth><Children (0-21)><Children's Hospital><Clinic><Clinical><Clinical Faculty><Clinical Investigator><Clinical Nurse Educator><Clinical Research><Clinical Study><Collaborations><Communities><Computational toolkit><Connective Tissue><Core Facility><Data><Development><Development and Research><Device or Instrument Development><Devices><Diabetes Mellitus><Discipline><Disease><Disorder><Dysfunction><EXTMR><Education><Education and Training><Educational aspects><Educational workshop><Engineering><Environment><Europe><Exercise><Extramural><Extramural Activities><Faculty><Functional disorder><Funding><Genetic Diseases><Genomics><Goals><Grant Proposals><Health Status><History><Home><Hospitals><Human><Image><Individual><Infrastructure><Injury><Institution><Interdisciplinary Research><Interdisciplinary Study><Intermediary Metabolism><International><Investigators><Length><Level of Health><Malignant Neoplasms><Malignant Tumor><Measurement><Measures><Mechanics><Mentorship><Metabolic><Metabolic Processes><Metabolism><Mission><Mitochondria><Modeling><Modern Man><Movement><Multidisciplinary Collaboration><Multidisciplinary Research><Multiscale Mechanics><Muscle><Muscle Disease><Muscle Disorders><Muscle Tissue><Muscular Diseases><Muscular Dystrophies><Myodystrophica><Myodystrophy><Myopathic Conditions><Myopathic Diseases and Syndromes><Myopathic disease or syndrome><Myopathy><NCI Center for Cancer Research><Neuromuscular research><Nurse Educator><Nursing Faculty><Nursing Staff Developer><Nursing Staff Development Specialist><Organ><Organelles><Pathologic><Pathology><Patient-Centered Care><Pediatric Hospitals><Peripheral><Physicians><Physiopathology><Population><Productivity><Proteins><Proteomics><Public Health><QOL><Quality of life><R & D><R&D><Recording of previous events><Research><Research Personnel><Research Resources><Research Training><Researchers><Resources><Scientist><Series><Services><Skeletal Muscle><Speed><Striated Muscles><Structure><Techniques><Technology><Testing><Therapeutic Agents><Time><Tissues><Training><Training and Education><Translational Research><Translational Science><United States><Universities><Viral Vector><Voluntary Muscle><Washington><Work><Workshop><aerobic metabolism><aerobic respiration><age associated><age correlated><age dependent><age linked><age related><age specific><aged muscle><aging of muscle><analytical tool><biomechanical><body movement><bone><computational toolbox><computational tools><computational toolset><computerized tools><conference><convention><cost effective><developmental><device development><diabetes><disease mechanisms study><early-career faculty><experience><genetic condition><genetic disorder><health level><high reward><high risk><histories><homes><human progenitor><human stem cells><imaging><improved><injuries><innovate><innovation><innovative><insight><instrument development><instrumentation><interdisciplinary approach><interest><kids><malignancy><mechanic><mechanical><metabolism measurement><metabolomics><metabonomics><mitochondrial><model of animal><multi-scale mechanics><multidisciplinary><multidisciplinary approach><muscle aging><muscle dystrophy><muscle system><muscular><muscular disorder><muscular system><neoplasm/cancer><neuromuscular plasticity><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><news><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><outreach><oxidative metabolism><pathophysiology><progenitor biology><progenitor cell biology><progenitor cell model><progenitor model><programs><recruit><research and development><research faculty><sarcopenia><sarcopenic><skill acquisition><skill development><skills training><stem and progenitor biology><stem and progenitor cell model><stem cell based model><stem cell biology><stem cell derived model><stem cell model><success><summit><symposia><symposium><therapeutic agent development><therapeutic development><therapeutic target><tool><tool development><translation research><translational investigation><treatment research><treatment strategy><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MICHAEL REGNIER

UNIVERSITY OF WASHINGTON, SEATTLE, WA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$788,834

FY 2025

Project Title

UW Center for Translational Muscle Research

Grant Number:

5P30AR074990-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/5/2019

End Date:

3/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT - OVERALL The University of Washington (UW) Center for Translational Muscle Research (CTMR) will continue to provide critical resources and programs to enhance productivity of investigators to address multi-scale and multidisciplinary research of muscle disease and treatment strategies. Ou...

Research Terms

<0-11 years old><Acceleration><Address><Advocate><Affect><Aging><Animal Model><Animal Models and Related Studies><Applications Grants><Area><Assay><Award><Basic Research><Basic Science><Bioassay><Biological Assay><Biology><Biomechanics><Body Tissues><Canada><Cancer Center><Cancers><Cell Body><Cell Respiration><Cells><Cellular Respiration><Center for Cancer Research><Child><Child Youth><Children (0-21)><Children's Hospital><Clinic><Clinical><Clinical Faculty><Clinical Investigator><Clinical Nurse Educator><Clinical Research><Clinical Study><Collaborations><Communities><Computational toolkit><Connective Tissue><Core Facility><Data><Development><Development and Research><Device or Instrument Development><Devices><Diabetes Mellitus><Discipline><Disease><Disorder><Dysfunction><EXTMR><Education><Education and Training><Educational aspects><Educational workshop><Engineering><Environment><Europe><Exercise><Extramural><Extramural Activities><Faculty><Functional disorder><Funding><Genetic Diseases><Genomics><Goals><Grant Proposals><Health Status><History><Home><Hospitals><Human><Image><Individual><Infrastructure><Injury><Institution><Interdisciplinary Research><Interdisciplinary Study><Intermediary Metabolism><International><Investigators><Length><Level of Health><Malignant Neoplasms><Malignant Tumor><Measurement><Measures><Mechanics><Mentorship><Metabolic><Metabolic Processes><Metabolism><Mission><Mitochondria><Modeling><Modern Man><Movement><Multidisciplinary Collaboration><Multidisciplinary Research><Multiscale Mechanics><Muscle><Muscle Disease><Muscle Disorders><Muscle Tissue><Muscular Diseases><Muscular Dystrophies><Myodystrophica><Myodystrophy><Myopathic Conditions><Myopathic Diseases and Syndromes><Myopathic disease or syndrome><Myopathy><NCI Center for Cancer Research><Neuromuscular research><Nurse Educator><Nursing Faculty><Nursing Staff Developer><Nursing Staff Development Specialist><Organ><Organelles><Pathologic><Pathology><Patient-Centered Care><Pediatric Hospitals><Peripheral><Physicians><Physiopathology><Population><Productivity><Proteins><Proteomics><Public Health><QOL><Quality of life><R & D><R&D><Recording of previous events><Research><Research Personnel><Research Resources><Research Training><Researchers><Resources><Scientist><Series><Services><Skeletal Muscle><Speed><Striated Muscles><Structure><Techniques><Technology><Testing><Therapeutic Agents><Time><Tissues><Training><Training and Education><Translational Research><Translational Science><United States><Universities><Viral Vector><Voluntary Muscle><Washington><Work><Workshop><aerobic metabolism><aerobic respiration><age associated><age correlated><age dependent><age linked><age related><age specific><aged muscle><aging of muscle><analytical tool><biomechanical><body movement><bone><computational toolbox><computational tools><computational toolset><computerized tools><conference><convention><cost effective><developmental><device development><diabetes><disease mechanisms study><early-career faculty><experience><genetic condition><genetic disorder><health level><high reward><high risk><histories><homes><human progenitor><human stem cells><imaging><improved><injuries><innovate><innovation><innovative><insight><instrument development><instrumentation><interdisciplinary approach><interest><kids><malignancy><mechanic><mechanical><metabolism measurement><metabolomics><metabonomics><mitochondrial><model of animal><multi-scale mechanics><multidisciplinary><multidisciplinary approach><muscle aging><muscle dystrophy><muscle system><muscular><muscular disorder><muscular system><neoplasm/cancer><neuromuscular plasticity><new approaches><new drug target><new drug treatments><new druggable target><new drugs><new pharmacological therapeutic><new pharmacotherapy target><new therapeutic target><new therapeutics><new therapy><new therapy target><news><next generation therapeutics><novel><novel approaches><novel drug target><novel drug treatments><novel druggable target><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel pharmacotherapy target><novel strategies><novel strategy><novel therapeutic target><novel therapeutics><novel therapy><novel therapy target><outreach><oxidative metabolism><pathophysiology><progenitor biology><progenitor cell biology><progenitor cell model><progenitor model><programs><recruit><research and development><research faculty><sarcopenia><sarcopenic><skill acquisition><skill development><skills training><stem and progenitor biology><stem and progenitor cell model><stem cell based model><stem cell biology><stem cell derived model><stem cell model><success><summit><symposia><symposium><therapeutic agent development><therapeutic development><therapeutic target><tool><tool development><translation research><translational investigation><treatment research><treatment strategy><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DEBRA J. UMBERSON

UNIVERSITY OF TEXAS AT AUSTIN, AUSTIN, TX

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$768,600

FY 2025

Project Title

Center on Aging and Population Sciences

Grant Number:

2P30AG066614-06

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2020

End Date:

8/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Center on Aging and Population Sciences (CAPS) at The University of Texas at Austin (UT) seeks to renew P30 Demography and Economics of Aging Center infrastructure support to continue successful programs and launch new initiatives to support population-based research on aging. CAPS’s mission is ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

TUHINA NEOGI

BOSTON UNIVERSITY MEDICAL CAMPUS, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$752,928

FY 2025

Project Title

Boston University CCCR

Grant Number:

5P30AR072571-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/11/2019

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL ABSTRACT The Boston University P30 CCCR emphasizes rheumatic and musculoskeletal disease (RMD) epidemiology and patient-oriented clinical research. The first cycle of our CCCR has been highly productive and successful in expanding the network of RMD researchers leveraging our expertise and r...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mary C Nakamura

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$726,685

FY 2025

Project Title

RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY

Grant Number:

5P30AR070155-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/21/2016

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT PREMIER, the UCSF Precision Medicine in Rheumatology Center (P30), provides critically important resources and expertise to enable cutting-edge research to advance precision medicine in the rheumatic diseases. PREMIER brings together clinical expertise, defined patient cohor...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Fernanda Laezza

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$717,392

FY 2025

Project Title

Gulf Coast Center for Precision Environmental Health

Grant Number:

5P30ES030285-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/15/2019

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Texas Medical Center (TMC), encompassing the top research-intensive institutions in the Gulf Coast Region, has emerged as an Environmental Health Sciences (EHS) research powerhouse, driven by the establishment in 2019 of the Gulf Coast Center for Precision Environmental Health (GC-CPEH). The Str...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Cheryl L. Walker

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$717,392

FY 2025

Project Title

Gulf Coast Center for Precision Environmental Health

Grant Number:

5P30ES030285-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/15/2019

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Texas Medical Center (TMC), encompassing the top research-intensive institutions in the Gulf Coast Region, has emerged as an Environmental Health Sciences (EHS) research powerhouse, driven by the establishment in 2019 of the Gulf Coast Center for Precision Environmental Health (GC-CPEH). The Str...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CLIFTON O BINGHAM

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$701,658

FY 2025

Project Title

Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)

Grant Number:

5P30AR070254-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/9/2016

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overview PROJECT SUMMARY The abiding philosophy of the Johns Hopkins Division of Rheumatology is that the critical pathway to understanding human autoimmune rheumatic diseases is through the study of large numbers of well-defined patients, followed over time, with the collection of rich phenotypic d...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Antony Rosen

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$701,658

FY 2025

Project Title

Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)

Grant Number:

5P30AR070254-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/9/2016

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overview PROJECT SUMMARY The abiding philosophy of the Johns Hopkins Division of Rheumatology is that the critical pathway to understanding human autoimmune rheumatic diseases is through the study of large numbers of well-defined patients, followed over time, with the collection of rich phenotypic d...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Erik M Ullian

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, SAN FRANCISCO, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$699,202

FY 2025

Project Title

P30 - Core Grant for Vision Research

Grant Number:

1P30EY037668-01

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/17/2025

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL COMPONENT Project Summary The main objectives of this NEI Core Grant for Vision Research is to support the study of the visual system's structure, development, and function in both healthy and diseased states. The ultimate goal is to prevent, alleviate, or cure vision-related diseases, as we...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KARL J JEPSEN

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$692,840

FY 2025

Project Title

Michigan Integrative Musculoskeletal Health Core Center (Overall Application)

Grant Number:

5P30AR069620-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2016

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Michigan Integrative Musculoskeletal Health Core Center - Overview Project Summary Musculoskeletal disorders remain an enormous public healthcare problem, accounting for more than fifty percent of chronic conditions in developed countries. The current financial landscape not only challenges investig...

Research Terms

<21+ years old><AI system><Acceleration><Accounting><Adult><Adult Human><Artificial Intelligence><Assay><Basic Research><Basic Science><Bioassay><Biological Assay><Body Tissues><Budgets><Cartilage><Cartilaginous Tissue><Center Core Grants><Chronic><Clinical><Clinical Research><Clinical Study><Collaborations><Communication><Communities><Complex thinking><Comprehensive Health Care><Computer Reasoning><Critical Thinking><Data Analyses><Data Analysis><Data Analytics><Dentistry><Developed Countries><Differences between sexes><Differs between sexes><Discipline><Disease><Disorder><Education><Educational aspects><Effectiveness><Engineering><Environment><Evaluative Thinking><Experimental Designs><Foundations><Funding><Funding Agency><Funding Source><Generalized Growth><Goals><Growth><Health><Health Care><Health Care Systems><Health Promotion><Histology><Home><Individual><Industrialized Countries><Industrialized Nations><Injury><Institution><Interdisciplinary Research><Interdisciplinary Study><Investigators><Leadership><Life Cycle><Life Cycle Stages><Ligaments><Machine Intelligence><Machine Learning><Medicine><Mentorship><Michigan><Mission><Molecular><Multidisciplinary Collaboration><Multidisciplinary Research><Muscle><Muscle Tissue><Musculoskeletal><Musculoskeletal Diseases><NIAMS><NIH><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><National Institutes of Health><Organ><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Prevalence><Prevention><Public Health><Reproducibility><Research><Research Personnel><Research Resources><Research Support><Researchers><Resources><Risk><Salutogenesis><Scholarship><Science><Scientist><Series><Services><Sex Differences><Sexual differences><Structure><System><Talents><Techniques><Technology><Tendon structure><Tendons><Tissue Growth><Tissues><Training><Translational Research><Translational Science><United States><United States National Institutes of Health><Universities><adulthood><age associated><age associated difference><age based difference><age correlated><age dependent><age dependent difference><age dependent variation><age difference><age linked><age related><age related difference><age related variation><age specific><age specific difference><bone><clinical relevance><clinically relevant><community building><comprehensive care><data analysis core><data analysis research core><data analytics core><data analytics research core><data interpretation><developed country><developed nation><developed nations><differ by age><difference across age><difference in age><disability><flexibility><flexible><homes><hospital care><injuries><injury of musculoskeletal system (disorder)><injury of musculoskeleted system><innovate><innovation><innovative><interest><life course><life span><lifespan><machine based learning><medical attention><member><muscular><musculoskeletal disorder><musculoskeletal injury><musculoskeletal trauma><novel><ontogeny><operation><operations><outreach program><programs><promoting health><sex><sex based differences><sex-dependent differences><sex-related differences><sex-specific differences><translation research><translational investigation><variation by age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John D Ash

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$675,750

FY 2025

Project Title

Core Grant for Vision Research

Grant Number:

5P30EY008098-37

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

SUMMARY – OVERALL COMPONENT This P30 renewal proposal requests continued funding to support the operation of six resource modules within the Vision Institute (VI) at Mercy Pavilion of the University of Pittsburgh. The VI provides a home base for the basic and clinical vision research for ~30 vision ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Kyriakos S Markides

UNIVERSITY OF TEXAS MED BR GALVESTON, GALVESTON, TX

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$662,656

FY 2025

Project Title

The Texas Resource Center on Minority Aging Research (RCMAR)

Grant Number:

5P30AG059301-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2018

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

This is an application to renew the Texas RCMAR, initially funded in 2018 based at the University of Texas Medical Branch (UTMB) in Galveston with the University of Texas at Austin (UT-Austin) as a collaborating institution. A major innovation of the proposed RCMAR’s second cycle is that we will use...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David J. Calkins

VANDERBILT UNIVERSITY MEDICAL CENTER, NASHVILLE, TN

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$659,111

FY 2025

Project Title

Core Grant in Vision Research

Grant Number:

5P30EY008126-38

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

5/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY The Vanderbilt Vision Research Center (VVRC) promotes transformative vision research, spanning the eye and its diseases to visual cognition, memory, attention, and integration. We request continued support for 7 well-coordinated service modules coordinated through the administrative...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

W MATTHEW PETROLL

UT SOUTHWESTERN MEDICAL CENTER, DALLAS, TX

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$656,000

FY 2025

Project Title

Core Grant for Vision Research

Grant Number:

5P30EY030413-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2019

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Core Abstract The overall goal of this NEI Core Center Grant for Vision Research is to enhance the capabilities of vision research scientists by facilitating easy access to equipment, training, and technical support that will expand experimental capabilities, add rigor and reproducibility, r...

Research Terms

<Adeno-Associated Viruses><Animals><Area><Award><Body Tissues><Cell Body><Cells><Center Core Grants><Collaborations><Contract Services><Core Grant><DNA><Deoxyribonucleic Acid><Dependoparvovirus><Dependovirus><Development><EXTMR><Environment><Equipment><Extramural><Extramural Activities><Eye><Eyeball><Faculty><Fostering><Foundations><Funding><Genes><Goals><Grant><Institution><Investigators><Lentivirinae><Lentivirus><MD students><Maintenance><Medical Students><Medical center><Microscopy><Non-Polyadenylated RNA><Organoids><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Phenotype><Postdoc><Postdoctoral Fellow><Privatization><Production><Productivity><Progenitor Cells><Publications><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><Reproducibility><Research><Research Activity><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Ribonucleic Acid><Scientific Publication><Scientist><Services><Sight><Students><System><Technical Expertise><Techniques><Time><Tissues><Training><Universities><Virus><Vision><Vision research><Visual System><Work><adeno associated virus group><cell imaging><cellular imaging><cost effective><developmental><experience><graduate student><iPS><iPSC><iPSCs><improved><in vivo><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><interest><medical school students><member><novel><operation><operations><post-doc><post-doctoral><post-doctoral trainee><programs><quantitative imaging><recruit><research associates><stem cells><technical skills><vision development><vision science><visual development><visual function><visual science><visual system development>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vernon Michael Holers

UNIVERSITY OF COLORADO DENVER, Aurora, CO

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$654,010

FY 2025

Project Title

Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis

Grant Number:

5P30AR079369-05

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/10/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

A substantial cadre of investigators at the University of Colorado are focused on characterizing the molecular origins and causal mechanisms that drive the initiation and preclinical phases of rheumatic and autoimmune diseases. One of the most important outcomes of those efforts has been the demonst...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bogi Andersen

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$652,758

FY 2025

Project Title

Skin Biology Resource-Based Center at UCI

Grant Number:

5P30AR075047-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/2019

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The broad, long-term objective of the UC Irvine Skin Biology and Disease Resource-based Center is to promote significant and innovative discoveries in regulatory mechanisms in skin biology and disease through cross-fertilization between multiple disciplines, integrated through systems biology. The...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anand K Ganesan

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$652,758

FY 2025

Project Title

Skin Biology Resource-Based Center at UCI

Grant Number:

5P30AR075047-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/2019

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The broad, long-term objective of the UC Irvine Skin Biology and Disease Resource-based Center is to promote significant and innovative discoveries in regulatory mechanisms in skin biology and disease through cross-fertilization between multiple disciplines, integrated through systems biology. The...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Arthur D Lander

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$652,758

FY 2025

Project Title

Skin Biology Resource-Based Center at UCI

Grant Number:

5P30AR075047-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/2019

End Date:

4/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The broad, long-term objective of the UC Irvine Skin Biology and Disease Resource-based Center is to promote significant and innovative discoveries in regulatory mechanisms in skin biology and disease through cross-fertilization between multiple disciplines, integrated through systems biology. The...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CLAIRE H MITCHELL

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$650,000

FY 2025

Project Title

P30 Core Grant For Vision Research

Grant Number:

2P30EY001583-51

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/1997

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall - Project Summary The broad goal of this proposal is to provide core support services for 16 Participating Investigators and over 40 Associate Investigators to: (1) enhance the quality and quantity of their research; (2) facilitate collaborations between investigators with different backgrou...

Research Terms

<2-photon><Affect><Animal Model><Animal Models and Related Studies><Basic Research><Basic Science><Bioinformatics><Biometrics><Biometry><Biostatistics><Blindness><Body Tissues><Cellular biology><Clinical Research><Clinical Study><Collaborations><Computer Models><Computer Software Tools><Computerized Models><Confocal Microscopy><Core Grant><Custom><DNA Molecular Biology><DNA Therapy><Data><Data Analyses><Data Analysis><Diminished Vision><Disease><Disorder><Electrophysiology><Electrophysiology (science)><Equipment><Experimental Designs><Eye><Eyeball><Gene Transfer Clinical><Genetic Intervention><Goals><Grant><Image><In Vitro><Investigators><Low Vision><Maintenance><Molecular Biology><Molecular Genetics><National Eye Institute><Neurophysiology / Electrophysiology><Partial Sight><Pennsylvania><Physiology><Primates><Primates Mammals><Public Health><Qualifying><R-Series Research Projects><R01 Mechanism><R01 Program><Reduced Vision><Reproducibility><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Researchers><Resources><Retina><Retinal Degeneration><Scientist><Services><Sight><Software Tools><Source><Stimulus><Subnormal Vision><Tissues><Universities><Vision><Vision research><Visual Cortex><Visual Pathways><Visual System><Visual impairment><awake><cell biology><cognitive neuroscience><computational modeling><computational models><computer based models><computerized modeling><curating data><customs><data acquisition><data acquisitions><data curation><data interpretation><degenerative retina diseases><design and construct><design and construction><electrophysiological><gene repair therapy><gene therapy><gene-based therapy><genetic therapy><genomic therapy><image-based method><imaging><imaging method><imaging modality><in vivo><insight><instrument><instrumentation><model of animal><multi-electrode arrays><multielectrode arrays><novel><programs><recruit><repair><repaired><restore sight><restore vision><retina degeneration><retinal degenerative><retinal degenerative diseases><sight restoration><skills><software toolkit><two-photon><vision impairment><vision loss><vision restoration><visual cortical><visual function><visual loss><visual performance><visually impaired>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sharon M Moe

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$649,835

FY 2025

Project Title

Indiana Core Center for Clinical Research in Musculoskeletal Health

Grant Number:

5P30AR072581-09

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2017

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

RESOURCE CORE: Modified Project Summary/Abstract Section Musculoskeletal (MSK) conditions are the leading contributor to disability worldwide. There is a reciprocal and perpetuating relationship between the MSK system and chronic disease. Chronic health conditions contribute to abnormal muscle and b...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BELA ANAND-APTE

CLEVELAND CLINIC LERNER COM-CWRU, CLEVELAND, OH

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$644,002

FY 2025

Project Title

NEI Center Core Grant for Vision Research

Grant Number:

5P30EY025585-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2016

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Core Project Summary The overall aim of the Cole Eye Institute (CEI) Core Facilities for Vision Research is to facilitate the analysis of the structure, function and disease mechanisms that affect the visual system by providing centralized assess to shared resources. The Core Facilities will...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Irina A Pikuleva

CASE WESTERN RESERVE UNIVERSITY, CLEVELAND, OH

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$644,000

FY 2025

Project Title

CWRU NEI Vision Center Core Grant

Grant Number:

5P30EY011373-29

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT Overall Component The Visual Sciences Research Center (VSRC) at Case Western Reserve University (CWRU) requests continuing support for a P30 Core Grant for Vision Research. The VSRC was founded in 1996 and has undergone tremendous growth since the first P30 grant award in 1997 and subsequen...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

MATTHEW J SILVA

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$640,899

FY 2025

Project Title

RESOURCE BASED CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINE

Grant Number:

5P30AR074992-07

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/15/2019

End Date:

6/30/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall. The NIH has made substantial research investments in response to the large burden of musculoskeletal diseases in the United States. The Washington University Resource-Based Center for Musculoskeletal Biology and Medicine was formed to enhance NIH-funded, musculoskeletal research on our camp...

Research Terms

<21+ years old><Acceleration><Address><Adult><Adult Human><Affect><American><Analgesia Tests><Animal Model><Animal Models and Related Studies><Animals><Arthritis><Award><Back Ache><Back Pain><Backache><Basic Research><Basic Science><Behavior><Biology><Biomechanics><Body Tissues><Bone Injury><Career Mobility><Categories><Center Core Grants><Communities><Development><Disease><Disorder><Disseminated Malignant Neoplasm><EXTMR><Education><Educational aspects><Effectiveness><Engineering><Evaluation Research><Extramural><Extramural Activities><Faculty><Fostering><Fracture><Funding><Future><Grant><Group Affiliation><Health Care><Histology><Institution><Instruction><Investigators><Investments><Knowledge><Leadership><Link><Measures><Medicine><Metastatic Cancer><Metastatic Malignant Neoplasm><Methods><Microscopy><Modeling><Musculoskeletal><Musculoskeletal Diseases><Musculoskeletal structure><NIAMS><NIH><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><National Institutes of Health><Nociception Tests><Osteoporosis><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pain><Pain Assessment><Pain Measurement><Pain measure><Painful><Principal Investigator><Publications><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Roentgen Rays><Scientific Publication><Secure><Series><Staining method><Stains><Structure><Techniques><Testing><Tissues><Training><Training Support><United States><United States National Institutes of Health><Universities><University resources><Washington><Work><X-Radiation><X-Ray Radiation><X-ray><Xray><adulthood><arthritic><biomechanical><bone><bone fracture><career advancement><career transition><cell imaging><cellular imaging><conference><convention><cost><cost effective><design><designing><developmental><image-based method><imaging method><imaging modality><improved><in vivo><joint damage><joint injury><joint trauma><mechanical properties><medical college><medical schools><member><model of animal><morphometry><mouse model><murine model><musculoskeletal disorder><next generation><outreach><pain assay><pre-clinical><pre-clinical research><preclinical><preclinical research><programs><recruit><response><school of medicine><summit><symposia><symposium>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DEEPAK SHUKLA

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$638,938

FY 2025

Project Title

P30 Core Grant for Vision Research

Grant Number:

5P30EY001792-46

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/1997

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY: CENTER CORE The vision science research program at the University of Illinois at Chicago (UIC) has been supported by one of the longest-running core grants from the National Eye Institute (NEI). The overarching goal of the Center Core Grant for Vision Research is to support, strengt...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Paul Douglas Gamlin

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$629,480

FY 2025

Project Title

UAB Core Grant for Vision Research

Grant Number:

5P30EY003039-45

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/1997

End Date:

7/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

UAB Center for Vision Research - Overall Core Project Summary/Abstract In 1979, an NEI Core grant was first awarded to UAB. Over the next 41 years, the institution's commitment to strategic growth resulted in significant expansion of vision research. Participants have increased from 13 in 2 departme...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Machelle T. Pardue

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$626,000

FY 2025

Project Title

P30-Core Grant for Vision Research

Grant Number:

5P30EY006360-40

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Overall Summary Continued support is requested for the NEI Core Grant for Vision Research that supports investigators of the Atlanta Vision Research Community (AVRC). This Center Grant renewal application includes three Resource/Service Cores: (1) Structural Biology and Imaging, (2) Functional Genom...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vladimir Jivkov Kefalov

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$624,293

FY 2025

Project Title

NEI UCI Center Core Grant for Vision Research

Grant Number:

5P30EY034070-04

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2022

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT This P30 application seeks support for the Cores of Vision Research within the University of California Irvine (UCI) that will strengthen and enhance NEI R01-funded research. The project also aims to support the major expansion of vision research currently under way at UCI. It will broaden ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LINDA D HAZLETT

WAYNE STATE UNIVERSITY, DETROIT, MI

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$615,627

FY 2025

Project Title

Core Grant for Vision Research

Grant Number:

5P30EY004068-42

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/1997

End Date:

7/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary (Overall) Continuing funds are requested by 18 vision scientists (holding 20 eligible NEI R01 grants) and their personnel to support three resource and an administrative core in the merged Department of Ophthalmology, Visual and Anatomical Sciences (former Ophthalmology and Anatomy/C...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LINDA M ZANGWILL

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$610,615

FY 2025

Project Title

NEI Center Core Grant for Vision Research

Grant Number:

5P30EY022589-13

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

SUMMARY Overall The overall purpose of the Center Core Grant for Vision Research is to provide core services and resources to enhance and accelerate the productivity and impact of the vision research community at the University of California, San Diego. Specifically, the Center Core Grant for Vision...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Michelle C Callegan

UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OKLAHOMA CITY, OK

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$580,000

FY 2025

Project Title

P30 Center Core Grant for Vision Research

Grant Number:

5P30EY021725-15

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2011

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT Overall The goals of this P30 Vision Core Renewal Application are to manage and maintain existing and new core facilities that will provide expertise, technical support, equipment access, and personnel training for 24 independent vision research laboratories at the University of Oklahoma He...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Sayoko E Moroi

OHIO STATE UNIVERSITY, Columbus, OH

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$571,235

FY 2025

Project Title

The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP)

Grant Number:

5P30EY032857-04

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2022

End Date:

6/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

OVERALL MULTI-COMPONENT NEI P30 PROPOSAL abstract The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP) has established the expanding vision research scientists across five academic units (i.e., College of Medicine (COM), College of Optometry (COO), College of Engineering (COE)...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Janey L Wiggs

MASSACHUSETTS EYE AND EAR INFIRMARY, BOSTON, MA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$570,177

FY 2025

Project Title

P30 Core Grant for Vision Research

Grant Number:

5P30EY014104-22

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/1/2002

End Date:

8/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Massachusetts Eye and Ear (MEE) is an internationally-recognized leading institution for academic ophthalmology and vision research. MEE is the primary institution for the Department of Ophthalmology at Harvard Medical School, one of the largest academic departments of Ophthalmology world-wide. ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mahnaz Shahidi

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$554,475

FY 2025

Project Title

Center Core Grant for Vision Research

Grant Number:

5P30EY029220-08

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/30/2018

End Date:

6/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY: OVERALL CENTER CORE The overarching goal of the Center Core Grant for Vision Research is to support, strengthen and broaden basic and translational vision science research at the University of Southern California. The Center Core will provide shared resources accessible to a group o...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Val C. Sheffield

UNIVERSITY OF IOWA, IOWA CITY, IA

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$525,300

FY 2025

Project Title

Multidisciplinary Investigations in Visual Science

Grant Number:

5P30EY025580-10

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2016

End Date:

6/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY The goal of this National Eye Institute (NEI) P30 competitive renewal is to continue to enhance the research activities of NEI-funded investigators at The University of Iowa. This will be achieved by providing a suite of Core Services, performed by skilled technical staff and supervi...

Research Terms

<3-D><3-Dimensional><3D><Acute><Anterior><Bioinformatics><Bioinformatics core><Bioinformatics research core><Bioinformatics resource core><Biometrics><Biometry><Biostatistics><Biostatistics Core><Body Tissues><COVID crisis><COVID epidemic><COVID pandemic><COVID testing><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 testing><COVID-19 years><COVID19 testing><Center Core Grants><Common Rat Strains><Communication><Communities><Computing Methodologies><Data Set><Doppler OCT><Electroretinography><Equipment><Experimental Designs><Faculty><Fluorescein Angiography><Funding><Fundus><Gene Expression><Goals><Gonioscopy><Grant><Histologic><Histologically><Intraocular Pressure><Investigation><Investigators><Iowa><Laboratories><Laboratory Personnel><Light><Methods><Mice><Mice Mammals><Murine><Mus><National Eye Institute><OCT Tomography><Ocular Tension><Optical Coherence Tomography><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Phenotype><Photography><Photoradiation><Physiologic Intraocular Pressure><Procedures><Productivity><Pupil light reflex><Rat><Rats Mammals><Rattus><Reproducibility><Research><Research Activity><Research Personnel><Research Resources><Research Technics><Research Techniques><Researchers><Resources><Rodent><Rodentia><Rodents Mammals><Roentgen Rays><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 testing><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Services><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Sight><Standardization><Statistical Methods><Supervision><Technical Expertise><Techniques><Testing><Tissues><Training><Universities><Update><Vision><Vision research><Work><X-Radiation><X-Ray Radiation><X-ray><Xray><behavior measurement><behavioral measure><behavioral measurement><computational methodology><computational methods><computer based method><computer methods><computing method><confocal imaging><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 testing><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease testing><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus testing><cost><database of Genotypes and Phenotypes><dbGaP><electroretinogram><experience><experimental analysis><improved><intra-ocular pressure><laser capture microdissection><live cell image><live cell imaging><live cellular image><live cellular imaging><meeting><meetings><member><molecular imaging><molecule imaging><multidisciplinary><new technology><novel technologies><open source><optical Doppler tomography><optical coherence Doppler tomography><programs><pupillary light reflex><pupillary reflex><reconstruction><response><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 testing><statistic methods><technical skills><testing for COVID><testing of COVID><three dimensional><vision science><visual function><visual science>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Susana Marcos

UNIVERSITY OF ROCHESTER, ROCHESTER, NY

Good lead · 62/100

Likely hiring

Above-average budget

Active award

Team-scale grant

$523,602

FY 2025

Project Title

Core grant for vision research

Grant Number:

5P30EY001319-51

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

3/1/1997

End Date:

7/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

The Center for Visual Science at the University of Rochester seeks to renew its NEI P30 Core Grant to support 23 participating investigators engaged in vision research. 13 of the participating investigators hold a total of 17 eligible NEI R01 grants and these investigators will have highest priority...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Adrian Lynn Oblak

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$660,563

FY 2026

Project Title

The Role of Aspergillus versicolor and the Th2 Lung-Brain Axis in Alzheimer's Disease-like Neuropathology

Grant Number:

5R01AG076142-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia in the elderly. Available AD treatment is unable to halt disease progression, highlighting the urgent need to identify the potential etiology and pathobiology driving AD. The ro...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joshua A Boyce

BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$656,461

FY 2026

Project Title

Eicosanoid Networks in Aspirin Hypersensitivity

Grant Number:

5R01AI136041-13

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/4/2017

End Date:

11/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Summary/Abstract This application for renewed support continues its focus on the mechanisms responsible for aspirin sensitivity, a defining feature of aspirin exacerbated respiratory disease (AERD). AERD is a debilitating clinical syndrome characterized by severe sinonasal and bronchial inflammation...

Research Terms

<5-Lipoxygenase><AGE receptor><Accessory Sinuses><Acetylsalicylic Acid><Affinity><Agonist><Alveolar><Amphoterin><Amphoterin Gene><Antibodies><Arachidonate 5-Lipoxygenase><Arachidonic Acid 5-Lipoxygenase><Arachidonic Acids><Aspirin><Asthma><Autocrine Systems><Binding><Biology><Blood Platelets><Blood Vessels><Body Tissues><Bronchial Asthma><Bronchial Constriction><Bronchoconstriction><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Clinical><Cys-LT><CysLT(2) receptor><CysLT2 receptor><DNA-Binding Proteins><Dinoprostone><Disease><Disorder><Drug Targeting><Dysfunction><Eicosanoids><Event><Extravasation><FM1 Gene Product><Functional disorder><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G-Protein-Coupled Receptors><GPCR><Genetic><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Human><Hypersensitivity><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Inflammation><Interleukins><Intracellular Communication and Signaling><LTA4 Synthase><LTC4><LTC4 synthase><LTD4><Leakage><Leukotriene A Synthase><Leukotriene A4 Synthase><Leukotriene A4 Synthetase><Leukotriene C-4><Leukotriene C4><Leukotriene D-4><Leukotriene D4><Ligand Binding><Lung><Lung Respiratory System><Lymphoid Cell><Marrow Mast Cell><Marrow platelet><Mediating><Mediator><Mice><Mice Mammals><Microsomes><Modeling><Modern Man><Molecular><Molecular Interaction><Multiple Polyps><Murine><Mus><Myeloid Cells><Nasal><Nasal Passages Nose><Nasal Sinuses><Nasal cavity/Paranasal><Nasal cavity/Paranasal sinuses><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nose><PGE2><PGE2 alpha><PGE2alpha><Paranasal Sinuses><Parents><Pathology><Pathway interactions><Patients><Phenotype><Physiologic><Physiological><Physiology><Physiopathology><Platelet Activation><Platelets><Play><Property><Prostaglandin E2><Prostaglandin E2 alpha><Prostaglandin E2alpha><Prostaglandins><Prostanoids><Pulmonary Body System><Pulmonary Organ System><RAGE receptor><Reaction><Receptor Protein><Receptor Signaling><Refractory><Regulation><Respiratory System><Respiratory System, Nose, Nasal Passages><Respiratory Tracts><Respiratory tract structure><Role><SBP-1><SBP-1 Gene><Samter's triad><Signal Transduction><Signal Transduction Systems><Signaling><Sinus><Site><Spillage><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Syndrome><Testing><Therapeutic><Thrombocytes><Tissue Basophils><Tissues><Transgenic Mice><advanced glycosylation end product receptor><airway epithelium inflammation><airway inflammation><airway smooth muscle><amphoterin receptor><antagonism><antagonist><aspirin-exacerbated respiratory disease><aspirin-induced asthma><asthma attack><asthma exacerbation><autocrine><base><bases><biological signal transduction><cell type><cellular targeting><chronic rhinosinusitis><cysteinyl leukotriene receptor><cysteinyl leukotriene receptor 2><cysteinyl-leukotriene><desensitization><exacerbation in asthma><exacerbation prone asthma><exacerbation prone asthmatic><human subject><immunopathology><in vivo><innovate><innovation><innovative><insight><leukotriene A4-glutathione S-leukotrienyltransferase><leukotriene C4 synthetase><leukotriene-C4 synthase><lipid mediator><mast cell><mastocyte><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><parent><pathophysiology><pathway><pharmacologic><polyposis><preference><prevent><preventing><programs><pulmonary><receptor><receptor expression><receptor for AGE><receptor for advanced glycation end product><receptor for advanced glycation endproducts><receptor of AGE><recruit><respiratory><respiratory inflammation><respiratory smooth muscle><respiratory tract inflammation><response><social role><therapeutic agent development><therapeutic development><therapeutic target><tool><translational opportunities><translational potential><vascular>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Chuanfu Li

EAST TENNESSEE STATE UNIVERSITY, JOHNSON CITY, TN

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$576,326

FY 2026

Project Title

Novel Role of Lactate in Sepsis Impaired Immune Function

Grant Number:

5R01AI174020-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/12/2023

End Date:

10/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Sepsis represents a life-threatening disorder caused by a dysregulated host response. Sepsis survivors frequently have long-term immune dysfunction that contributes to high mortality from opportunistic infections. Clinical data shows that lactate levels strongly and positively correlate with severit...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

BRIAN M POLSTER

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$510,639

FY 2026

Project Title

Targeting mitochondrial Complex I in neonatal hypoxia-ischemia

Grant Number:

5R01NS122777-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/15/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary Neonatal hypoxic ischemic encephalopathy (HIE) is characterized by a protracted series of pathophysiological events that, without intervention, are devastating. HIE can result in neurodevelopmental delays, epilepsy, cognitive and motor issues, or death. The current standard of clini...

Research Terms

<0-4 weeks old><3-mononitrotyrosine><3-nitrotyrosine><Active Oxygen><Acute><After Care><After-Treatment><Aftercare><Ammon Horn><Amphoterin><Amphoterin Gene><Animals><Apoptosis><Apoptosis Pathway><Apoptotic><BBB permeabilization><BBB permeable><Behavioral Assay><Birth><Body Tissues><Brain><Brain Hypoxia-Ischemia><Brain Nervous System><Cause of Death><Cell Body><Cell Communication and Signaling><Cell Death><Cell Signaling><Cells><Cessation of life><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Chronic><Clinical><Cognitive><Common Rat Strains><Complex><Cornu Ammonis><Data><Death><Development><Diagnosis><Dose><Drugs><Dysfunction><Electron Transport><Encephalon><Energy Expenditure><Energy Metabolism><Epilepsy><Epileptic Seizures><Epileptics><Event><Exhibits><Exposure to><FM1 Gene Product><Failure><Female><Ferricytochrome c><Ferrocytochrome c><Functional disorder><Genetic><Genetic Models><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Hippocampus><Histopathology><Homolog of Drosophila TOLL><Hortega cell><Hour><Hyperoxia><Hypothermia><Hypoxic-Ischemic Brain Injury><Immune><Immunes><Immunohistochemistry><Immunohistochemistry Cell/Tissue><Immunohistochemistry Staining Method><In Vitro><In vivo analysis><Induction of Apoptosis><Infant><Infant Care><Inflammatory><Inflammatory Response><Injury><Intervention><Intracellular Communication and Signaling><Ischemia-Reperfusion Injury><Ischemic Heart><Ischemic Heart Disease><Ischemic myocardium><KI mice><Knock-in Mouse><Label><Lesion><Measures><Mediating><Medication><Methods><Mice><Mice Mammals><Microglia><Mitochondria><Modeling><Morbidity><Motor><Multiple Injuries><Multiple Trauma><Murine><Mus><Myocardial Ischemia><Neonatal asphyxia-induced brain injury><Neonatal hypoxic brain injury><Nerve Cells><Nerve Unit><Neural Cell><Neural Development><Neurocyte><Neurologic outcome><Neurological outcome><Neurons><Newborn Infant><Newborns><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Outcome><Outcome Measure><Oxidative Stress><Oxygen Radicals><Parturition><Pathway interactions><Pharmaceutical Preparations><Phase><Physiopathology><Pro-Oxidants><Production><Programmed Cell Death><Publishing><Rat><Rats Mammals><Rattus><Reactive Oxygen Species><Recovery><Reperfusion Damage><Reperfusion Injury><Reperfusion Therapy><Residual><Residual state><Respiration><Rice><Rodent Model><Role><SBP-1><SBP-1 Gene><Secondary to><Seizure Disorder><Series><Signal Transduction><Signal Transduction Systems><Signaling><Staining method><Stains><Succinates><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><TLR4><TLR4 gene><Testing><Therapeutic><Tissues><Toll Homologue><Work><baby care><behavior outcome><behavioral outcome><biological signal transduction><blood-brain barrier permeabilization><blood-brain barrier permeable><bloodbrain barrier permeabilization><bloodbrain barrier permeable><brain tissue><cardiac ischemia><clinical care><cohort><coronary ischemia><cytochrome c><cytokine><developmental><disability><drug/agent><electron transfer><epilepsia><epileptogenic><functional outcomes><gene signatures><genetic signature><gitter cell><glial activation><glial cell activation><heart ischemia><hippocampal><hyperoxygenation><hypoxia/ischemia><hypoxic ischemic encephalopathy><improved><in vivo><in vivo evaluation><in vivo testing><infant health care><inhibitor><injuries><knockin mice><male><measurable outcome><mesoglia><microglial cell><microgliocyte><mitochondrial><mouse model><murine model><myocardial ischemia/hypoxia><myocardium ischemia><natural hypothermia><necrocytosis><neonatal HIE><neonatal brain hypoxia-ischemia><neonatal hypoxia-ischemia><neonatal hypoxic-ischemic brain damage><neonatal hypoxic-ischemic brain injury><neonatal hypoxic-ischemic encephalopathy><neural inflammation><neurodevelopment><neuroinflammation><neuroinflammatory><neuronal><neuroprotection><neuroprotective><newborn care><newborn child><newborn children><nitrotyrosine><novel><outcome measurement><oxidation><pathophysiology><pathway><perivascular glial cell><polytrauma><post treatment><postnatal><pre-clinical><preclinical><prevent><preventing><reperfusion><respiratory mechanism><response><sex><sex dimorphism><sexual dimorphism><sexually dimorphic><social role><toll-like receptor 4><translation strategy><translational approach><translational strategy><♀><♂>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JAYLYN Waddell WADDELL

UNIVERSITY OF MARYLAND BALTIMORE, BALTIMORE, MD

Good lead · 60/100

Likely hiring

Above-average budget

Active award

$510,639

FY 2026

Project Title

Targeting mitochondrial Complex I in neonatal hypoxia-ischemia

Grant Number:

5R01NS122777-05

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/15/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary Neonatal hypoxic ischemic encephalopathy (HIE) is characterized by a protracted series of pathophysiological events that, without intervention, are devastating. HIE can result in neurodevelopmental delays, epilepsy, cognitive and motor issues, or death. The current standard of clini...

Research Terms

<0-4 weeks old><3-mononitrotyrosine><3-nitrotyrosine><Active Oxygen><Acute><After Care><After-Treatment><Aftercare><Ammon Horn><Amphoterin><Amphoterin Gene><Animals><Apoptosis><Apoptosis Pathway><Apoptotic><BBB permeabilization><BBB permeable><Behavioral Assay><Birth><Body Tissues><Brain><Brain Hypoxia-Ischemia><Brain Nervous System><Cause of Death><Cell Body><Cell Communication and Signaling><Cell Death><Cell Signaling><Cells><Cessation of life><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Chronic><Clinical><Cognitive><Common Rat Strains><Complex><Cornu Ammonis><Data><Death><Development><Diagnosis><Dose><Drugs><Dysfunction><Electron Transport><Encephalon><Energy Expenditure><Energy Metabolism><Epilepsy><Epileptic Seizures><Epileptics><Event><Exhibits><Exposure to><FM1 Gene Product><Failure><Female><Ferricytochrome c><Ferrocytochrome c><Functional disorder><Genetic><Genetic Models><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Hippocampus><Histopathology><Homolog of Drosophila TOLL><Hortega cell><Hour><Hyperoxia><Hypothermia><Hypoxic-Ischemic Brain Injury><Immune><Immunes><Immunohistochemistry><Immunohistochemistry Cell/Tissue><Immunohistochemistry Staining Method><In Vitro><In vivo analysis><Induction of Apoptosis><Infant><Infant Care><Inflammatory><Inflammatory Response><Injury><Intervention><Intracellular Communication and Signaling><Ischemia-Reperfusion Injury><Ischemic Heart><Ischemic Heart Disease><Ischemic myocardium><KI mice><Knock-in Mouse><Label><Lesion><Measures><Mediating><Medication><Methods><Mice><Mice Mammals><Microglia><Mitochondria><Modeling><Morbidity><Motor><Multiple Injuries><Multiple Trauma><Murine><Mus><Myocardial Ischemia><Neonatal asphyxia-induced brain injury><Neonatal hypoxic brain injury><Nerve Cells><Nerve Unit><Neural Cell><Neural Development><Neurocyte><Neurologic outcome><Neurological outcome><Neurons><Newborn Infant><Newborns><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Outcome><Outcome Measure><Oxidative Stress><Oxygen Radicals><Parturition><Pathway interactions><Pharmaceutical Preparations><Phase><Physiopathology><Pro-Oxidants><Production><Programmed Cell Death><Publishing><Rat><Rats Mammals><Rattus><Reactive Oxygen Species><Recovery><Reperfusion Damage><Reperfusion Injury><Reperfusion Therapy><Residual><Residual state><Respiration><Rice><Rodent Model><Role><SBP-1><SBP-1 Gene><Secondary to><Seizure Disorder><Series><Signal Transduction><Signal Transduction Systems><Signaling><Staining method><Stains><Succinates><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><TLR4><TLR4 gene><Testing><Therapeutic><Tissues><Toll Homologue><Work><baby care><behavior outcome><behavioral outcome><biological signal transduction><blood-brain barrier permeabilization><blood-brain barrier permeable><bloodbrain barrier permeabilization><bloodbrain barrier permeable><brain tissue><cardiac ischemia><clinical care><cohort><coronary ischemia><cytochrome c><cytokine><developmental><disability><drug/agent><electron transfer><epilepsia><epileptogenic><functional outcomes><gene signatures><genetic signature><gitter cell><glial activation><glial cell activation><heart ischemia><hippocampal><hyperoxygenation><hypoxia/ischemia><hypoxic ischemic encephalopathy><improved><in vivo><in vivo evaluation><in vivo testing><infant health care><inhibitor><injuries><knockin mice><male><measurable outcome><mesoglia><microglial cell><microgliocyte><mitochondrial><mouse model><murine model><myocardial ischemia/hypoxia><myocardium ischemia><natural hypothermia><necrocytosis><neonatal HIE><neonatal brain hypoxia-ischemia><neonatal hypoxia-ischemia><neonatal hypoxic-ischemic brain damage><neonatal hypoxic-ischemic brain injury><neonatal hypoxic-ischemic encephalopathy><neural inflammation><neurodevelopment><neuroinflammation><neuroinflammatory><neuronal><neuroprotection><neuroprotective><newborn care><newborn child><newborn children><nitrotyrosine><novel><outcome measurement><oxidation><pathophysiology><pathway><perivascular glial cell><polytrauma><post treatment><postnatal><pre-clinical><preclinical><prevent><preventing><reperfusion><respiratory mechanism><response><sex><sex dimorphism><sexual dimorphism><sexually dimorphic><social role><toll-like receptor 4><translation strategy><translational approach><translational strategy><♀><♂>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Constantinos G. Broustas

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 60/100

Likely hiring

Solid budget

Active award

Team-scale grant

$495,545

FY 2026

Project Title

Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome

Grant Number:

5U01AI172853-04

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2023

End Date:

1/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

SUMMARY A mass casualty radiation event, such as the detonation of an improvised nuclear device or radiological dispersal device, could lead to severe hemorrhage, multi-organ failure, and infection, potentially leading to sepsis and/or death. The hematopoietic system and the gastrointestinal (GI) tr...

Research Terms

<16S RNA sequencing><16S RNAseq><16S gene sequencing><16S rDNA amplicon sequencing><16S rRNA DNA sequencing><16S rRNA amplicon sequencing><16S rRNA gene amplicon sequencing><16S rRNA gene sequencing><16S rRNA genomic profiling><16S rRNA sequencing><16S ribosomal RNA gene sequencing><16S ribosomal RNA sequencing><16S seq><16S sequencing><16s rRNA seq><Accidents><Acute><Acute Radiation Syndrome><Address><Affect><Alimentary Canal><Amphoterin><Amphoterin Gene><Animal Model><Animal Models and Related Studies><Animals><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Architecture><Assay><Autoregulation><Bacteria><Bioassay><Biological Assay><Bleeding><Blood monocyte><Body Tissues><Bone Marrow><Bone Marrow Reticuloendothelial System><C57BL/6 Mouse><Cell Body><Cell Count><Cell Death><Cell Number><Cells><Cellular injury><Cessation of life><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Colon><Death><Development><Devices><Digestive Tract><Dose><Drugs><Dysfunction><Engineering / Architecture><Epithelial Cells><Epithelium><Event><Exposure to><FDA approved><FDA licensed drugs><FDA-approved agents><FDA-approved drug><FDA-approved medications><FDA-approved pharmaceuticals><FDA-approved therapeutic agent><FM1 Gene Product><Food and Drug Administration approved drug><Food and Drug Administration approved medications><Food and Drug Administration approved pharmaceuticals><Functional disorder><Funding><GI Tract><GI commensal><GI microbiota><Gastrointestinal Injury><Gastrointestinal Tract><Gastrointestinal microbiota><Gastrointestinal tract structure><General Radiology><Germ-Free><Gnotobiotic><Gnotobiotics><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HT-29><HT-29 Cells><HT29 Cells><Hematologic Body System><Hematologic Organ System><Hematopoietic><Hematopoietic Body System><Hematopoietic System><Hemorrhage><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Homeostasis><Homolog of Drosophila TOLL><Hour><Human><Immune><Immunes><In Vitro><Infection><Inflammation><Inflammatory><Inflammatory Bowel Diseases><Inflammatory Bowel Disorder><Inflammatory Response><Injury><Intestinal><Intestines><Invaded><KO mice><Knock-out Mice><Knockout Mice><LD-50><LD50><Length><Lethal Dose 50><Ligands><Lipopolysaccharides><MOF syndrome><Macrophage><Marrow monocyte><Medication><Mice><Mice Mammals><Miscellaneous Antibiotic><Modeling><Modern Man><Molecular><Molecular Target><Morphology><Mucosa><Mucosal Tissue><Mucous Membrane><Mucous body substance><Mucus><Multiple Organ Dysfunction Syndrome><Multiple Organ Failure><Murine><Mus><Mφ><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nuclear><Null Mouse><Oral Administration><Oral Drug Administration><Pathway interactions><Pattern><Permeability><Pharmaceutical Preparations><Physiological Homeostasis><Physiopathology><Production><Public Health><Radiation><Radiation Accidents><Radiation Dose><Radiation Dose Unit><Radiation Injuries><Radiation Protection><Radiation Toxicity><Radiation exposure><Radiology><Radiology Specialty><Radioprotection><Radioprotective><Radiotoxicity><Resolution><Ribosomal RNA Genes><Role><SBP-1><SBP-1 Gene><Sepsis><Severities><Signal Pathway><Structure><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Surface><Syndrome><TLR protein><TLR4><TLR4 gene><Testing><Therapeutic><Time><Tissues><Toll Homologue><Toll-Like Receptor Family Gene><Toll-like receptors><Toxic effect><Toxicities><Transgenic Mice><access restrictions><alimentary tract><animal rule><bacterial community><blood loss><bowel><bowel inflammation><cell damage><cell injury><cellular damage><commensal bacteria in the gastrointestinal tract><commensal bacteria in the gut><commensal bacteria in the intestine><commensal flora><commensal microbes><commensal microbiota><commensal microflora><cytokine><damage to cells><determine efficacy><developmental><digestive canal><drug development><drug/agent><dysbacteriosis><dysbiosis><dysbiotic><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><enteric commensal><enteric microbial community><enteric microbiota><evaluate efficacy><examine efficacy><fecal microbial community><fecal microbiota><gastrointestinal><gastrointestinal commensal><gastrointestinal microbial flora><gut commensal><gut community><gut flora><gut inflammation><gut microbe community><gut microbial community><gut microbial composition><gut microbial consortia><gut microbiota><gut microbiotic><gut microflora><hemopoietic><improved><in vivo><inflamed bowel><inflamed gut><inflamed intestine><inflammatory disease of the intestine><inflammatory disorder of the intestine><injuries><injury to cells><injury to the intestines><intestinal autoinflammation><intestinal barrier><intestinal commensal><intestinal epithelium><intestinal flora><intestinal inflammation><intestinal injury><intestinal microbiota><intestinal microflora><intestinal mucosal barrier><intestinal tract microflora><intraoral drug delivery><irradiation><irradiation injury><irradiation response><mass casualty><medical countermeasure><microbial imbalance><microbiome><microbiome community composition><microbiome composition><microbiome species composition><microbiome structure><microbiota composition><model of animal><monocyte><mouse model><mucous><multiorgan failure><multiple organ system failure><murine model><necrocytosis><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathogen><pathophysiology><pathway><preservation><public health emergency><rRNA Genes><radiation disaster><radiation effect><radiation event><radiation incident><radiation mitigation><radiation mitigator><radiation poisoning><radiation response><radio-protection><radio-protective><radiological accident><radiological disaster><radiological event><radiological incident><radiological mitigation><radiological mitigator><radiomitigation><radiomitigator><regenerate new tissue><regenerate tissue><regenerating damaged tissue><regenerating tissue><resolutions><response><response to radiation><social role><systemic inflammation><systemic inflammatory response><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><timeline><tissue regeneration><tissue regrowth><tissue renewal><tissue specific regeneration><toll-like receptor 4><transplant model><treatment group>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Helen C Turner

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Good lead · 60/100

Likely hiring

Solid budget

Active award

Team-scale grant

$495,545

FY 2026

Project Title

Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome

Grant Number:

5U01AI172853-04

Activity Code:

U01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2023

End Date:

1/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

SUMMARY A mass casualty radiation event, such as the detonation of an improvised nuclear device or radiological dispersal device, could lead to severe hemorrhage, multi-organ failure, and infection, potentially leading to sepsis and/or death. The hematopoietic system and the gastrointestinal (GI) tr...

Research Terms

<16S RNA sequencing><16S RNAseq><16S gene sequencing><16S rDNA amplicon sequencing><16S rRNA DNA sequencing><16S rRNA amplicon sequencing><16S rRNA gene amplicon sequencing><16S rRNA gene sequencing><16S rRNA genomic profiling><16S rRNA sequencing><16S ribosomal RNA gene sequencing><16S ribosomal RNA sequencing><16S seq><16S sequencing><16s rRNA seq><Accidents><Acute><Acute Radiation Syndrome><Address><Affect><Alimentary Canal><Amphoterin><Amphoterin Gene><Animal Model><Animal Models and Related Studies><Animals><Antibiotic Agents><Antibiotic Drugs><Antibiotics><Architecture><Assay><Autoregulation><Bacteria><Bioassay><Biological Assay><Bleeding><Blood monocyte><Body Tissues><Bone Marrow><Bone Marrow Reticuloendothelial System><C57BL/6 Mouse><Cell Body><Cell Count><Cell Death><Cell Number><Cells><Cellular injury><Cessation of life><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Colon><Death><Development><Devices><Digestive Tract><Dose><Drugs><Dysfunction><Engineering / Architecture><Epithelial Cells><Epithelium><Event><Exposure to><FDA approved><FDA licensed drugs><FDA-approved agents><FDA-approved drug><FDA-approved medications><FDA-approved pharmaceuticals><FDA-approved therapeutic agent><FM1 Gene Product><Food and Drug Administration approved drug><Food and Drug Administration approved medications><Food and Drug Administration approved pharmaceuticals><Functional disorder><Funding><GI Tract><GI commensal><GI microbiota><Gastrointestinal Injury><Gastrointestinal Tract><Gastrointestinal microbiota><Gastrointestinal tract structure><General Radiology><Germ-Free><Gnotobiotic><Gnotobiotics><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HT-29><HT-29 Cells><HT29 Cells><Hematologic Body System><Hematologic Organ System><Hematopoietic><Hematopoietic Body System><Hematopoietic System><Hemorrhage><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Homeostasis><Homolog of Drosophila TOLL><Hour><Human><Immune><Immunes><In Vitro><Infection><Inflammation><Inflammatory><Inflammatory Bowel Diseases><Inflammatory Bowel Disorder><Inflammatory Response><Injury><Intestinal><Intestines><Invaded><KO mice><Knock-out Mice><Knockout Mice><LD-50><LD50><Length><Lethal Dose 50><Ligands><Lipopolysaccharides><MOF syndrome><Macrophage><Marrow monocyte><Medication><Mice><Mice Mammals><Miscellaneous Antibiotic><Modeling><Modern Man><Molecular><Molecular Target><Morphology><Mucosa><Mucosal Tissue><Mucous Membrane><Mucous body substance><Mucus><Multiple Organ Dysfunction Syndrome><Multiple Organ Failure><Murine><Mus><Mφ><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nuclear><Null Mouse><Oral Administration><Oral Drug Administration><Pathway interactions><Pattern><Permeability><Pharmaceutical Preparations><Physiological Homeostasis><Physiopathology><Production><Public Health><Radiation><Radiation Accidents><Radiation Dose><Radiation Dose Unit><Radiation Injuries><Radiation Protection><Radiation Toxicity><Radiation exposure><Radiology><Radiology Specialty><Radioprotection><Radioprotective><Radiotoxicity><Resolution><Ribosomal RNA Genes><Role><SBP-1><SBP-1 Gene><Sepsis><Severities><Signal Pathway><Structure><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Surface><Syndrome><TLR protein><TLR4><TLR4 gene><Testing><Therapeutic><Time><Tissues><Toll Homologue><Toll-Like Receptor Family Gene><Toll-like receptors><Toxic effect><Toxicities><Transgenic Mice><access restrictions><alimentary tract><animal rule><bacterial community><blood loss><bowel><bowel inflammation><cell damage><cell injury><cellular damage><commensal bacteria in the gastrointestinal tract><commensal bacteria in the gut><commensal bacteria in the intestine><commensal flora><commensal microbes><commensal microbiota><commensal microflora><cytokine><damage to cells><determine efficacy><developmental><digestive canal><drug development><drug/agent><dysbacteriosis><dysbiosis><dysbiotic><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><enteric commensal><enteric microbial community><enteric microbiota><evaluate efficacy><examine efficacy><fecal microbial community><fecal microbiota><gastrointestinal><gastrointestinal commensal><gastrointestinal microbial flora><gut commensal><gut community><gut flora><gut inflammation><gut microbe community><gut microbial community><gut microbial composition><gut microbial consortia><gut microbiota><gut microbiotic><gut microflora><hemopoietic><improved><in vivo><inflamed bowel><inflamed gut><inflamed intestine><inflammatory disease of the intestine><inflammatory disorder of the intestine><injuries><injury to cells><injury to the intestines><intestinal autoinflammation><intestinal barrier><intestinal commensal><intestinal epithelium><intestinal flora><intestinal inflammation><intestinal injury><intestinal microbiota><intestinal microflora><intestinal mucosal barrier><intestinal tract microflora><intraoral drug delivery><irradiation><irradiation injury><irradiation response><mass casualty><medical countermeasure><microbial imbalance><microbiome><microbiome community composition><microbiome composition><microbiome species composition><microbiome structure><microbiota composition><model of animal><monocyte><mouse model><mucous><multiorgan failure><multiple organ system failure><murine model><necrocytosis><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathogen><pathophysiology><pathway><preservation><public health emergency><rRNA Genes><radiation disaster><radiation effect><radiation event><radiation incident><radiation mitigation><radiation mitigator><radiation poisoning><radiation response><radio-protection><radio-protective><radiological accident><radiological disaster><radiological event><radiological incident><radiological mitigation><radiological mitigator><radiomitigation><radiomitigator><regenerate new tissue><regenerate tissue><regenerating damaged tissue><regenerating tissue><resolutions><response><response to radiation><social role><systemic inflammation><systemic inflammatory response><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><timeline><tissue regeneration><tissue regrowth><tissue renewal><tissue specific regeneration><toll-like receptor 4><transplant model><treatment group>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Harmeet Malhi

MAYO CLINIC ROCHESTER, ROCHESTER, MN

Good lead · 58/100

Training-friendly

Solid budget

Very recent

Active award

$466,334

FY 2026

Project Title

Multidisciplinary Training in Digestive Diseases

Grant Number:

5T32DK007198-51

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

1/1/1979

End Date:

12/31/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

In this renewal application of an established (47 years), successful multidisciplinary training program in Digestive Diseases, we will continue to train qualified postdoctoral individuals (M.D., and/or Ph.D.) for academic careers in digestive diseases. Our interdisciplinary, full time faculty of 40 ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rishikesan Kamaleswaran

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 56/100

Above-average budget

Very recent

Active award

Team-scale grant

$777,277

FY 2026

Project Title

The Georgia Cystic Fibrosis Data Warehouse

Grant Number:

5U24HL171672-03

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

3/1/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

1 PROJECT SUMMARY 2 Cystic fibrosis (CF) is the second-most common life-shortening inherited disease of Americans, arising from 3 mutations in the gene encoding the CFTR ion channel. A lifelong disease, CF impacts multiple organ systems 4 resulting in substantial treatment burden, although most o...

Research Terms

<0-11 years old><0-4 weeks old><4 year old><4 years of age><Accreditation><Active Follow-up><Address><Age><American><Animal Model><Animal Models and Related Studies><Architecture><Award><Biological Specimen Banks><Biological Substance Banks><Biomedical Research><Body System><CF lung disease><CF patients><CF related diabetes><CFTR><CFTR Protein><Caring><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Center Core Grants><Cessation of life><Child><Child Youth><Children (0-21)><Clinic><Clinical><Clinical Data><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Data Analyses><Data Analysis><Death><Development><Diagnosis><Disease><Disease Progression><Disorder><Drugs><Dysfunction><Ecologic Systems><Ecological Systems><Ecosystem><Elderly><Engineering / Architecture><Ethics><Event><Faculty><Foundations><Functional disorder><Genes><Genetic Change><Genetic Diseases><Genetic defect><Genetic mutation><Goals><Grant><Health><Health Care><Hereditary Disease><Human><Inborn Genetic Diseases><Individual><Inherited disorder><Institution><Investigation><Investigators><Ion Channel><Ionic Channels><Length of Life><Life><Link><Long-term cohort><Longevity><Longitudinal Studies><Longitudinal Surveys><Longitudinal cohort><Lung><Lung Diseases><Lung Respiratory System><Maintenance Therapy><Malnutrition><Medication><Membrane Channels><Mission><Modern Man><Modernization><Morbidity><Mucoviscidosis><Mutation><NHLBI><NIH><National Heart, Lung, and Blood Institute><National Institutes of Health><Neonatal Screening><Newborn Infant><Newborn Infant Screening><Newborns><Nutritional Deficiency><Occidental><Organ System><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Patients><Persons><Pharmaceutical Preparations><Physiopathology><Pilot Projects><Pneumonia><Pulmonary Cystic Fibrosis><Pulmonary Diseases><Pulmonary Disorder><Research><Research Personnel><Research Resources><Research Specimen><Research Support><Researchers><Resources><Running><Sampling><Scientist><Specimen><Supportive Therapy><Supportive care><Technology><Therapeutic><Time><Training><Translations><Undernutrition><United States><United States National Institutes of Health><Universities><accredited><active followup><advanced age><age 4><age 4 years><ages><biobank><biological specimen repository><biorepository><biosample repository><biospecimen bank><biospecimen repository><clinical database><cloud based><co-morbid><co-morbidity><cohort><comorbidity><computational infrastructure><computer infrastructure><cystic fibrosis lung><cystic fibrosis lung disease><cystic fibrosis patients><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><data interpretation><data preservation><data resource><data sharing><data streams><data warehouse><design><designing><developmental><dietary deficiency><disease of the lung><disorder of the lung><drug/agent><ethical><experience><follow up><follow-up><followed up><followup><four year old><four years of age><genetic condition><genetic disorder><genome mutation><geriatric><hereditary disorder><heritable disorder><human disease><human subject><improved><inborn error><individuals with CF><individuals with cystic fibrosis><infancy><infantile><inherited diseases><inherited genetic disease><inherited genetic disorder><kids><long-term study><longitudinal outcome studies><longitudinal research study><lung disorder><malnourished><model of animal><mortality><newborn child><newborn children><newborn screening><nutrition deficiency><nutrition deficiency disorder><nutritional deficiency disorder><pathophysiology><patients with CF><patients with cystic fibrosis><pilot study><preservation><privacy preservation><pulmonary><recruit><response><response to therapy><response to treatment><senior citizen><specimen bank><specimen repository><survival prediction><therapeutic response><therapy response><translation><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><white race><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NAEL A MCCARTY

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 56/100

Above-average budget

Very recent

Active award

Team-scale grant

$777,277

FY 2026

Project Title

The Georgia Cystic Fibrosis Data Warehouse

Grant Number:

5U24HL171672-03

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

3/1/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

1 PROJECT SUMMARY 2 Cystic fibrosis (CF) is the second-most common life-shortening inherited disease of Americans, arising from 3 mutations in the gene encoding the CFTR ion channel. A lifelong disease, CF impacts multiple organ systems 4 resulting in substantial treatment burden, although most o...

Research Terms

<0-11 years old><0-4 weeks old><4 year old><4 years of age><Accreditation><Active Follow-up><Address><Age><American><Animal Model><Animal Models and Related Studies><Architecture><Award><Biological Specimen Banks><Biological Substance Banks><Biomedical Research><Body System><CF lung disease><CF patients><CF related diabetes><CFTR><CFTR Protein><Caring><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Center Core Grants><Cessation of life><Child><Child Youth><Children (0-21)><Clinic><Clinical><Clinical Data><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Data Analyses><Data Analysis><Death><Development><Diagnosis><Disease><Disease Progression><Disorder><Drugs><Dysfunction><Ecologic Systems><Ecological Systems><Ecosystem><Elderly><Engineering / Architecture><Ethics><Event><Faculty><Foundations><Functional disorder><Genes><Genetic Change><Genetic Diseases><Genetic defect><Genetic mutation><Goals><Grant><Health><Health Care><Hereditary Disease><Human><Inborn Genetic Diseases><Individual><Inherited disorder><Institution><Investigation><Investigators><Ion Channel><Ionic Channels><Length of Life><Life><Link><Long-term cohort><Longevity><Longitudinal Studies><Longitudinal Surveys><Longitudinal cohort><Lung><Lung Diseases><Lung Respiratory System><Maintenance Therapy><Malnutrition><Medication><Membrane Channels><Mission><Modern Man><Modernization><Morbidity><Mucoviscidosis><Mutation><NHLBI><NIH><National Heart, Lung, and Blood Institute><National Institutes of Health><Neonatal Screening><Newborn Infant><Newborn Infant Screening><Newborns><Nutritional Deficiency><Occidental><Organ System><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Patients><Persons><Pharmaceutical Preparations><Physiopathology><Pilot Projects><Pneumonia><Pulmonary Cystic Fibrosis><Pulmonary Diseases><Pulmonary Disorder><Research><Research Personnel><Research Resources><Research Specimen><Research Support><Researchers><Resources><Running><Sampling><Scientist><Specimen><Supportive Therapy><Supportive care><Technology><Therapeutic><Time><Training><Translations><Undernutrition><United States><United States National Institutes of Health><Universities><accredited><active followup><advanced age><age 4><age 4 years><ages><biobank><biological specimen repository><biorepository><biosample repository><biospecimen bank><biospecimen repository><clinical database><cloud based><co-morbid><co-morbidity><cohort><comorbidity><computational infrastructure><computer infrastructure><cystic fibrosis lung><cystic fibrosis lung disease><cystic fibrosis patients><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><data interpretation><data preservation><data resource><data sharing><data streams><data warehouse><design><designing><developmental><dietary deficiency><disease of the lung><disorder of the lung><drug/agent><ethical><experience><follow up><follow-up><followed up><followup><four year old><four years of age><genetic condition><genetic disorder><genome mutation><geriatric><hereditary disorder><heritable disorder><human disease><human subject><improved><inborn error><individuals with CF><individuals with cystic fibrosis><infancy><infantile><inherited diseases><inherited genetic disease><inherited genetic disorder><kids><long-term study><longitudinal outcome studies><longitudinal research study><lung disorder><malnourished><model of animal><mortality><newborn child><newborn children><newborn screening><nutrition deficiency><nutrition deficiency disorder><nutritional deficiency disorder><pathophysiology><patients with CF><patients with cystic fibrosis><pilot study><preservation><privacy preservation><pulmonary><recruit><response><response to therapy><response to treatment><senior citizen><specimen bank><specimen repository><survival prediction><therapeutic response><therapy response><translation><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><white race><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Arlene A Stecenko

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 56/100

Above-average budget

Very recent

Active award

Team-scale grant

$777,277

FY 2026

Project Title

The Georgia Cystic Fibrosis Data Warehouse

Grant Number:

5U24HL171672-03

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

3/1/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

1 PROJECT SUMMARY 2 Cystic fibrosis (CF) is the second-most common life-shortening inherited disease of Americans, arising from 3 mutations in the gene encoding the CFTR ion channel. A lifelong disease, CF impacts multiple organ systems 4 resulting in substantial treatment burden, although most o...

Research Terms

<0-11 years old><0-4 weeks old><4 year old><4 years of age><Accreditation><Active Follow-up><Address><Age><American><Animal Model><Animal Models and Related Studies><Architecture><Award><Biological Specimen Banks><Biological Substance Banks><Biomedical Research><Body System><CF lung disease><CF patients><CF related diabetes><CFTR><CFTR Protein><Caring><Caucasian><Caucasian Race><Caucasians><Caucasoid><Caucasoid Race><Center Core Grants><Cessation of life><Child><Child Youth><Children (0-21)><Clinic><Clinical><Clinical Data><Cystic Fibrosis><Cystic Fibrosis Transmembrane Conductance Regulator><DNA mutation><Data><Data Analyses><Data Analysis><Death><Development><Diagnosis><Disease><Disease Progression><Disorder><Drugs><Dysfunction><Ecologic Systems><Ecological Systems><Ecosystem><Elderly><Engineering / Architecture><Ethics><Event><Faculty><Foundations><Functional disorder><Genes><Genetic Change><Genetic Diseases><Genetic defect><Genetic mutation><Goals><Grant><Health><Health Care><Hereditary Disease><Human><Inborn Genetic Diseases><Individual><Inherited disorder><Institution><Investigation><Investigators><Ion Channel><Ionic Channels><Length of Life><Life><Link><Long-term cohort><Longevity><Longitudinal Studies><Longitudinal Surveys><Longitudinal cohort><Lung><Lung Diseases><Lung Respiratory System><Maintenance Therapy><Malnutrition><Medication><Membrane Channels><Mission><Modern Man><Modernization><Morbidity><Mucoviscidosis><Mutation><NHLBI><NIH><National Heart, Lung, and Blood Institute><National Institutes of Health><Neonatal Screening><Newborn Infant><Newborn Infant Screening><Newborns><Nutritional Deficiency><Occidental><Organ System><Outcome><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Patients><Persons><Pharmaceutical Preparations><Physiopathology><Pilot Projects><Pneumonia><Pulmonary Cystic Fibrosis><Pulmonary Diseases><Pulmonary Disorder><Research><Research Personnel><Research Resources><Research Specimen><Research Support><Researchers><Resources><Running><Sampling><Scientist><Specimen><Supportive Therapy><Supportive care><Technology><Therapeutic><Time><Training><Translations><Undernutrition><United States><United States National Institutes of Health><Universities><accredited><active followup><advanced age><age 4><age 4 years><ages><biobank><biological specimen repository><biorepository><biosample repository><biospecimen bank><biospecimen repository><clinical database><cloud based><co-morbid><co-morbidity><cohort><comorbidity><computational infrastructure><computer infrastructure><cystic fibrosis lung><cystic fibrosis lung disease><cystic fibrosis patients><cystic fibrosis related diabetes><cystic fibrosis transmembrane regulator><data interpretation><data preservation><data resource><data sharing><data streams><data warehouse><design><designing><developmental><dietary deficiency><disease of the lung><disorder of the lung><drug/agent><ethical><experience><follow up><follow-up><followed up><followup><four year old><four years of age><genetic condition><genetic disorder><genome mutation><geriatric><hereditary disorder><heritable disorder><human disease><human subject><improved><inborn error><individuals with CF><individuals with cystic fibrosis><infancy><infantile><inherited diseases><inherited genetic disease><inherited genetic disorder><kids><long-term study><longitudinal outcome studies><longitudinal research study><lung disorder><malnourished><model of animal><mortality><newborn child><newborn children><newborn screening><nutrition deficiency><nutrition deficiency disorder><nutritional deficiency disorder><pathophysiology><patients with CF><patients with cystic fibrosis><pilot study><preservation><privacy preservation><pulmonary><recruit><response><response to therapy><response to treatment><senior citizen><specimen bank><specimen repository><survival prediction><therapeutic response><therapy response><translation><translational investigator><translational researcher><translational scientist><treatment response><treatment responsiveness><white race><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Bolanle Famakin

UNIVERSITY OF WISCONSIN-MADISON, MADISON, WI

Good lead · 56/100

Training-friendly

Very recent

Active award

Career award

$239,490

FY 2026

Project Title

Astrocyte-specific TLR4 signaling and Blood Brain Barrier permeability following acute focal cerebral ischemia

Grant Number:

5K08NS130144-04

Activity Code:

K08

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

3/1/2023

End Date:

2/29/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY/ABSTRACT Currently approved stroke therapies include underutilized, time-limited, systemic thrombolysis and mechanical recanalization options. Therefore, there is a need for more affordable and flexible approaches to treatment that can be disseminated widely. One approach includes ta...

Research Terms

<7S Gamma Globulin><92-kDa Gelatinase><92-kDa Type IV Collagenase><Abscission><Acquired brain injury><Acute><Adhesives><Affect><Amphoterin><Amphoterin Gene><Antibodies><Apoplexy><Astrocytes><Astrocytus><Astroglia><Attenuated><Award><BBB permeabilization><BBB permeable><Blood - brain barrier anatomy><Blood Serum><Blood-Brain Barrier><Body Tissues><Brain><Brain Injuries><Brain Nervous System><Brain Vascular Accident><Cell Body><Cell Communication and Signaling><Cell Signaling><Cell Survival><Cell Viability><Cells><Cerebral Ischemia><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Common Rat Strains><Complement><Complement Proteins><D-Glucose><DNA Recombination><Data><Development><Dextrose><Encephalon><Equipment><Excision><Extirpation><Extravasation><FM1 Gene Product><Fluorescence><Foundations><Funding><Gelatinase B><Gene Expression><Genetic Recombination><Glucose><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Hemato-Encephalic Barrier><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Homolog of Drosophila TOLL><Hortega cell><Hypoxia><Hypoxic><IgG><Immune><Immune Cell Activation><Immune system><Immunes><Immunoblotting><Immunoglobulin G><Immunohistochemistry><Immunohistochemistry Cell/Tissue><Immunohistochemistry Staining Method><Immunomodulation><Incubated><Inflammation><Innate Immunity><Intracellular Communication and Signaling><Ischemia><Knowledge><Lead><Leakage><Ligands><MMP-9><MMP-9 Protein><Macrophage><Macrophage Gelatinase><Matrix Metalloproteinase-9><Mechanics><Mediating><Mice><Mice Mammals><Microglia><Middle Cerebral Artery Occlusion><Modeling><Molecular><Murine><Mus><Mφ><Native Immunity><Natural Immunity><Non-Specific Immunity><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nonspecific Immunity><O element><O2 element><Outcome><Oxygen><Oxygen Deficiency><Pathway interactions><Patients><Pattern><Pb element><Permeability><Phase><Process><RNA Seq><RNA sequencing><RNAseq><Rat><Rats Mammals><Rattus><Recombinants><Recombination><Removal><Research><Role><SBP-1><SBP-1 Gene><Serum><Signal Induction><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Specificity><Spillage><Staining method><Stains><Stroke><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Surgical Removal><TLR protein><TLR4><TLR4 gene><Tamoxifen><Testing><Therapeutic><Time><Tissues><Toll Homologue><Toll-Like Receptor Family Gene><Toll-like receptors><Type V Collagenase><Validation><Vascular Permeabilities><Walking><Western Blotting><Western Immunoblotting><after stroke><astrocytic glia><attenuate><attenuates><behavior outcome><behavioral outcome><biological signal transduction><blood-brain barrier permeabilization><blood-brain barrier permeable><bloodbrain barrier><bloodbrain barrier permeabilization><bloodbrain barrier permeable><brain attack><brain damage><brain microvasculature><brain microvessels><brain-injured><career><cerebral microvasculature><cerebral microvessels><cerebral vascular accident><cerebrovascular accident><clinical relevance><clinically relevant><complementation><deprivation><developmental><flexibility><flexible><foot><gitter cell><heavy metal Pb><heavy metal lead><immune activation><immune modulation><immune regulation><immunologic reactivity control><immunomodulatory><immunoregulation><immunoregulatory><improved><improved outcome><in vitro Model><in vivo><injured><injury to tissue><mechanic><mechanical><mesoglia><microglial cell><microgliocyte><nerve cell death><nerve cell loss><neuro-vascular><neuro-vascular unit><neurobehavioral><neuron cell death><neuron cell loss><neuron death><neuron loss><neuronal cell death><neuronal cell loss><neuronal death><neuronal loss><neurovascular><neurovascular unit><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><pathway><perivascular glial cell><phospho-proteomics><phosphoproteomics><post stroke><poststroke><protein blotting><resection><response><social role><stroke outcome><stroke therapy><stroke treatment><stroked><strokes><thrombolysis><tissue injury><toll-like receptor 4><transcriptome sequencing><transcriptomic sequencing><transcriptomics><treating stroke><validations>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alexandru Daniel Iordan

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Good lead · 56/100

Training-friendly

Very recent

Active award

Career award

$128,520

FY 2026

Project Title

Understanding the Role of Alzheimer’s Disease Pathology in Mild Behavioral Impairment

Grant Number:

5K01AG086617-02

Activity Code:

K01

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/15/2025

End Date:

3/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Project Summary An estimated 6.7 million US adults live with Alzheimer’s disease (AD) and related dementias (ADRD); a figure that is expected to more than double by 2060 unless new prevention strategies or treatments emerge. Although later-life neuropsychiatric symptoms have been associated with a g...

Research Terms

<21+ years old><AD and related dementia><AD biological marker><AD biomarker><AD dementia><AD pathology><AD related biomarker><AD related dementia><ADRD><Accounting><Address><Adult><Adult Human><Affect><Alzheimer Type Dementia><Alzheimer disease dementia><Alzheimer sclerosis><Alzheimer syndrome><Alzheimer's><Alzheimer's Disease><Alzheimer's Disease and its related dementias><Alzheimer's and related dementias><Alzheimer's biomarker><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease and related forms of dementia><Alzheimer's disease biological marker><Alzheimer's disease biomarker><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease pathology><Alzheimer's disease related biomarker><Alzheimer's disease related dementia><Alzheimer's pathology><Alzheimer's related biomarker><Alzheimers Dementia><Alzheimer’s biological marker><Amentia><Area><Atrophic><Atrophy><Behavioral><Bilateral><Blood><Blood Reticuloendothelial System><Brain><Brain Nervous System><Brain region><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Data><Dementia><Diagnostic><Disease><Disorder><Disturbance in cognition><Dysfunction><Early Diagnosis><Emotional><Encephalon><Functional disorder><Funding><Future><Goals><Impaired cognition><Individual><Inferior><Intervention><Investigators><K01 Award><K01 Mechanism><K01 Program><Knowledge><Life><Link><Long-term cohort><Longitudinal cohort><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Measures><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Memory><Mentored Research Scientist Development Award><Mentored Training Award><Michigan><Modeling><NMR Imaging><NMR Tomography><Nerve Degeneration><Network-based><Neuranatomies><Neuranatomy><Neuroanatomies><Neuroanatomy><Neuron Degeneration><Non-pharmacologic Therapy><Nonpharmacologic Intervention><Nonpharmacologic Therapy><Nonpharmacologic approach><Nonpharmacologic treatment><Nuclear Magnetic Resonance Imaging><Outcome><Parietal Lobe><Pathology><Pattern><Phase><Phenotype><Physiopathology><Pilot Projects><Preventative strategy><Prevention strategy><Preventive strategy><Primary Senile Degenerative Dementia><QOL><Quality of life><Research><Research Personnel><Research Scientist Development Award><Researchers><Risk><Role><Severities><Standardization><Structure><Symptoms><Testing><Training><Translating><Zeugmatography><adulthood><analog><behavioral impairment><biomarker in AD><biomarker in Alzheimer's><biomarker in Alzheimer's disease><blood-based biomarker><blood-based marker><brain atrophy><cerebral atrophy><cognitive dysfunction><cognitive loss><cohort><cortical atrophy><cost effective><dementia risk><early detection><emotional experience><gray matter><high definition><high-resolution><impaired behavior><improved><indexing><medial temporal area><medial temporal lobe><mesial temporal area><mesial temporal lobe><mild cognitive decline><mild cognitive disorder><mild cognitive dysfunction><mild cognitive impairment><mild cognitive loss><mild neurocognitive impairment><neural><neural circuit><neural circuitry><neural control><neural degeneration><neural imaging><neural network><neural regulation><neuro-imaging><neurocircuitry><neurodegeneration><neurodegenerative><neuroimaging><neurological degeneration><neurological imaging><neuromodulation><neuromodulatory><neuronal degeneration><neuropsychiatric symptom><neuroregulation><new marker><non-drug therapy><non-drug treatment><nondrug therapy><nondrug treatment><novel><novel biomarker><novel marker><older adult><older adulthood><open label><open label study><parietal cortex><pathophysiology><pilot study><pre-clinical><preclinical><primary degenerative dementia><regional atrophy><risk factor for dementia><risk for dementia><senile dementia of the Alzheimer type><single molecule><skills><social role><substantia grisea><synaptic circuit><synaptic circuitry><transcranial direct current stimulation><treatment planning><treatment strategy>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Benjamin Michael Hampstead

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Good lead · 54/100

Likely hiring

Above-average budget

Active award

$818,448

FY 2025

Project Title

Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI)

Grant Number:

5R35AG072262-05

Activity Code:

R35

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

4/15/2021

End Date:

3/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.
• Award size is strong enough to merit immediate review.

Project Abstract

Abstract Project description: The NIA’s Alzheimer’s disease and related dementia (ADRD) Milestone 8 focuses on the development and translation of non-pharmacologic interventions and is particularly timely given four facts. First, existing pharmacologic agents have shown limited success. Second, the ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Abigail S Hackam

UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, CORAL GABLES, FL

Good lead · 54/100

Likely hiring

Solid budget

Active award

Team-scale grant

$340,610

FY 2025

Project Title

Miami Center for Vision Research

Grant Number:

5P30EY014801-20

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

5/1/2004

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

SUMMARY The Evelyn F. and William L. McKnight Vision Research Center (MVRC) coordinates all aspects of the research mission of the Bascom Palmer Eye Institute (BPEI) and draws together all NIH- NEI funded eye and vision research investigators across the University of Miami and nearby institutions. T...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JIANREN MAO

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 52/100

Likely hiring

Solid budget

Active award

$477,289

FY 2026

Project Title

Co-Targeting IL-6 and EGFRsignaling for the Treatment of Schwannomatosis and Associated Pain

Grant Number:

5R01NS126187-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/1/2022

End Date:

11/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT Schwannomatosis (SWN) is a genetic disorder characterized by multiple non-malignant schwannomas growing on the spine and peripheral nerves. Patients with SWN overwhelmingly present with intractable, debilitating chronic pain, severe enough to cause permanent disability. The etiology of pain...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lei Xu

MASSACHUSETTS GENERAL HOSPITAL, BOSTON, MA

Good lead · 52/100

Likely hiring

Solid budget

Active award

$477,289

FY 2026

Project Title

Co-Targeting IL-6 and EGFRsignaling for the Treatment of Schwannomatosis and Associated Pain

Grant Number:

5R01NS126187-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

12/1/2022

End Date:

11/30/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

ABSTRACT Schwannomatosis (SWN) is a genetic disorder characterized by multiple non-malignant schwannomas growing on the spine and peripheral nerves. Patients with SWN overwhelmingly present with intractable, debilitating chronic pain, severe enough to cause permanent disability. The etiology of pain...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lewis Z. Shi

UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL

Good lead · 52/100

Likely hiring

Solid budget

Active award

$402,861

FY 2026

Project Title

T cell-intrinsic metabolic control of radiotherapy

Grant Number:

5R01CA279849-03

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2024

End Date:

1/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT Unprecedented clinical successes in past 12 years with immune checkpoint blockers (ICBs) such as anti- CTLA-4 and anti-PD-1 re-instigate strong interests in recent years to study the interplay between radiotherapy (RT) and the immune system, a long-forgone observation. Recen...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jianxiong Jiang

UNIVERSITY OF TENNESSEE HEALTH SCI CTR, MEMPHIS, TN

Good lead · 52/100

Likely hiring

Solid budget

Active award

$385,000

FY 2026

Project Title

Inflammatory regulation of epileptogenesis after status epilepticus

Grant Number:

5R01NS100947-09

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/3/2018

End Date:

11/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY As the second most common neurological emergency, status epilepticus (SE) is a group of life-threatening conditions that are characterized by hypersynchronous epileptic activity that lasts for five minutes or longer without full return of consciousness, and the overall SE-associated ...

Research Terms

<(TNF)-α><21+ years old><3'5'-cyclic ester of AMP><3-D><3-Dimensional><3D><5-Isothiocyanatofluorescein><7S Gamma Globulin><Ablation><Acute><Adenosine Cyclic 3',5'-Monophosphate><Adenosine Cyclic Monophosphate><Adenosine, cyclic 3',5'-(hydrogen phosphate)><Adult><Adult Human><Adventitial Cell><Adverse effects><Albumins><Ammon Horn><Amphoterin><Amphoterin Gene><Anti-epileptogenic><Anticonvulsant Agent><Anticonvulsant Drugs><Anticonvulsants><Anticonvulsive Agents><Anticonvulsive Drugs><Antiepileptogenic><Apoplexy><Astrocytes><Astrocytus><Astroglia><Astroprotein><B-Cell Differentiation Factor><B-Cell Differentiation Factor-2><B-Cell Stimulatory Factor-2><BBB disruption><BBB permeabilization><BBB permeable><BCDF><BDNF><BSF-2><BSF2><Behavioral><Beta Proprotein Interleukin 1><Blood - brain barrier anatomy><Blood Cells><Blood Proteins><Blood monocyte><Blood-Brain Barrier><Brain><Brain Inflammation><Brain Neoplasia><Brain Neoplasms><Brain Nervous System><Brain Tumors><Brain Vascular Accident><Brain-Derived Neurotrophic Factor><CNS infection><CREB><CREB1><CREB1 gene><Cachectin><Causality><Cell Communication and Signaling><Cell Signaling><Central Nervous System Infections><Central Nervous System Infectious Disease><Central Nervous System Infectious Disorder><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Chronic><Cognitive deficits><Conscious><Consciousness><Cornu Ammonis><Coupled><Cyclic AMP><Darkness><Death Rate><Development><Dinoprostone><Disease><Disease Progression><Disorder><Drug Therapy><Drugs><Dysfunction><EEG><Electroencephalogram><Electroencephalography><Encephalitis><Encephalon><Endothelial Cells><Epilepsy><Epileptic Seizures><Epileptics><Epileptogenesis><Etiology><Extravasation><FDA approved><FITC><FM1 Gene Product><Fluorescein-5-isothiocyanate><Functional disorder><Funding><G(s), alpha Subunit><G(s), α Subunit><G(s)alpha><G(s)α><GFA-Protein><GFAP><GTP-Binding Protein alpha Subunits, Gs><GTP-Binding Protein α Subunits, Gs><Generalized Convulsive Status Epilepticus><Generalized Status Epilepticus><Genetic><Glial Fibrillary Acid Protein><Glial Fibrillary Acidic Protein><Glial Intermediate Filament Protein><Gliosis><Goals><Grand Mal Status Epilepticus><Grant><Gs alpha Family G-Protein><Gsα><Gαs><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HPGF><Hemato-Encephalic Barrier><Heparin-Binding Protein p30><Hepatocyte-Stimulating Factor><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Hippocampus><Hortega cell><Hybridoma Growth Factor><IFN-beta 2><IFNB2><IL-1 beta><IL-1 β><IL-1-b><IL-1β><IL-6><IL1-Beta><IL1-β><IL1B Protein><IL1F2><IL1β><IL6 Protein><IgG><Immunoglobulin G><Impairment><In Vitro><Infection><Infiltration><Inflammation><Inflammation Mediators><Inflammatory><Interleukin 1beta><Interleukin-1 beta><Interleukin-1β><Interleukin-6><Intracellular Communication and Signaling><Leakage><Leucocytic infiltrate><Life><Light><MGI-2><Macrophage-Derived TNF><Marrow monocyte><Mediating><Medication><Mice><Mice Mammals><Microglia><Modeling><Modification><Molecular><Monocyte-Derived TNF><Murine><Mus><Myeloid Differentiation-Inducing Protein><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurologic><Neurological><Neurological emergencies><Neurons><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Occluding Junctions><Outcome><PGE2><PGE2 alpha><PGE2alpha><Pathologic><Pathway interactions><Patients><Pericapillary Cell><Pericytes><Peripheral Blood Cell><Perivascular Cell><Pharmaceutical Preparations><Pharmacological Treatment><Pharmacotherapy><Phase><Photoradiation><Physiopathology><Plasmacytoma Growth Factor><Play><Preinterleukin 1 Beta><Prevention><Process><Prostaglandin E2><Prostaglandin E2 alpha><Prostaglandin E2alpha><Prostaglandins><Prostanoids><Proteins><Receptor Protein><Refractory><Regulation><Regulatory Ns Protein><Research><Risk><Risk Factors><Rodent><Rodentia><Rodents Mammals><Role><Rouget Cells><SBP-1><SBP-1 Gene><Seizure Disorder><Seizures><Series><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Spillage><Status Epilepticus><Stimulatory Gs G-Protein><Stroke><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Tamoxifen><Testing><Tight Junctions><Time><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Work><Zonula Occludens><acquired epilepsy><acquired factor><adenosine 3'5' monophosphate><adulthood><alpha Subunit Stimulatory GTP-Binding Protein><alpha-Gs><anxiety-like behavior><astrocytic glia><biological signal transduction><blood-brain barrier disruption><blood-brain barrier permeabilization><blood-brain barrier permeable><bloodbrain barrier><bloodbrain barrier disruption><bloodbrain barrier permeabilization><bloodbrain barrier permeable><brain attack><brain endothelial cell><brain microvascular endothelial cell><brain vascular endothelial cell><cAMP><cAMP Response Element-Binding Protein 1><causation><cell type><cerebral endothelial cell><cerebral microvascular endothelial cell><cerebral vascular accident><cerebral vascular endothelial cell><cerebrovascular accident><co-morbid><co-morbidity><cognitive defects><comorbidity><cytokine><developmental><disease causation><drug development><drug discovery><drug intervention><drug treatment><drug/agent><epilepsia><epilepsy prevention><epileptogenic><fluoro jade><gene manipulation><genetic manipulation><genetically manipulate><genetically perturb><gitter cell><glial activation><glial cell activation><hippocampal><in vivo><inflammatory mediator><inhibitor><insight><interferon beta 2><kainate><knock-down><knockdown><mPGES-1><mesoglia><microglial cell><microgliocyte><monocyte><mortality rate><mouse PGE synthase 1><nerve cell death><nerve cell loss><neural inflammation><neuro-vascular><neuro-vascular unit><neuroinflammation><neuroinflammatory><neuron cell death><neuron cell loss><neuron death><neuron loss><neuronal><neuronal cell death><neuronal cell loss><neuronal death><neuronal loss><neuropathologic><neuropathological><neuropathology><neurotoxic><neurovascular><neurovascular unit><new drug target><new druggable target><new pharmacotherapy target><new therapeutic target><new therapy target><novel><novel drug target><novel druggable target><novel pharmacotherapy target><novel therapeutic target><novel therapy target><object recognition><occludin><pathophysiology><pathway><perivascular glial cell><pharmaceutical intervention><pharmacologic><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><prevent><preventable epilepsy><preventing><receptor><seizure drug><seizure medication><side effect><social role><stroked><strokes><three dimensional><tumor><tumors in the brain><α-Gs>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Anna Goodman Hoover

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Good lead · 52/100

Likely hiring

Solid budget

Active award

$368,566

FY 2026

Project Title

A university-community partnership to reduce exposure to disinfection byproducts in Appalachia

Grant Number:

5R01ES032396-06

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/1/2021

End Date:

10/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs) .. DBPs include trihalomethanes (TH Ms), haloacetic acids (HAAs), chlorate, and other compounds that have been associated wit...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jason Unrine

UNIVERSITY OF KENTUCKY, LEXINGTON, KY

Good lead · 52/100

Likely hiring

Solid budget

Active award

$368,566

FY 2026

Project Title

A university-community partnership to reduce exposure to disinfection byproducts in Appalachia

Grant Number:

5R01ES032396-06

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

1/1/2021

End Date:

10/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Appalachian Kentuckians in Martin and Letcher Counties are grappling with a health-threatening drinking water crisis arising from exposures to disinfection by-products (DBPs) .. DBPs include trihalomethanes (TH Ms), haloacetic acids (HAAs), chlorate, and other compounds that have been associated wit...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lionel B Ivashkiv

HOSPITAL FOR SPECIAL SURGERY, New York, NY

Good lead · 52/100

Likely hiring

Solid budget

Active award

$352,440

FY 2026

Project Title

Cytokine Balance in Rheumatoid Arthritis

Grant Number:

5R01AR050401-20

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/10/2004

End Date:

1/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Activated synovial macrophages (M[phi]s) are major producers of pathogenic cytokines, and play a key role in RA pathogenesis. The long term goals of this project are to understand mechanisms that regulate the balance between activating and feedback inhibitory signaling pathways that are activated in...

Research Terms

<(TNF)-α><AP-1><AP-1 Enhancer-Binding Protein><AP1><AP1 protein><ATF><Ablation><Activator Protein-1><Amphoterin><Amphoterin Gene><Antibody Response><Antigen-Antibody Complex><Apical><Arthritis><Atrophic Arthritis><Attenuated><Autocrine Systems><B-Cell Differentiation Factor><B-Cell Differentiation Factor Gene><B-Cell Differentiation Factor-2><B-Cell Stimulatory Factor 2 Gene><B-Cell Stimulatory Factor-2><B-Cells><B-Lymphocytes><B-cell><BAC clone><BACs><BCDF><BSF-2><BSF-2 Gene><BSF2><BSF2 Gene><Bacterial Artificial Chromosomes><Basal Transcription Factor><Basal transcription factor genes><Beta-2 Gene Interferon><Blood monocyte><Body Tissues><CAP-18><CAP18><CAP18 lipopolysaccharide-binding protein><CRAMP protein><CSIF><CSIF-10><Cachectin><Cell Body><Cell Communication and Signaling><Cell Death><Cell Signaling><Cell surface><Cells><Chemotactic Cytokines><Chromatin><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Cnlp><Cytokine Signal Transduction><Cytokine Signaling><Cytokine Synthesis Inhibitory Factor><DNA><Dendritic Cells><Deoxyribonucleic Acid><Disease><Disorder><Endocytosis><Endogenous Interferon Beta><Endosomes><Enhancer-Binding Protein AP1><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Equilibrium><Exhibits><Extracellular Matrix Degradation><FLJ11330><FM1 Gene Product><Feedback><Fibroblast Interferon><Gene Activation><Gene Inactivation><Gene Silencing><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genes><Genetic Transcription><Goals><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><HPGF><HSF Gene><Heparin-Binding Protein p30><Hepatocyte Stimulatory Factor Gene><Hepatocyte-Stimulating Factor><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Homologous Chemotactic Cytokines><Host Defense><Human><Hybridoma Growth Factor><Hybridoma Growth Factor Gene><Hypoxia><Hypoxic><IFN><IFN-beta 2><IFN-β><IFNB2><IFNB2 Gene><IFNb><IKK epsilon><IKKepsilon><IL-10><IL-6><IL-6 Gene><IL10><IL10A><IL6><IL6 Protein><IL6 gene><Immune Complex><Immunoglobulin Enhancer-Binding Protein><In Vitro><Individual><Infiltration><Inflammation><Inflammatory><Inflammatory Arthritis><Intercrines><Interferon-β><Interferons><Interleukin 10 Precursor><Interleukin 6 (Interferon, Beta 2) Gene><Interleukin-10><Interleukin-6><Interleukin-6 Gene><Intracellular Communication and Signaling><Joints><Knowledge><LEF Transcription Factor><LL37><Link><Lymphoid Enhancer Factor><MGI-2><Macrophage><Macrophage-Derived TNF><Marrow monocyte><Mediating><Membrana Synovialis Capsulae Articularis><Mice><Mice Mammals><Modeling><Modern Man><Molecular><Monocyte-Derived TNF><Murine><Mus><Myeloid Cells><Myeloid Differentiation-Inducing Protein><Mφ><NF-Kb-Activating Kinase Gene><NF-kB><NF-kappa B><NF-kappaB><NFKB><Natural Interferon Beta><Natural human interferon beta><Non-Polyadenylated RNA><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nuclear Factor kappa B><Nuclear Transcription Factor NF-kB><Nucleic Acid Binding><Nucleic Acids><Oxygen Deficiency><Pathogenesis><Pathogenicity><Pathologic><Pathology><Pathway interactions><Patients><Pattern><Peptides><Physiologic><Physiological><Plasmacytoma Growth Factor><Play><Production><RNA><RNA Expression><RNA Gene Products><Receptosomes><Regulation><Resolution><Rheumatoid Arthritis><Ribonucleic Acid><SBP-1><SBP-1 Gene><SIS cytokines><STAT3><STAT3 gene><Seminal><Signal Pathway><Signal Transduction><Signal Transduction Systems><Signaling><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Synovial Membrane><Synovitis><Synovium><T Cell Factor><T2K><TBK1><TBK1 gene><TCF Transcription Factor><TIL4><TLR protein><TLR2><TLR2 gene><TLR2 receptor><TLR3><TLR3 gene><TLR7><TLR7 gene><TLR8><TLR8 gene><TNF><TNF A><TNF Alpha><TNF gene><TNF-α><TNFA><TNFα><Testing><Therapeutic><Tissues><Toll-Like Receptor 2><Toll-Like Receptor 3><Toll-Like Receptor 7><Toll-Like Receptor 8><Toll-Like Receptor Family Gene><Toll-like receptors><Toll/Interleukin 1 Receptor-Like 4><Toll/Interleukin 1 Receptor-Like 4 Gene><Toll/Interleukin 1 Receptor-Like Protein 4><Transcription><Transcription Factor AP-1><Transcription Factor NF-kB><Transcription Factor Proto-Oncogene><Transcription factor genes><Transgenic Mice><Tumor Necrosis Factor><Tumor Necrosis Factor-alpha><Veiled Cells><Work><activating transcription factor><arthritic><attenuate><attenuates><autocrine><balance><balance function><biological signal transduction><cathelicidin antimicrobial peptide><cathelin-like protein><cathelin-related antimicrobial peptide><chemoattractant cytokine><chemokine><chromatin remodeling><cytokine><epigenetically><epigenomics><gene induction><in vivo Model><induction of genes><inflamed joint><inflamed synovial tissue><inflamed synovium><inhibitor><insight><interferon beta 2><joint damage><joint inflammation><joint injury><joint swelling><joint trauma><kappa B Enhancer Binding Protein><monocyte><necrocytosis><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><nuclear factor kappa beta><pathway><patient subclass><patient subcluster><patient subgroups><patient subpopulations><patient subsets><patient subtypes><resistance to therapy><resistant to therapy><resolutions><response><rheumatic arthritis><selective expression><selectively expressed><sensor><synergism><synovial inflammation><therapeutic resistance><therapeutic target><therapy resistant><trafficking><transcription factor><transcriptional silencing><treatment resistance>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Charles J Cho

EMORY UNIVERSITY, ATLANTA, GA

Good lead · 48/100

Training-friendly

Recent

Active award

Career award

$155,693

FY 2026

Project Title

THE ROLE OF RIBOSOMES IN METAPLASIA IN THE GASTROINTESTINAL TRACT

Grant Number:

5K01DK137030-03

Activity Code:

K01

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/4/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY / ABSTRACT This K01 application proposes a ﬁve-year career development and research program focused on determining how ribosomes are regulated during zymogenic cell (ZC) metaplasia and how this process plays a critical role in regeneration and tumorigenesis. Candidate: Charles J. Cho...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Habibul Ahsan

UNIVERSITY OF CHICAGO, CHICAGO, IL

Good lead · 48/100

Training-friendly

Very recent

Active award

$135,000

FY 2026

Project Title

Chicago UP on the Environmental Health Sciences

Grant Number:

5R25ES031873-07

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/1/2020

End Date:

3/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

ABSTRACT Chicago’s community areas demonstrate wide variation in environmental quality, disease risk, and outcomes, indicating a critical need for environmental health research across the city. In 2017, the “ChicAgo Center for Health and EnvironmenT (CACHET)” was established at UChicago – the first ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Briseis A Aschebrook-Kilfoy

UNIVERSITY OF CHICAGO, CHICAGO, IL

Good lead · 48/100

Training-friendly

Very recent

Active award

$135,000

FY 2026

Project Title

Chicago UP on the Environmental Health Sciences

Grant Number:

5R25ES031873-07

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/1/2020

End Date:

3/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

ABSTRACT Chicago’s community areas demonstrate wide variation in environmental quality, disease risk, and outcomes, indicating a critical need for environmental health research across the city. In 2017, the “ChicAgo Center for Health and EnvironmenT (CACHET)” was established at UChicago – the first ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Evan Ratzan

BOSTON CHILDREN'S HOSPITAL, BOSTON, MA

Good lead · 48/100

Training-friendly

Recent

Active award

Career award

$132,705

FY 2026

Project Title

Defining the role of MET components in vestibular hair cell maturation and gene therapy responsiveness

Grant Number:

5K99DC022343-02

Activity Code:

K99

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/17/2024

End Date:

11/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Abstract Balance and equilibrioception depend on vestibular hair cells that encode motion through mechanoelectrical transduction channels (MET) during movements of the head. Mutations in mechanoelectrical transduction channel genes (Tmc, Cib, Tmie, Lhfpl5) result in issues with hearing and balance i...

Research Terms

<21+ years old><ARHGEF5><ARHGEF5 gene><Actins><Adult><Adult Human><Affect><Aminoglycoside Agents><Aminoglycoside Antibiotics><Aminoglycoside Drugs><Auditory><Autopsy><Brain><Brain Nervous System><CDDP><CIB2><Calcium><Calcium and Integrin Binding Protein 2><Calcium-Binding Proteins><Cell Body><Cell Communication and Signaling><Cell Death><Cell Function><Cell Maturation><Cell Physiology><Cell Process><Cell Signaling><Cell Survival><Cell Viability><Cell membrane><Cells><Cellular Function><Cellular Mechanotransduction><Cellular Physiology><Cellular Process><Cis-diammine-dichloroplatinum><Cis-diamminedichloridoplatinum><Cis-diamminedichloro Platinum (II)><Cis-dichloroammine Platinum (II)><Cis-platinous Diamine Dichloride><Cis-platinum II><Cis-platinum II Diamine Dichloride><Cisplatin><Cisplatina><Cisplatinum><Clinical><Cochlea><Cochlear Organ><Coloring Agents><Compensation><Complex><Corti Cell><Cysplatyna><Cytoplasmic Membrane><DNA Therapy><DNA mutation><Data><Development><Diagnosis><Dichlorodiammineplatinum><Dyes><Dysfunction><Encephalon><Equilibrium><Equilibrium Hair Cell><Event><Evoked Potentials><Exhibits><Experimental Designs><FISH Technic><FISH Technique><FISH analysis><FISH assay><Failure><Fiber><Fluorescence Agents><Fluorescence In Situ Hybridization><Fluorescent Agents><Fluorescent Dyes><Fluorescent in Situ Hybridization><Foundations><Functional disorder><Future><GEF5><Gene Alteration><Gene Mutation><Gene Transfer Clinical><Genes><Genetic><Genetic Change><Genetic Intervention><Genetic defect><Genetic mutation><Goals><Hair Cells><Head Movements><Hearing><Human><Image><Injections><Injury><Internal Ear><Intracellular Communication and Signaling><K element><KO mice><Knock-out Mice><Knockout Mice><Labyrinth><Link><Mechanical Signal Transduction><Mechanics><Mechanosensory Transduction><Mediating><Mice><Mice Mammals><Modern Man><Motion><Murine><Mus><Mutation><Natural regeneration><Neonatal><Null Mouse><Organ><P60><Patients><Permeability><Persons><Peyrone's Chloride><Peyrone's Salt><Phenotype><Physiopathology><Plasma Membrane><Platinum Diamminodichloride><Play><Population><Potassium><Precision therapeutics><Proteins><Quantitative RTPCR><Quantitative Reverse Transcriptase PCR><Regeneration><Research Methodology><Research Methods><Rest><Role><Saccule and Utricle><Sensory><Signal Transduction><Signal Transduction Systems><Signaling><Source><Subcellular Process><TIM1><Testing><Therapeutic><Therapeutic Intervention><Utricle structure><Utricles><Vestibular><Vestibular Hair Cells><Vestibular System Function><Vestibular function><Viral><adulthood><aged mice><aged mouse><balance><balance disorder><balance function><balance impairment><biological signal transduction><calcium indicator><cis dichlorodiammineplatinum><cis platinum compound><cis-Diaminedichloroplatinum><cis-Diamminedichloroplatinum><cis-Diamminedichloroplatinum(II)><cis-Dichlorodiammineplatinum(II)><cis-Platinum><critical period><determine efficacy><developmental><disturbed balance><drug induced hearing impairment><drug induced hearing loss><ear hair cell><effective therapy><effective treatment><efficacy analysis><efficacy assessment><efficacy determination><efficacy evaluation><efficacy examination><elderly mice><equilibration disorder><equilibrium disorder><evaluate efficacy><examine efficacy><fluorescent dye/probe><gene defect><gene repair therapy><gene replacement><gene replacement therapy><gene therapy><gene-based therapy><genetic therapy><genome mutation><genomic therapy><imaging><in vivo><injuries><inner ear><interest><intervention therapy><mechanic><mechanical><mechanical force><mechanosensing><mechanotransduction><mouse model><murine model><mutant allele><necrocytosis><necropsy><neuronal circuit><neuronal circuitry><new diagnostics><next generation diagnostics><novel diagnostics><oculovestibular reflex><old mice><ototoxic><ototoxicity><pathophysiology><plasmalemma><postmortem><precision therapies><precision treatment><pup><qRTPCR><regenerate><regional difference><repair><repaired><research and methods><resilience><resilient><response><sensor><social role><timeline><transduction efficiency><uptake><vestibo-ocular reflexes><vestibular system><vestibulo-occular system><vestibulo-ocular reflex><vestibulo-oculomotor reflex><vestibuloocular reflexes>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lauren M Aleksunes

RUTGERS BIOMEDICAL AND HEALTH SCIENCES, Newark, NJ

Good lead · 48/100

Training-friendly

Very recent

Active award

$129,400

FY 2026

Project Title

Summer Research Experience Programs (R25)

Grant Number:

2R25ES020721-16

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/9/2011

End Date:

4/30/2031

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY This is a competitive renewal application for continued support of the Rutgers Summer Undergraduate Research Fellowship (SURF) program. The SURF program provides undergraduates with 10-week basic science and translational hands-on research experiences in environmental health sciences...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Debra L Laskin

RUTGERS BIOMEDICAL AND HEALTH SCIENCES, Newark, NJ

Good lead · 48/100

Training-friendly

Very recent

Active award

$129,400

FY 2026

Project Title

Summer Research Experience Programs (R25)

Grant Number:

2R25ES020721-16

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/9/2011

End Date:

4/30/2031

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

PROJECT SUMMARY This is a competitive renewal application for continued support of the Rutgers Summer Undergraduate Research Fellowship (SURF) program. The SURF program provides undergraduates with 10-week basic science and translational hands-on research experiences in environmental health sciences...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Deirdre Nolfi-Donegan

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Good lead · 48/100

Training-friendly

Recent

Active award

Career award

$128,436

FY 2026

Project Title

Mechanisms of platelet stimulation in hemolysis

Grant Number:

5K08HL155488-05

Activity Code:

K08

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

2/15/2022

End Date:

1/31/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT While sickle cell disease (SCD) is instigated by a mutant hemoglobin that polymerizes in hypoxia to cause hemolysis and vaso-occlusion, inflammation plays a fundamental role in propagating this pathogenesis. SCD patients are at significantly higher risk of thrombosis, which contributes to s...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca Ann Faulkner

UT SOUTHWESTERN MEDICAL CENTER, DALLAS, TX

Good lead · 48/100

Training-friendly

Recent

Active award

Career award

$111,249

FY 2026

Project Title

Elucidating the sterol-sensing mechanisms that regulate lipid metabolism.

Grant Number:

5K99GM154062-02

Activity Code:

K99

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2024

End Date:

1/31/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY Flux through the mevalonate (MVA) pathway is tightly controlled to ensure cells continuously synthesize nonsterol isoprenoids but avoid overproducing cholesterol and other sterols. Endoplasmic reticulum (ER)- localized HMG CoA reductase (HMGCR), the rate limiting enzyme in MVA pathw...

Research Terms

<1,1-Bisphosphonate Ester><20S Catalytic Proteasome><20S Core Proteasome><20S Proteasome><20S Proteosome><25-hydroxycholesterol><3-Hydroxy-3-methylglutaryl CoA Reductase><ACAT><ACAT enzyme><ASCVD><Acceleration><Acyl CoA><Acyl Coenzyme A><Acyl-CoA-Cholesterol Acyltransferase><AmB><AmBisome><Amphocil><Amphotec><Amphotercin B><Amphotericin B><Amphoterin><Amphoterin Gene><Atherosclerosis><Atherosclerotic Cardiovascular Disease><Autoregulation><Basal Transcription Factor><Basal transcription factor genes><Binding><Binding Proteins><Biochemical><Blood Plasma><CRISPR approach><CRISPR based approach><CRISPR method><CRISPR methodology><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based method><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 technology><Cas nuclease technology><Cell Body><Cells><Chemistry><Cholesterol><Cholesterol Acyltransferase><Cholesterol Esterifying Enzyme><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Complement><Complement Proteins><Complex><Coupled><Coupling><Cryo-electron Microscopy><Cryoelectron Microscopy><DNA mutation><Data><Development><Dimethylallyltransferase><Dimethylallyltranstransferase><Disease><Disorder><Dolichyl Phosphate Synthetase><Drugs><Electron Cryomicroscopy><Endoplasmic Reticulum><Ensure><Enzyme Gene><Enzymes><Ergastoplasm><Event><FM1 Gene Product><Farnesylpyrophosphate Synthetase><Fatty Acyl CoA><Feedback><Fungizone><Future><GGDP><GGPP cpd><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Genomics><Geranylgeranyl Pyrophosphate Synthetase><Geranylpyrophosphate Synthetase><Goals><HMG CoA Reductases><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><Hepatic><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Homeostasis><Hydroxymethylglutaryl-CoA reductase><Hypercholesteremia><Immune Precipitation><Immunoprecipitation><Incidence><Integral Membrane Protein><Intrinsic Membrane Protein><KI mice><Knock-in><Knock-in Mouse><Knock-out><Knockout><LDL><LDL Cholesterol><LDL Cholesterol Lipoproteins><LDL Lipoproteins><LDL Receptors><LDLR gene><Ligand Binding Protein><Ligand Binding Protein Gene><Lipids><Lipoprotein LDL Receptors><Liver><Long-Chain Acyl CoA><Low Density Lipoprotein Cholesterol><Low Density Lipoprotein Receptor><Low-Density Lipoproteins><Macropain><Macroxyproteinase><Mass Photometry/Spectrum Analysis><Mass Spectrometry><Mass Spectroscopy><Mass Spectrum><Mass Spectrum Analyses><Mass Spectrum Analysis><Mediating><Medication><Membrane><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Menaquinone><Mentors><Methylation><Mice><Mice Mammals><Molecular><Molecular Configuration><Molecular Conformation><Molecular Genetics><Molecular Interaction><Molecular Stereochemistry><Molecular Target><Monitor><Multicatalytic Proteinase><Murine><Mus><Mutation><Mysteclin-F><Nerylpyrophosphate Synthetase><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Parents><Pathway interactions><Pharmaceutical Preparations><Phase><Photoaffinity Labels><Physiological Homeostasis><Plasma><Plasma Serum><Play><Post-Translational Regulation><Posttranslational Regulation><Prenyltransferase><Prevention therapy><Prosome><Proteasome><Proteasome Endopeptidase Complex><Protein Binding><Protein Cleavage><Protein Family><Proteins><Proteolysis><Proteosome><RNA Expression><Reaction><Regulation><Regulatory Element><Reporting><Research><Resistance><Reticuloendothelial System, Serum, Plasma><SBP-1><SBP-1 Gene><SR-45023A><Scientist><Short interfering RNA><Sterol O-Acyltransferase><Sterols><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Surface Proteins><System><Techniques><Therapeutic><Training><Transcription><Transcription Activation><Transcription Factor Proto-Oncogene><Transcription factor genes><Transcriptional Activation><Transcriptional Control><Transcriptional Regulation><Transmembrane Protein><Transmembrane Protein Gene><Ubiquitilation><Ubiquitination><Ubiquitinoylation><Vitamin K 2><Vitamin K Quinone><Vitamin K2><Wild Type Mouse><acyl-CoA cholesterol acyltransferase><apomine><atheromatosis><atherosclerotic disease><atherosclerotic vascular disease><beta-Lipoprotein Cholesterol><beta-Lipoproteins><bound protein><career><cholest-5-ene-3 beta,25-diol><complementation><conformation><conformational><conformational state><conformationally><conformations><crosslink><cryo-EM><cryoEM><cryogenic electron microscopy><developmental><drug efficacy><drug/agent><fat metabolism><genome mutation><geranylgeraniol diphosphate><geranylgeranyl pyrophosphate><hepatic body system><hepatic organ system><high blood cholesterol><hypercholesterolemia><inhibitor><innovate><innovation><innovative><insight><interdisciplinary approach><interest><isoprenoid><knockin><knockin mice><lipid metabolism><membrane structure><mevalonate><multicatalytic endopeptidase complex><multidisciplinary approach><new approaches><novel><novel approaches><novel strategies><novel strategy><parent><pathway><prevent><preventing><professor><protein activation><resistant><siRNA><synthetic enzyme><transcription factor><ubiquination><ubiquitin conjugation><wildtype mouse>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

William L. Dewey

VIRGINIA COMMONWEALTH UNIVERSITY, RICHMOND, VA

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$787,486

FY 2025

Project Title

Training in the pharmacology of abused drugs

Grant Number:

5T32DA007027-50

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/1976

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

During the current funding period, this program has continued its outstanding record of educating scholars as independent investigators and leaders in drug-abuse research. Since the submission of our last competitive application in 2015, competition for support from this program has been robust, and...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lauren M Aleksunes

RUTGERS BIOMEDICAL AND HEALTH SCIENCES, Newark, NJ

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$627,221

FY 2025

Project Title

Training in Environmental Toxicology

Grant Number:

5T32ES007148-39

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/1987

End Date:

6/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

The Joint Graduate Program in Toxicology (JGPT) is an interdepartmental training program in mechanistic toxicology at Rutgers University. Founded in 1981, the JGPT has trained more than 200 doctoral students, postdoctoral fellows, and clinician scientists. Graduates of the JGPT have established dist...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LEE ARMISTEAD DENSON

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$574,321

FY 2025

Project Title

Pediatric Gastroenterology and Nutrition Training Grant

Grant Number:

2T32DK007727-31

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

1/1/1995

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

This application requests continued funding for an innovative and highly successful T32 training program in Pediatric Gastroenterology, Hepatology and Nutrition (GI) at Cincinnati Children’s Hospital Medical Center. The training program, funded by the NIH for 30 years, has consistently produced much...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SHEHZAD Z. SHEIKH

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$545,801

FY 2025

Project Title

Gastroenterology Research Training

Grant Number:

5T32DK007737-30

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

8/1/1996

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

ABSTRACT This is a competitive renewal application for years 25-30 of a program to train postdoctoral investigators in basic and translational gastrointestinal research. An interdisciplinary faculty of 17 established mentors and 3 mentors-in-training is drawn from the Center for Gastrointestinal Bio...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

KECIA Nicole CARROLL

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$514,679

FY 2025

Project Title

Research Training Program in Pediatric Exposomics

Grant Number:

5T32HD049311-19

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2007

End Date:

4/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary The Developmental Origins of Health and Disease (DOHaD) theory posits that early-life environment contributes to nearly all common pediatric diseases (asthma, learning disorders, birth defects, obesity) and to diseases in adult life. Recently the nascent field of “exposomics” -the st...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Robert O Wright

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Good lead · 46/100

Training-friendly

Above-average budget

Active award

$514,679

FY 2025

Project Title

Research Training Program in Pediatric Exposomics

Grant Number:

5T32HD049311-19

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2007

End Date:

4/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.
• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary The Developmental Origins of Health and Disease (DOHaD) theory posits that early-life environment contributes to nearly all common pediatric diseases (asthma, learning disorders, birth defects, obesity) and to diseases in adult life. Recently the nascent field of “exposomics” -the st...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jenny Huanjiao Zhou

YALE UNIVERSITY, NEW HAVEN, CT

Good lead · 46/100

Likely hiring

Solid budget

Active award

$418,750

FY 2025

Project Title

Investigating the role of mitochondrial dysfunction in the pathogenesis of retinal vascular diseases

Grant Number:

5R01EY033333-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/1/2022

End Date:

7/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT Angiogenesis is the process of blood vessel formation in which proliferating endothelial cells (ECs) sprout from preexisting vessels to extend a vascular network. Either impaired or excessive angiogenesis is associated with the pathogenesis of human retina diseases such as r...

Research Terms

<3-D><3-Dimensional><3D><ALK-5 protein><ALK-5 receptor><ALK5><Activin A Receptor Type II-Like Kinase 53kDa><Activin Receptor-Like Kinase 5><Adventitial Cell><Age><Age related macular degeneration><Age-Related Maculopathy><Aging><Aneurysm><Apoplexy><Apoptosis><Apoptosis Pathway><Armed Forces Personnel><Arteries><Arteriovenous Angioma><Arteriovenous Hemangioma><Arteriovenous malformation><Assay><Attenuated><Basal Transcription Factor><Basal transcription factor genes><Bioassay><Biochemical><Biological Assay><Blindness><Blood Vessels><Brain Vascular Accident><C-jun Amino-Terminal Kinase><C-jun Kinase-1><C-jun N-Terminal Kinase 1><CSAID-Binding Protein 1><CSAID-Binding Protein 2><CSBP2><Canes><Cardiovascular Diseases><Cell Body><Cell Communication and Signaling><Cell Growth in Number><Cell Multiplication><Cell Proliferation><Cell Signaling><Cells><Cellular Proliferation><Cellular biology><Cerebral Stroke><Cerebrovascular Apoplexy><Cerebrovascular Stroke><Charcot-Bouchard Aneurysm><Coats' disease><Coats' syndrome><Cues><Cytokine-Suppressive Antiinflammatory Drug-Binding Protein 1><Cytokine-Suppressive Antiinflammatory Drug-Binding protein 2><DNA mutation><Data><Defect><Diabetes Mellitus><Diabetic Retinopathy><Diving><Elderly><Endothelial Cells><Exhibits><Extracellular Signal-Regulated Kinase Gene><Exudative retinopathy><Eye><Eyeball><Familial exudative vitreoretinopathy><Feedback><Gene Expression><Gene Transcription><General Transcription Factor Gene><General Transcription Factors><Generalized Growth><Generations><Genes><Genetic><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Glycolysis><Glycolysis Pathway><Growth><Human><Hypertension><Hypervascular><Impairment><In Vitro><Intracellular Communication and Signaling><JN Kinase><JNK><JNK Mitogen-Activated Protein Kinases><JNK1><JNK1 Kinase><JNK1 protein><JNK1A2><JNK21B1/2><Leber miliary aneurysm><MAP Kinase 8><MAP Kinase 8 Gene><MAP Kinase Gene><MAPK><MAPK14><MAPK14 Mitogen-Activated Protein Kinase><MAPK14 gene><MAPK8><MAPK8 Mitogen-Activated Protein Kinase><MAPK8 gene><Mediating><Metabolic Pathway><Mice><Mice Mammals><Microaneurysm><Miliary aneurysms of retina><Military><Military Personnel><Mitochondria><Mitochondrial Proteins><Mitogen-Activated Protein Kinase 14><Mitogen-Activated Protein Kinase 8><Mitogen-Activated Protein Kinase Gene><Modeling><Modern Man><Molecular><Murine><Mus><Mutant Strains Mice><Mutation><Mxi2><Nuclear><Oxidation-Reduction><PRKM8><Pathogenesis><Pathologic><Pathway interactions><Penetration><Pericapillary Cell><Pericytes><Perivascular Cell><Phenotype><Phosphorylation><Process><Production><Programmed Cell Death><Proliferating><Protein Phosphorylation><Proteins><RNA Expression><Racemose Angioma><Racemose Hemangioma><Redox><Respiration><Retina><Retinal Blood Vessels><Retinal Diseases><Retinal Disorder><Retinal Vessels><Role><Rouget Cells><SAP Kinase-1><SAPK/JNK><SAPK1 Mitogen-Activated Protein Kinase><SAPK1/JNK><SAPK2A><SKR4><Serine/Threonine-Protein Kinase Receptor R4><Signal Transduction><Signal Transduction Systems><Signaling><Stress-Activated Protein Kinase 2A><Stress-Activated Protein Kinase JNK1><Stress-Activated Protein Kinase gamma><Stroke><Structure><TGF-beta type I receptor><TGFBR-1><Therapeutic Intervention><Thioredoxin-2><Tissue Growth><Transcription><Transcription Factor Proto-Oncogene><Transcription factor genes><Transforming Growth Factor Beta Receptor I><Transforming Growth Factor Beta Receptor Type I><Vascular Diseases><Vascular Disorder><Vascular Endothelial Cell><Vascular Hypertensive Disease><Vascular Hypertensive Disorder><Walking Sticks><advanced age><age dependent macular degeneration><age induced macular degeneration><age related macular disease><age related macular dystrophy><aged><ages><angiogenesis><attenuate><attenuates><biological signal transduction><blood vessel development><blood vessel disorder><blood vessel formation><brain attack><c-jun N-Terminal Kinase><cardiovascular disorder><cell biology><cerebral vascular accident><cerebrovascular accident><complex IV><diabetes><effective therapy><effective treatment><genome mutation><geriatric><global gene expression><global transcription profile><high blood pressure><hyperpiesia><hyperpiesis><hypertensive disease><hypertensive disorder><inhibitor><intervention therapy><jun-NH2-Terminal Kinase><malformation><microscope imaging><microscopic imaging><microscopy imaging><military population><mitochondrial><mitochondrial dysfunction><mouse mutant><novel><ontogeny><oxidation reduction reaction><p38><p38 MAP Kinase><p38 MAPK Gene><p38 Mitogen Activated Protein Kinase><p38 Protein Kinase><p38 SAPK><p38-Alpha><p38Alpha><pathway><pharmacologic><postnatal><recruit><respiratory><respiratory mechanism><retina blood vessel structure><retina disease><retina disorder><retinal vascular network><retinal vascular structure><retinal vasculature><retinopathy><scRNA sequencing><scRNA-seq><senile macular disease><senior citizen><single cell RNA-seq><single cell RNAseq><single cell expression profiling><single cell transcriptomic profiling><single-cell RNA sequencing><social role><stress-activated protein kinase 1><stroked><strokes><three dimensional><transcription factor><transcriptome><vascular><vascular abnormality><vascular dysfunction><vasculopathy><vision loss><visual loss>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Leo Le Wang

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Good lead · 46/100

Likely hiring

Solid budget

Active award

$406,250

FY 2025

Project Title

Multicomponent hydrogels activating wound-induced hair neogenesis for scarless wound healing.

Grant Number:

1DP5OD039379-01

Activity Code:

DP5

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

8/6/2025

End Date:

7/31/2030

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Proposal Summary/Abstract Candidate: Dr. Leo Wang holds a BA, MS, MD, and PhD from the University of Pennsylvania, where he completed dermatology residency and currently is a Clinical Instructor and postdoctoral fellow working with Dr. George Cotsarelis in the Department of Dermatology. In 2025, Dr....

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

THOMAS C IRVING

ILLINOIS INSTITUTE OF TECHNOLOGY, CHICAGO, IL

Good lead · 46/100

Likely hiring

Solid budget

Active award

$346,820

FY 2025

Project Title

Analysis Tools for Fiber Diffraction of Muscle

Grant Number:

5R01GM144555-04

Activity Code:

R01

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

6/1/2022

End Date:

5/31/2027

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Synchrotron small angle X-ray fiber diffraction is the method of choice for obtaining structural and physiological information in the same experiment from active muscle. Experimental questions addressed range from basic biophysical questions regarding mechanisms of force production and regulation to...

Research Terms

<2-dimensional><AI system><Acceleration><Actin Filaments><Actin-Activated ATPase><Address><Adoption><Algorithms><Animal Model><Animal Models and Related Studies><Area><Artificial Intelligence><Biophysics><Biopsy><Cardiac Diseases><Cardiac Disorders><Cardiomyopathies><Center Core Grants><Code><Coding System><Communities><Computational toolkit><Computer Reasoning><Computer Simulation><Computer based Simulation><Computer software><Contracting Opportunities><Contracts><DNA mutation><Data><Data Analyses><Data Analysis><Data Set><Development><Diffuse><Disease><Disorder><Documentation><Fiber><Funding><Future><Generations><Genetic Change><Genetic defect><Genetic mutation><Goals><Grant><Heart Diseases><Hereditary><Human><Inherited><Laboratories><Machine Intelligence><Methodology><Methods><Microfilaments><Modeling><Modern Man><Molecular><Msec><Muscle><Muscle Disease><Muscle Disorders><Muscle Fibers><Muscle Tissue><Muscle function><Muscular Diseases><Mutation><MyBP-C protein><Myocardial Diseases><Myocardial Disorder><Myocardiopathies><Myofilaments><Myopathic Conditions><Myopathic Diseases and Syndromes><Myopathic disease or syndrome><Myopathy><Myosin ATPase><Myosin Adenosine Triphosphatase><Myosin Adenosinetriphosphatase><Myosins><Myotubes><NIAMS><NIGMS><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><National Institute of General Medical Sciences><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pattern><Performance><Persons><Phenotype><Photons><Physiologic><Physiological><Position><Positioning Attribute><Procedures><Production><Productivity><Property><Publishing><Regulation><Reproducibility><Research Resources><Resolution><Resources><Rhabdomyocyte><Roentgen Rays><Sarcomeres><Skeletal Fiber><Skeletal Muscle><Skeletal Muscle Cell><Skeletal Muscle Fiber><Skeletal Myocytes><Software><Source><Striated Muscles><Structure><Synchrotrons><Techniques><Technology><Testing><Thick Filament><Thin Filament><Time><Training><Validation><Voluntary Muscle><Work><X ray diffraction><X ray diffraction analysis><X-Radiation><X-Ray Radiation><X-ray><Xray><Xray diffraction><automated analysis><base><bases><beamline><biophysical foundation><biophysical principles><biophysical sciences><computational simulation><computational toolbox><computational tools><computational toolset><computerized simulation><computerized tools><connectin><data interpretation><data reduction><data tools><deep learning><deep learning method><deep learning strategy><detector><develop software><developing computer software><developmental><electron density><experiment><experimental research><experimental study><experiments><genome mutation><heart disorder><improved><indexing><millisecond><model of animal><muscle structure><muscle system><muscular><muscular disorder><muscular structure><muscular system><myocardium disease><myocardium disorder><myosin-binding protein C><nebulin><new approaches><novel><novel approaches><novel strategies><novel strategy><pre-clinical><preclinical><predictive tools><programs><resolutions><simulation><software development><titin><tool><two-dimensional><user-friendly><validations>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

RICHARD D SCHULICK

UNIVERSITY OF COLORADO DENVER, Aurora, CO

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$156,000

FY 2025

Project Title

UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer

Grant Number:

3P30CA046934-37S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Abstract Early-onset colorectal cancer (EOCRC), defined as diagnosis before age 50, has shown a significant rise in incidence, contrasting with declining rates in late-onset CRC. EOCRC tumors frequently exhibit microsatellite stability and harbor TP53 mutations. Despite extensive RNA sequencing effo...

Research Terms

<3TC><Age><Anti-Retroviral Agents><Antibodies><Antioncogene Protein p53><Automobile Driving><B-Cells><B-Lymphocytes><B-cell><Biological Function><Biological Process><Cancer Center><Cell Body><Cells><Cellular Immune Function><Cellular Tumor Antigen P53><Characteristics><Colorectal Cancer><Cytoplasm><DNA><DNA Sequence><DNA mutation><Data><Deoxyribonucleic Acid><Development><Diagnosis><ERVs><Endogenous Retroviruses><Exhibits><FDA approved><Family><Family member><Frequencies><Gene Transcription><Genes><Genetic><Genetic Change><Genetic Transcription><Genetic defect><Genetic mutation><Genome><Germ Lines><HERVs><Human Endogenous Retroviruses><Human Genome><Image><Immune><Immune Cell Activation><Immune Evasion><Immune Markers><Immune Surveillance><Immune infiltrates><Immune response><Immunes><Immunofluorescence><Immunofluorescence Immunologic><Immunologic Markers><Immunologic Subtyping><Immunologic Surveillance><Immunomodulation><Immunophenotyping><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Immunosurveillance><In Situ Hybridization><Incidence><Individual><Institution><Lamivudine><Length><Link><Location><Maps><Mediating><Metastasis><Metastasize><Metastatic Lesion><Metastatic Mass><Metastatic Neoplasm><Metastatic Tumor><Microsatellite Markers><Microsatellite Repeats><Microsatellites><Mutate><Mutation><Neoplasm Metastasis><Non-Polyadenylated RNA><Oncoprotein p53><P53><PDX model><Pathway interactions><Patient derived xenograft><Patients><Persons><Phase 2 Clinical Trials><Phase II Clinical Trials><Phenotype><Phosphoprotein P53><Phosphoprotein pp53><Play><Population><Protein TP53><Publications><RNA><RNA Expression><RNA Gene Probes><RNA Gene Products><RNA Probes><RNA Seq><RNA Sequences><RNA sequencing><RNAseq><Repetitive Element><Repetitive Regions><Repetitive Sequence><Research><Resource Sharing><Retroelements><Retroviridae><Retroviruses><Ribonucleic Acid><Role><Scientific Publication><Secondary Neoplasm><Secondary Tumor><T-Cells><T-Lymphocyte><TP53><TP53 gene><TRP53><Testing><Therapeutic><Tissue Sample><Transcript><Transcription><Translating><Tumor Cell><Tumor Promotion><Tumor Protein p53><Tumor Protein p53 Gene><Tumor Suppressor Proteins><Tumor Tissue><Tumor-infiltrating immune cells><Validation><Virus-Retrovirus><ages><anti-retroviral><antiretroviral therapy><antiretroviral treatment><cancer diagnosis><cancer metastasis><cancer microenvironment><cancer progression><colon cancer cell line><colon cancer patients><colorectal cancer cell line><colorectal cancer patients><colorectal cancer progression><design><designing><developmental><diagnostic biomarker><diagnostic development><diagnostic marker><differential expression><differentially expressed><driving><early colo-rectal cancer><early colorectal cancer><early onset colo-rectal cancer><early onset colorectal cancer><genome mutation><global gene expression><global transcription profile><host response><human whole genome><imaging><immune activation><immune cell infiltrate><immune cell infiltration of tumors><immune cells infiltrating the tumor><immune cells that infiltrate the tumor><immune evasive><immune function><immune microenvironment><immune modulation><immune regulation><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immune-based biomarkers><immunologic reactivity control><immunological biomarkers><immunological markers><immunomodulatory><immunoregulation><immunoregulatory><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive microenvironment><immunosuppressive response><immunosuppressive tumor microenvironment><improved><improved outcome><in situ Hybridization Genetics><in situ Hybridization Staining Method><infiltration of tumors by immune cells><intratumoral immune cell><intratumoral immune infiltrate><long read seq><long-read sequencing><long-read transcript sequencing><medical college><medical schools><member><mouse model><murine model><mutant><neoplasm progression><neoplastic cell><neoplastic progression><p53 Antigen><p53 Genes><p53 Tumor Suppressor><pathway><patient derived xenograft model><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><phase II protocol><primary end point><primary endpoint><protein p53><resistance to therapy><resistant to therapy><response><response to therapy><response to treatment><school of medicine><social role><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><targeted drug therapy><targeted drug treatments><targeted therapeutic><targeted therapeutic agents><targeted therapy><targeted treatment><therapeutic resistance><therapeutic response><therapeutically effective><therapy resistant><therapy response><thymus derived lymphocyte><transcriptional differences><transcriptome><transcriptome sequencing><transcriptomic sequencing><transcriptomics><treatment resistance><treatment response><treatment responsiveness><trend><tumor><tumor cell metastasis><tumor growth><tumor immune cell><tumor immune infiltrate><tumor immune microenvironment><tumor infiltration of immune cells><tumor microenvironment><tumor progression><tumor suppressor><tumor-immune system interactions><validations><young colo-rectal cancer><young colorectal cancer><young onset colo-rectal cancer><young onset colorectal cancer>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Boris Pasche

WAYNE STATE UNIVERSITY, DETROIT, MI

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$154,000

FY 2025

Project Title

P30 Administrative Supplement for Early-Onset Cancer Research: Repurposing orphan drugs for early-onset endometrial cancer

Grant Number:

3P30CA022453-43S2

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/8/1997

End Date:

11/30/2026

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT Endometrial cancer (EC) is the 4th most common cancer in women but has been understudied due to curative hysterectomy being available for patients with early-stage disease. As the incidence for EC rises year over year, the rates of early-onset EC (patients under 50 years of...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Suresh S. Ramalingam

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$149,977

FY 2025

Project Title

Administrative Supplement: The ASCEND (Advancing Skills in Contracting and Execution for NIH-Designated Grants) Initiative

Grant Number:

3P30CA138292-16S3

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

4/7/2009

End Date:

3/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

PROJECT SUMMARY/ABSTRACT Low- and middle-income countries (LMICs) in Sub-Saharan Africa are playing an increasingly prominent role in NIH-funded cancer prevention and control research. However, these institutions often lack the administrative infrastructure necessary to manage the full life cycle o...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LINDA M ZANGWILL

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$147,443

FY 2025

Project Title

NEI Center Core Grant for Vision Research

Grant Number:

3P30EY022589-13S1

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

4/30/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

SUMMARY Overall The overall purpose of the Center Core Grant for Vision Research is to provide core services and resources to enhance and accelerate the productivity and impact of the vision research community at the University of California, San Diego. Specifically, the Center Core Grant for Vision...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Eric R. Fearon

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$125,000

FY 2025

Project Title

Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy

Grant Number:

3P30CA046592-36S2

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

6/1/1997

End Date:

5/31/2028

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Abstract The P30 ETCTN Leadership Supplement is requested to support the oversight and conduct of the investigator- initiated phase 1 clinical trial NCI10464 “Phase 1 Study of Olaparib in Combination with Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy in Loc...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Thomas James Lynch

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 44/100

Likely hiring

Active award

Team-scale grant

$70,000

FY 2025

Project Title

CCSG Supplement: Early Career Cancer Clinical Investigator Award (ECIA)

Grant Number:

3P30CA015704-50S3

Activity Code:

P30

Mechanism:

Research Centers

Agency:

NIH

Start Date:

1/1/1997

End Date:

12/31/2029

Why this may be worth a closer look

• Mechanism often supports lab expansion or staff hiring.

Project Abstract

Dr. Jonathan Sham is an early-career academic hepatopancreatobiliary (HPB) surgical oncologist with a focus on improving outcomes in patients with surgical diseases of the liver, pancreas, and biliary tree. He is heavily involved in the Fred Hutchinson Cancer Center (FHCC) and NCI clinical trial inf...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAPHNE A. HAAS-KOGAN

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,606,288

FY 2025

Project Title

Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science

Grant Number:

5U54CA274516-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Basic scientists and clinical investigators from Dana-Farber/Harvard Cancer Center (DF/HCC) join forces with their counterparts at University of California, San Francisco’s (UCSF) Helen Diller Family Comprehensive Cancer Center to propose a Harvard/UCSF ROBIN Center. Our Objective is...

Research Terms

<0-11 years old><21+ years old><AI system><Accounting><Address><Adult><Adult Human><Adverse Late Effects><Advisory Committees><Advocate><Anatomic Sites><Anatomic structures><Anatomy><Artificial Intelligence><Award><Biological><Biological Markers><Biology><Boston><California><Cancer Biology><Cancer Center><Cancer Center Director><Cancers><Cell Body><Cells><Child><Child Youth><Childhood><Childhood Cancers><Childhood Glioma><Childhood Neoplasm><Childhood Solid Neoplasm><Childhood Solid Tumor><Childhood Tumor><Children (0-21)><Clinical><Clinical Investigator><Clinical Trials><Clinical Trials Network><Collection><Communities><Comprehensive Cancer Center><Computational Biology><Computer Reasoning><Core Facility><Credentialing><DNA mutation><Daphne><Daphne plant><Data><Data Science><Data Set><Definitive Radiation Therapy><Development><Discipline><Doctor of Medicine><Doctor of Philosophy><EBRT><EXTMR><Education><Educational aspects><Elements><Evolution><Experimental Therapies><External Beam RT><External Beam Radiation Therapy><External Radiation><Extramural><Extramural Activities><Face><Family><Funding><Future><General Population><General Public><Genetic><Genetic Change><Genetic defect><Genetic mutation><Heterogeneity><Image><Infrastructure><Infrequent Neoplasm><Infrequent Tumor><Institution><International><Intratumoral heterogeneity><Investigational Therapies><Investigational Treatments><Investigators><Iobenguane><Late Effects><M.D.><MIBG><Machine Intelligence><Machine Learning><Malignant Cell><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Neoplasms><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant Tumor><Malignant childhood cancer><Math Models><Medical><Methodology><Mission><Modality><Molecular><Mutation><NCI Organization><National Cancer Institute><National Clinical Trials Network><Neuroblastoma><Oncology><Oncology Cancer><Outcome><Patient advocacy><Patients><Pediatric Glioma><Pediatric Neoplasm><Pediatric Solid Tumor><Pediatric Tumor><Pediatric high-grade glioma><Persons><Ph.D.><PhD><Physics><Pilot Projects><Population><Position><Positioning Attribute><Process><Productivity><QOL><Quality of life><R-Series Research Projects><R01 Mechanism><R01 Program><Radiation><Radiation Biology><Radiation Oncologist><Radiation Oncology><Radiation therapy><Radiobiology><Radiogenomics><Radiopharmaceutical Compound><Radiopharmaceuticals><Radioresistance><Radiotherapeutics><Radiotherapy><Records><Regimen><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Researchers><Resistance><Resources><Robin><Robin bird><Sampling><San Francisco><Scientist><Solid Neoplasm><Solid Tumor><Specific qualifier value><Specified><Specimen><Students><Sum><Task Forces><Technology><Testing><Toxic effect><Toxicities><Training><Training Programs><Tumor Cell><Tumor Tissue><Universities><Variant><Variation><Work><adulthood><advisory team><bio-markers><biologic><biologic marker><biomarker><cancer cell><cancer genetics><cancer in a child><cancer in children><cancer research center director><child with cancer><childhood malignancy><childhood radiation><clinical material><cohort><computer biology><data integration><data modeling><design><designing><developmental><diffuse midline glioma><dosimetry><experience><experimental therapeutic agents><experimental therapeutics><external-beam radiation><faces><facial><genome mutation><genomic data><genomic dataset><heterogeneity in tumors><high risk><imaging><immune microenvironment><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><insight><intra-tumoral heterogeneity><intratumor heterogeneity><irradiation response><kids><m-Iodobenzylguanidine><machine based learning><malignancy><mathematic model><mathematical model><mathematical modeling><meta-Iodobenzylguanidine><metaiodobenzylguanidine><model of data><model the data><modeling of the data><multi-modality><multi-scale data><multimodality><multiscale data><neoplasm/cancer><neoplastic cell><novel><outreach program><pediatric><pediatric cancer><pediatric malignancy><pediatric radiation><physical science><pilot study><professor><programs><prospective><radiation during childhood><radiation in children><radiation resistance><radiation resistant><radiation response><radiation treatment><radio resistance><radioactive drugs><radioresistant><radiotherapeutic drugs><resistant><resistant to radiation><response><response to radiation><response to therapy><response to treatment><skills><spatial and temporal><spatial temporal><spatiotemporal><standard of care><therapeutic response><therapy response><treatment response><treatment responsiveness><treatment with radiation><tumor><tumor heterogeneity><tumor immune microenvironment><tumor-immune system interactions><tumors in children><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Franziska Michor

DANA-FARBER CANCER INST, BOSTON, MA

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,606,288

FY 2025

Project Title

Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science

Grant Number:

5U54CA274516-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/19/2023

End Date:

8/31/2028

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary Basic scientists and clinical investigators from Dana-Farber/Harvard Cancer Center (DF/HCC) join forces with their counterparts at University of California, San Francisco’s (UCSF) Helen Diller Family Comprehensive Cancer Center to propose a Harvard/UCSF ROBIN Center. Our Objective is...

Research Terms

<0-11 years old><21+ years old><AI system><Accounting><Address><Adult><Adult Human><Adverse Late Effects><Advisory Committees><Advocate><Anatomic Sites><Anatomic structures><Anatomy><Artificial Intelligence><Award><Biological><Biological Markers><Biology><Boston><California><Cancer Biology><Cancer Center><Cancer Center Director><Cancers><Cell Body><Cells><Child><Child Youth><Childhood><Childhood Cancers><Childhood Glioma><Childhood Neoplasm><Childhood Solid Neoplasm><Childhood Solid Tumor><Childhood Tumor><Children (0-21)><Clinical><Clinical Investigator><Clinical Trials><Clinical Trials Network><Collection><Communities><Comprehensive Cancer Center><Computational Biology><Computer Reasoning><Core Facility><Credentialing><DNA mutation><Daphne><Daphne plant><Data><Data Science><Data Set><Definitive Radiation Therapy><Development><Discipline><Doctor of Medicine><Doctor of Philosophy><EBRT><EXTMR><Education><Educational aspects><Elements><Evolution><Experimental Therapies><External Beam RT><External Beam Radiation Therapy><External Radiation><Extramural><Extramural Activities><Face><Family><Funding><Future><General Population><General Public><Genetic><Genetic Change><Genetic defect><Genetic mutation><Heterogeneity><Image><Infrastructure><Infrequent Neoplasm><Infrequent Tumor><Institution><International><Intratumoral heterogeneity><Investigational Therapies><Investigational Treatments><Investigators><Iobenguane><Late Effects><M.D.><MIBG><Machine Intelligence><Machine Learning><Malignant Cell><Malignant Childhood Neoplasm><Malignant Childhood Tumor><Malignant Neoplasms><Malignant Pediatric Neoplasm><Malignant Pediatric Tumor><Malignant Tumor><Malignant childhood cancer><Math Models><Medical><Methodology><Mission><Modality><Molecular><Mutation><NCI Organization><National Cancer Institute><National Clinical Trials Network><Neuroblastoma><Oncology><Oncology Cancer><Outcome><Patient advocacy><Patients><Pediatric Glioma><Pediatric Neoplasm><Pediatric Solid Tumor><Pediatric Tumor><Pediatric high-grade glioma><Persons><Ph.D.><PhD><Physics><Pilot Projects><Population><Position><Positioning Attribute><Process><Productivity><QOL><Quality of life><R-Series Research Projects><R01 Mechanism><R01 Program><Radiation><Radiation Biology><Radiation Oncologist><Radiation Oncology><Radiation therapy><Radiobiology><Radiogenomics><Radiopharmaceutical Compound><Radiopharmaceuticals><Radioresistance><Radiotherapeutics><Radiotherapy><Records><Regimen><Research><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Specimen><Researchers><Resistance><Resources><Robin><Robin bird><Sampling><San Francisco><Scientist><Solid Neoplasm><Solid Tumor><Specific qualifier value><Specified><Specimen><Students><Sum><Task Forces><Technology><Testing><Toxic effect><Toxicities><Training><Training Programs><Tumor Cell><Tumor Tissue><Universities><Variant><Variation><Work><adulthood><advisory team><bio-markers><biologic><biologic marker><biomarker><cancer cell><cancer genetics><cancer in a child><cancer in children><cancer research center director><child with cancer><childhood malignancy><childhood radiation><clinical material><cohort><computer biology><data integration><data modeling><design><designing><developmental><diffuse midline glioma><dosimetry><experience><experimental therapeutic agents><experimental therapeutics><external-beam radiation><faces><facial><genome mutation><genomic data><genomic dataset><heterogeneity in tumors><high risk><imaging><immune microenvironment><immunosuppressive microenvironment><immunosuppressive tumor microenvironment><improved><insight><intra-tumoral heterogeneity><intratumor heterogeneity><irradiation response><kids><m-Iodobenzylguanidine><machine based learning><malignancy><mathematic model><mathematical model><mathematical modeling><meta-Iodobenzylguanidine><metaiodobenzylguanidine><model of data><model the data><modeling of the data><multi-modality><multi-scale data><multimodality><multiscale data><neoplasm/cancer><neoplastic cell><novel><outreach program><pediatric><pediatric cancer><pediatric malignancy><pediatric radiation><physical science><pilot study><professor><programs><prospective><radiation during childhood><radiation in children><radiation resistance><radiation resistant><radiation response><radiation treatment><radio resistance><radioactive drugs><radioresistant><radiotherapeutic drugs><resistant><resistant to radiation><response><response to radiation><response to therapy><response to treatment><skills><spatial and temporal><spatial temporal><spatiotemporal><standard of care><therapeutic response><therapy response><treatment response><treatment responsiveness><treatment with radiation><tumor><tumor heterogeneity><tumor immune microenvironment><tumor-immune system interactions><tumors in children><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Zora Djuric

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,449,424

FY 2025

Project Title

Early Phase Clinical Cancer Prevention Consortium

Grant Number:

2UG1CA242632-06

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/7/2020

End Date:

7/31/2031

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary: Early Phase Clinical Cancer Prevention Consortium (ClinCaP) The ClinCaP consortium engages basic, translational and clinical investigators in both scientific discovery and clinical research to develop trials targeting the reversal of obesity-induced pathways that support increased c...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Scott Michael Schuetze

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,449,424

FY 2025

Project Title

Early Phase Clinical Cancer Prevention Consortium

Grant Number:

2UG1CA242632-06

Activity Code:

UG1

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/7/2020

End Date:

7/31/2031

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary: Early Phase Clinical Cancer Prevention Consortium (ClinCaP) The ClinCaP consortium engages basic, translational and clinical investigators in both scientific discovery and clinical research to develop trials targeting the reversal of obesity-induced pathways that support increased c...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CATHERINE A FITCH

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,222,211

FY 2025

Project Title

The University of Minnesota Demography and Economics of Aging and AD/ADRD Coordinating Center

Grant Number:

1U24AG097134-01

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The National Institute on Aging Demography and Economics Coordinating Center (NIA DECC) will help the NIA P30-funded Demography and Economics of Aging and AD/ADRD (D&E) Centers realize their full potential to generate impactful research, to facilitate new and innovative collaborations, and to broade...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Gina M Rumore

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,222,211

FY 2025

Project Title

The University of Minnesota Demography and Economics of Aging and AD/ADRD Coordinating Center

Grant Number:

1U24AG097134-01

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The National Institute on Aging Demography and Economics Coordinating Center (NIA DECC) will help the NIA P30-funded Demography and Economics of Aging and AD/ADRD (D&E) Centers realize their full potential to generate impactful research, to facilitate new and innovative collaborations, and to broade...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Robert Warren

UNIVERSITY OF MINNESOTA, MINNEAPOLIS, MN

Exploratory lead · 42/100

Large award

Active award

Team-scale grant

$1,222,211

FY 2025

Project Title

The University of Minnesota Demography and Economics of Aging and AD/ADRD Coordinating Center

Grant Number:

1U24AG097134-01

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2027

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

The National Institute on Aging Demography and Economics Coordinating Center (NIA DECC) will help the NIA P30-funded Demography and Economics of Aging and AD/ADRD (D&E) Centers realize their full potential to generate impactful research, to facilitate new and innovative collaborations, and to broade...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jill E Johnston

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Exploratory lead · 42/100

Above-average budget

Active award

Team-scale grant

$824,976

FY 2026

Project Title

Southern California Center for Children’s Environmental Health Translational Research

Grant Number:

5P2CES033433-05

Activity Code:

P2C

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/9/2021

End Date:

11/30/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Near-roadway and regional air pollution, industrial releases, goods movement and growing oil and gas production in urban areas vulnerable to wildfires all threaten to increase the burden of environmental disease. In California and worldwide, these threats disproportionately affect children. Air poll...

Research Terms

<0-11 years old><Academia><Address><Adverse effects><Affect><Air Pollution><Airway health><Area><Arts><California><Center for Translational Science Activities><Child><Child Health><Child Youth><Childhood><Children (0-21)><Cities><Collaborations><Communication><Communities><Community Networks><Country><Creativeness><Data><Decision Making><Development><Disease><Disorder><Education><Educational aspects><Educational workshop><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Foundations><Gases><Goals><Grant><Health><Industrialization><International><Intervention><Investigators><Journalism><Knowledge><Metabolic><Methods><Mission><Modeling><Movement><NIEHS><National Institute of Environmental Health Sciences><Neighborhoods><Network Analysis><Neural Development><Obesity><Oils><Outcome><Pathway Analysis><Pilot Projects><Postdoc><Postdoctoral Fellow><Production><Professional Organizations><Program Development><Public Health><Quasi-experiment><Quasi-experimental analysis><Quasi-experimental approach><Quasi-experimental design><Quasi-experimental methods><Quasi-experimental research><Quasi-experimental study><Quasi-experimental technique><Research Associate><Research Personnel><Research Resources><Research Support><Researchers><Resources><Rest><Schools><Science><Scientist><Sight><Societies><Sociology><Strategic Planning><System><Techniques><Testing><Training><Translating><Translational Research><Translational Science><Translations><Transportation><Universities><Urban Community><Vision><Wildfire><Work><Workshop><Youth><Youth 10-21><adiposity><artist><base><bases><body movement><career development><catalyst><civil society><community empowerment><community engagement><community partners><community science><community-based partners><conference><convention><corpulence><creativity><design><designing><developmental><engagement with communities><health science research><implementation science><improved><innovate><innovation><innovative><kids><multidisciplinary><neurodevelopment><new approaches><next generation><novel approaches><novel strategies><novel strategy><pediatric><peer><pilot study><post-doc><post-doctoral><post-doctoral trainee><professional association><professional membership><professional society><programs><public health intervention><recruit><research associates><respiratory health><social><social media><summit><symposia><symposium><tool><translation><translation research><translational health research><translational health science><translational investigation><translational investigator><translational research center><translational researcher><translational sciences center><translational scientist><trend><undergrad><undergraduate><undergraduate student><urban area><urban location><urban planning><urban region><visual function><wild fire><wildland fire><work group><working group><youngster><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Mary Kamai

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Exploratory lead · 42/100

Above-average budget

Active award

Team-scale grant

$824,976

FY 2026

Project Title

Southern California Center for Children’s Environmental Health Translational Research

Grant Number:

5P2CES033433-05

Activity Code:

P2C

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/9/2021

End Date:

11/30/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Near-roadway and regional air pollution, industrial releases, goods movement and growing oil and gas production in urban areas vulnerable to wildfires all threaten to increase the burden of environmental disease. In California and worldwide, these threats disproportionately affect children. Air poll...

Research Terms

<0-11 years old><Academia><Address><Adverse effects><Affect><Air Pollution><Airway health><Area><Arts><California><Center for Translational Science Activities><Child><Child Health><Child Youth><Childhood><Children (0-21)><Cities><Collaborations><Communication><Communities><Community Networks><Country><Creativeness><Data><Decision Making><Development><Disease><Disorder><Education><Educational aspects><Educational workshop><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Foundations><Gases><Goals><Grant><Health><Industrialization><International><Intervention><Investigators><Journalism><Knowledge><Metabolic><Methods><Mission><Modeling><Movement><NIEHS><National Institute of Environmental Health Sciences><Neighborhoods><Network Analysis><Neural Development><Obesity><Oils><Outcome><Pathway Analysis><Pilot Projects><Postdoc><Postdoctoral Fellow><Production><Professional Organizations><Program Development><Public Health><Quasi-experiment><Quasi-experimental analysis><Quasi-experimental approach><Quasi-experimental design><Quasi-experimental methods><Quasi-experimental research><Quasi-experimental study><Quasi-experimental technique><Research Associate><Research Personnel><Research Resources><Research Support><Researchers><Resources><Rest><Schools><Science><Scientist><Sight><Societies><Sociology><Strategic Planning><System><Techniques><Testing><Training><Translating><Translational Research><Translational Science><Translations><Transportation><Universities><Urban Community><Vision><Wildfire><Work><Workshop><Youth><Youth 10-21><adiposity><artist><base><bases><body movement><career development><catalyst><civil society><community empowerment><community engagement><community partners><community science><community-based partners><conference><convention><corpulence><creativity><design><designing><developmental><engagement with communities><health science research><implementation science><improved><innovate><innovation><innovative><kids><multidisciplinary><neurodevelopment><new approaches><next generation><novel approaches><novel strategies><novel strategy><pediatric><peer><pilot study><post-doc><post-doctoral><post-doctoral trainee><professional association><professional membership><professional society><programs><public health intervention><recruit><research associates><respiratory health><social><social media><summit><symposia><symposium><tool><translation><translation research><translational health research><translational health science><translational investigation><translational investigator><translational research center><translational researcher><translational sciences center><translational scientist><trend><undergrad><undergraduate><undergraduate student><urban area><urban location><urban planning><urban region><visual function><wild fire><wildland fire><work group><working group><youngster><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ROB S MCCONNELL

UNIVERSITY OF SOUTHERN CALIFORNIA, Los Angeles, CA

Exploratory lead · 42/100

Above-average budget

Active award

Team-scale grant

$824,976

FY 2026

Project Title

Southern California Center for Children’s Environmental Health Translational Research

Grant Number:

5P2CES033433-05

Activity Code:

P2C

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/9/2021

End Date:

11/30/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Near-roadway and regional air pollution, industrial releases, goods movement and growing oil and gas production in urban areas vulnerable to wildfires all threaten to increase the burden of environmental disease. In California and worldwide, these threats disproportionately affect children. Air poll...

Research Terms

<0-11 years old><Academia><Address><Adverse effects><Affect><Air Pollution><Airway health><Area><Arts><California><Center for Translational Science Activities><Child><Child Health><Child Youth><Childhood><Children (0-21)><Cities><Collaborations><Communication><Communities><Community Networks><Country><Creativeness><Data><Decision Making><Development><Disease><Disorder><Education><Educational aspects><Educational workshop><Environment><Environmental Health><Environmental Health Science><Evaluation><Faculty><Foundations><Gases><Goals><Grant><Health><Industrialization><International><Intervention><Investigators><Journalism><Knowledge><Metabolic><Methods><Mission><Modeling><Movement><NIEHS><National Institute of Environmental Health Sciences><Neighborhoods><Network Analysis><Neural Development><Obesity><Oils><Outcome><Pathway Analysis><Pilot Projects><Postdoc><Postdoctoral Fellow><Production><Professional Organizations><Program Development><Public Health><Quasi-experiment><Quasi-experimental analysis><Quasi-experimental approach><Quasi-experimental design><Quasi-experimental methods><Quasi-experimental research><Quasi-experimental study><Quasi-experimental technique><Research Associate><Research Personnel><Research Resources><Research Support><Researchers><Resources><Rest><Schools><Science><Scientist><Sight><Societies><Sociology><Strategic Planning><System><Techniques><Testing><Training><Translating><Translational Research><Translational Science><Translations><Transportation><Universities><Urban Community><Vision><Wildfire><Work><Workshop><Youth><Youth 10-21><adiposity><artist><base><bases><body movement><career development><catalyst><civil society><community empowerment><community engagement><community partners><community science><community-based partners><conference><convention><corpulence><creativity><design><designing><developmental><engagement with communities><health science research><implementation science><improved><innovate><innovation><innovative><kids><multidisciplinary><neurodevelopment><new approaches><next generation><novel approaches><novel strategies><novel strategy><pediatric><peer><pilot study><post-doc><post-doctoral><post-doctoral trainee><professional association><professional membership><professional society><programs><public health intervention><recruit><research associates><respiratory health><social><social media><summit><symposia><symposium><tool><translation><translation research><translational health research><translational health science><translational investigation><translational investigator><translational research center><translational researcher><translational sciences center><translational scientist><trend><undergrad><undergraduate><undergraduate student><urban area><urban location><urban planning><urban region><visual function><wild fire><wildland fire><work group><working group><youngster><youth age>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Nicole Beaulieu Perez

NEW YORK UNIVERSITY, NEW YORK, NY

Exploratory lead · 42/100

Training-friendly

Active award

Career award

$168,480

FY 2026

Project Title

Reducing Disparities in Mental and Metabolic Health among Predominantly Low-Income, Black and Hispanic Women with and without HIV

Grant Number:

5K08MD019998-03

Activity Code:

K08

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/21/2024

End Date:

2/28/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT In the United States, Black and Hispanic women (BHW) have the greatest risks of poverty, type 2 diabetes (T2D), and depression, problems which represent overlapping and mutually reinforcing epidemics. In the context of HIV, the economic, metabolic, and mental health risks are even greater, ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alex Wang

HARVARD MEDICAL SCHOOL, BOSTON, MA

Exploratory lead · 40/100

Training-friendly

Recent

Active award

$76,300

FY 2026

Project Title

Developmental Activity and Function of Layer 5 Cortical Circuits Following Early Postnatal Reorganization

Grant Number:

1F32NS146097-01

Activity Code:

F32

Mechanism:

Training, Individual

Agency:

NIH

Start Date:

4/1/2026

End Date:

2/28/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY The precise formation of circuits in the cerebral cortex, involving both excitatory pyramidal neurons (PNs) and inhibitory interneurons (INs), is crucial for proper brain function, with disruptions in this process being implicated in neurodevelopmental disorders such as autism, epile...

Research Terms

<2-photon><2-photon microscopy><21+ years old><ASD><Adult><Adult Human><Affect><Age><Animals><Area><Autism><Autistic Disorder><Automobile Driving><Behavior><Behavioral><Birth><Brain><Brain Nervous System><Calcium><Cell Body><Cells><Cerebral cortex><Connector Neuron><Coupled><Cyclic Somatostatin><Darkness><Detection><Development><Disease><Disorder><Early Infantile Autism><Encephalon><Epilepsy><Epileptic Seizures><Epileptics><Evolution><Exhibits><Eye><Eyeball><Goals><Growth Hormone Inhibiting Factors><Growth Hormone-Inhibiting Hormone><Image><Infantile Autism><Injections><Intercalary Neuron><Intercalated Neurons><Interneurons><Internuncial Cell><Internuncial Neuron><Kanner's Syndrome><Laboratories><Logic><Methods><Mice><Mice Mammals><Murine><Mus><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurodevelopmental Disorder><Neurological Development Disorder><Neurons><Parturition><Pattern><Perception><Performance><Population><Primary visual cortex><Process><Pyramidal neuron><Research Training><SRIH><SRIH-14><Schizophrenia><Schizophrenic Disorders><Seizure Disorder><Shapes><Sight><Somatostatin><Somatostatin-14><Somatotropin Release Inhibiting Factors><Somatotropin Release-Inhibiting Hormone><Specific qualifier value><Specificity><Specified><Striate Cortex><Striate area><Synapses><Synaptic><Time><Viral><Virus><Vision><Visual><Visual Evoked Potentials><Visual Evoked Response><Visual evoked cortical potential><Work><adult animal><adulthood><ages><area striata><autism spectral disorder><autism spectrum disorder><autistic spectrum disorder><calcium indicator><critical period><dark rear><dark rearing><dementia praecox><detection sensitivity><developmental><driving><epilepsia><epileptogenic><excitatory neuron><experience><genetic approach><genetic strategy><growth hormone release inhibiting factor><hippocampal pyramidal neuron><imaging><improved><information processing><innervation><insight><mature animal><nerve supply><neural><neurodevelopmental disease><neuronal><neuronal patterning><novel><post-natal development><postnatal><postnatal development><prevent><preventing><response><retinotopic map><schizophrenic><synapse><training project><two photon excitation microscopy><two photon microscopy><two-photon><visual excitation><visual field map><visual function><visual map><visual stimulus>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Trevor M Penning

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$499,142

FY 2025

Project Title

Translational Research Training Program in Environmental Health Sciences

Grant Number:

5T32ES019851-14

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2012

End Date:

6/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This application is for the continuation of a T32 Institutional Training Grant in Environmental Health Sciences (EHS) entitled: “Translational Research Training Program in EHS” (T32-ES019851) at the University of Pennsylvania (Penn). This training grant is the only dedicated mechanism to support for...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rebecca A Simmons

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$499,142

FY 2025

Project Title

Translational Research Training Program in Environmental Health Sciences

Grant Number:

5T32ES019851-14

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2012

End Date:

6/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This application is for the continuation of a T32 Institutional Training Grant in Environmental Health Sciences (EHS) entitled: “Translational Research Training Program in EHS” (T32-ES019851) at the University of Pennsylvania (Penn). This training grant is the only dedicated mechanism to support for...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ALEXANDER G ROBLING

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$488,736

FY 2025

Project Title

Comprehensive Musculoskeletal Training Program

Grant Number:

5T32AR065971-11

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2015

End Date:

6/30/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

In the two cycles of T32 support we have had to date, for our Comprehensive Musculoskeletal Training Program, (CMTP) we have successfully trained 15 predoc, 14 postdoc, and 19 summer medical students, for careers in musculoskeletal science. Most of those trainees have gone on to secure their own ind...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lisa A. Marsch

DARTMOUTH COLLEGE, HANOVER, NH

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$440,745

FY 2025

Project Title

Training in the Science of Co-Occurring Disorders

Grant Number:

2T32DA037202-11A1

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2014

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This renewal application proposal aims to sustain and enhance a unique predoctoral and postdoctoral training program in an emerging area of transdisciplinary research, co-occurring substance use and other psychiatric and medical disorders (COD). The need for this scientific focus continues to be vit...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

David W Hein

UNIVERSITY OF LOUISVILLE, LOUISVILLE, KY

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$411,036

FY 2025

Project Title

UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM

Grant Number:

5T32ES011564-20

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2002

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT We have made strategic changes in our environmental health sciences training program in response to the announced restructuring and redirection of NIEHS training programs. Participating Centers, Institutes, and Schools and the members of the training faculty provide critical resources for c...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Pierce Wise

UNIVERSITY OF LOUISVILLE, LOUISVILLE, KY

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$411,036

FY 2025

Project Title

UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAM

Grant Number:

5T32ES011564-20

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2002

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT We have made strategic changes in our environmental health sciences training program in response to the announced restructuring and redirection of NIEHS training programs. Participating Centers, Institutes, and Schools and the members of the training faculty provide critical resources for c...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Carmen Joseph Marsit

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$399,947

FY 2025

Project Title

Graduate and Postdoctoral Training in Environmental Health Science and Toxicology

Grant Number:

5T32ES012870-22

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2004

End Date:

6/30/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

The Training Program in the Environmental Health Sciences and Toxicology has as its vision to assure that trainees gain the skills they need to develop as successful independent, transdisciplinary, ethically engaged environmental health researchers and practitioners in a program informed by and alig...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NIR J BARZILAI

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$399,530

FY 2025

Project Title

Training in Aging Research

Grant Number:

5T32AG023475-24

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2004

End Date:

4/30/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This 5th competitive renewal application for an Institutional T32 training grant is made possible due to an outstanding base of aging research, funded mainly by the NIA at the Albert Einstein College of Medicine and Montefiore Health System. Included as the bedrock for this grant are the following p...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DEREK Major HUFFMAN

ALBERT EINSTEIN COLLEGE OF MEDICINE, BRONX, NY

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$399,530

FY 2025

Project Title

Training in Aging Research

Grant Number:

5T32AG023475-24

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2004

End Date:

4/30/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This 5th competitive renewal application for an Institutional T32 training grant is made possible due to an outstanding base of aging research, funded mainly by the NIA at the Albert Einstein College of Medicine and Montefiore Health System. Included as the bedrock for this grant are the following p...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jamie DeWitt

OREGON STATE UNIVERSITY, CORVALLIS, OR

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$392,511

FY 2025

Project Title

Integrated Regional Training Program in Environmental Health Sciences (IRTP)

Grant Number:

2T32ES007060-46

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/1979

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY/ABSTRACT The mission of the Integrated Regional Training Program in Environmental Health Sciences (IRTP) at Oregon State University (OSU) is to provide structured scientific, professional, and career development opportunities to train the next generation of environmental health scien...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Siva Kumar Kolluri

OREGON STATE UNIVERSITY, CORVALLIS, OR

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$392,511

FY 2025

Project Title

Integrated Regional Training Program in Environmental Health Sciences (IRTP)

Grant Number:

2T32ES007060-46

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/1979

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY/ABSTRACT The mission of the Integrated Regional Training Program in Environmental Health Sciences (IRTP) at Oregon State University (OSU) is to provide structured scientific, professional, and career development opportunities to train the next generation of environmental health scien...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Karina W. Davidson

FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, MANHASSET, NY

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$377,280

FY 2025

Project Title

STAGE TRIALS: Stage-model Training Approaches for Guiding Effective Translation of behavioral Research Interventions in Aging TriaLS

Grant Number:

1R25AG094542-01

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/20/2025

End Date:

5/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Abstract The STAGE TRIALS short-term curriculum will develop, deliver, and evaluate short-term education that will launch successful programs of behavioral interventions, informed by the NIH Stage, mechanism-focused conceptual model. Providing short courses in NIH Stage Model conceptualization and a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrea L Hevener

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$367,599

FY 2025

Project Title

Interdisciplinary Training Program in Metabolism (UCLA-ITPM)

Grant Number:

1T32DK138892-01A1

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2025

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

UCLA Interdisciplinary Training Program in Metabolism PROJECT SUMMARY The goal of the UCLA Interdisciplinary Training Program in Metabolism (ITPM) is to train the next generation of investigators who will advance prevention, treatment, and clinical care for metabolism-related diseases. The UCLA-ITP...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Tamer Sallam

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$367,599

FY 2025

Project Title

Interdisciplinary Training Program in Metabolism (UCLA-ITPM)

Grant Number:

1T32DK138892-01A1

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2025

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

UCLA Interdisciplinary Training Program in Metabolism PROJECT SUMMARY The goal of the UCLA Interdisciplinary Training Program in Metabolism (ITPM) is to train the next generation of investigators who will advance prevention, treatment, and clinical care for metabolism-related diseases. The UCLA-ITP...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PETER J TONTONOZ

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$367,599

FY 2025

Project Title

Interdisciplinary Training Program in Metabolism (UCLA-ITPM)

Grant Number:

1T32DK138892-01A1

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2025

End Date:

6/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

UCLA Interdisciplinary Training Program in Metabolism PROJECT SUMMARY The goal of the UCLA Interdisciplinary Training Program in Metabolism (ITPM) is to train the next generation of investigators who will advance prevention, treatment, and clinical care for metabolism-related diseases. The UCLA-ITP...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joshua Grill

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$359,160

FY 2025

Project Title

Training in Translational ADRD Neuroscience (TITAN)

Grant Number:

5T32AG073088-05

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Project Summary/Abstract Population aging is leading to a public health crisis in the growing number of people affected by Alzheimer’s disease (AD) and Related Dementias (ADRD). It has been more than 15 years since the last FDA approval for a new treatment for ADRD. To continue the dramatic progress...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Head

UNIVERSITY OF CALIFORNIA-IRVINE, IRVINE, CA

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$359,160

FY 2025

Project Title

Training in Translational ADRD Neuroscience (TITAN)

Grant Number:

5T32AG073088-05

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2021

End Date:

8/31/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Project Summary/Abstract Population aging is leading to a public health crisis in the growing number of people affected by Alzheimer’s disease (AD) and Related Dementias (ADRD). It has been more than 15 years since the last FDA approval for a new treatment for ADRD. To continue the dramatic progress...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Cheryl L. Walker

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$320,816

FY 2025

Project Title

Training in Precision Environmental Health Sciences

Grant Number:

5T32ES027801-07

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2018

End Date:

6/30/2029

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Precision Environmental Health seeks to understand how environmental exposures influence human health and disease, and use this knowledge for new prevention and intervention strategies. The Training in Precision Environmental Health Sciences (TPEHS) Program is a joint initiative of Baylor College of...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Joseph Keawe'aimoku Kaholokula

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$309,196

FY 2025

Project Title

Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the Pacific

Grant Number:

2R25CA244073-06

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2020

End Date:

8/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This application proposes to continue the “Cancer Research Education, Advancement, Training and Empowerment” (CREATE) program at the University of Hawai‘i Cancer Center (UHCC), a successful research experience for undergraduate and first-year graduate students with a focus on cancer health dispariti...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LENORA WM LOO

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$309,196

FY 2025

Project Title

Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the Pacific

Grant Number:

2R25CA244073-06

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2020

End Date:

8/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This application proposes to continue the “Cancer Research Education, Advancement, Training and Empowerment” (CREATE) program at the University of Hawai‘i Cancer Center (UHCC), a successful research experience for undergraduate and first-year graduate students with a focus on cancer health dispariti...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

GERTRAUD MASKARINEC

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$309,196

FY 2025

Project Title

Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the Pacific

Grant Number:

2R25CA244073-06

Activity Code:

R25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2020

End Date:

8/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This application proposes to continue the “Cancer Research Education, Advancement, Training and Empowerment” (CREATE) program at the University of Hawai‘i Cancer Center (UHCC), a successful research experience for undergraduate and first-year graduate students with a focus on cancer health dispariti...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Roberto Civitelli

WASHINGTON UNIVERSITY, SAINT LOUIS, MO

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$303,684

FY 2025

Project Title

Skeletal Disorders Training Program

Grant Number:

5T32AR060719-14

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2011

End Date:

4/30/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Washington University School of Medicine and the affiliated Barnes-Jewish Hospital have a 40-year tradition of excellence in musculoskeletal research, patient care, education and training. In 2011, the Skeletal Disorders Training Program (SDTP) was established under the leadership of Dr. Roberto Civ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Yvonne Claire Lee

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$298,166

FY 2025

Project Title

Rheumatology Research Training Program

Grant Number:

1T32AR085530-01

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY This proposal is a new submission of a National Research Service Award for Rheumatology Research Training at Northwestern University Feinberg School of Medicine. The overall objective of this training program is to produce a diverse pool of well-trained scientists with the skills nec...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Harris R Perlman

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 38/100

Training-friendly

Solid budget

Active award

$298,166

FY 2025

Project Title

Rheumatology Research Training Program

Grant Number:

1T32AR085530-01

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY This proposal is a new submission of a National Research Service Award for Rheumatology Research Training at Northwestern University Feinberg School of Medicine. The overall objective of this training program is to produce a diverse pool of well-trained scientists with the skills nec...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Pierre C Dagher

INDIANA UNIVERSITY INDIANAPOLIS, INDIANAPOLIS, IN

Exploratory lead · 36/100

Above-average budget

Active award

Team-scale grant

$878,240

FY 2025

Project Title

Indiana Center for Advanced Renal Microscopy and Molecular Imaging

Grant Number:

5U54DK137328-03

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

9/1/2023

End Date:

6/30/2028

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract (Center Overview) From its inception as an NIDDK-funded P50 Center in 2002, the mission of the Indiana O’Brien Center for Advanced Renal Microscopy has been to provide renal researchers with effective access to advanced forms of microscopy. Over the past 20 years of continu...

Research Terms

<3-D><3-Dimensional><3D><Applications Grants><Biological><Body Tissues><Collaborations><Common Rat Strains><Communities><Cytometry><Data><Development><Diabetes Mellitus><Dysfunction><Educational workshop><Environment><Equipment><Functional disorder><Funding><Generations><Goals><Grant Proposals><Hematology><HuBMAP><Human BioMolecular Atlas Program><Image><Image Analyses><Image Analysis><Imaging technology><Indiana><Individual><Infrastructure><Institution><Investigators><Kidney><Kidney Urinary System><Left><Light><Methods><Mice><Mice Mammals><Microscopy><Mission><Molecular><Murine><Mus><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Nebraska><Nephrology><Photoradiation><Physiology><Physiopathology><Publications><Quantitative Microscopy><Rat><Rats Mammals><Rattus><Renal Tissue><Reporter><Research><Research Personnel><Research Resources><Researchers><Resolution><Resource Development><Resources><Scientific Publication><Services><Techniques><Technology><Tissues><Training><United States National Institutes of Health><Universities><Washington><Work><Workshop><biologic><biomedical resource><career><computer imaging><design><designing><developmental><diabetes><digital imaging><experience><image evaluation><image interpretation><imaging><innovative technologies><intra-vital microscopy><intravital microscopy><microscope imaging><microscopic imaging><microscopy imaging><molecular imaging><molecule imaging><multi-photon><new technology><novel><novel technologies><outreach><pathophysiology><precision medicine><precision-based medicine><programs><renal><resolutions><spatial RNA sequencing><spatial gene expression analysis><spatial gene expression profiling><spatial resolved transcriptome sequencing><spatial transcriptome analysis><spatial transcriptome profiling><spatial transcriptome sequencing><spatial transcriptomics><spatially resolved transcriptomics><spatio transcriptomics><synergism><three dimensional><tool>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DEREK L STIREWALT

FRED HUTCHINSON CANCER CENTER, SEATTLE, WA

Exploratory lead · 36/100

Above-average budget

Active award

Team-scale grant

$877,701

FY 2025

Project Title

Stem Cell and Transplantation Biology

Grant Number:

5U54DK106829-11

Activity Code:

U54

Mechanism:

Research Centers

Agency:

NIH

Start Date:

8/1/2015

End Date:

7/31/2028

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

PROJECT SUMMARY/ABSTRACT - Overall The theme of this CCEH is focused on stem cell and transplantation biology. The aims are designed to overcome obstacles that prevent new investigators from joining this field. Specifically the four cores will provide investigators access to: Large numbers of human ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

OBIDIUGWU KENRIK DURU

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 36/100

Above-average budget

Active award

Team-scale grant

$710,311

FY 2025

Project Title

UCLA LIFT-UP (Leveraging Institutional support For Talented, Upcoming Physicians and/or Scientists)

Grant Number:

5U24DK132746-04

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/15/2022

End Date:

5/31/2027

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

UCLA LIFT-UP (Leveraging Institutional support For Talented, Upcoming Physicians and/or Scientists), proposes to develop a research and mentoring program that will contribute to strengthening the scientific workforce pursuing research careers aligned with the NIDDK mission. Our leadership team has a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

CAROL M MANGIONE

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 36/100

Above-average budget

Active award

Team-scale grant

$710,311

FY 2025

Project Title

UCLA LIFT-UP (Leveraging Institutional support For Talented, Upcoming Physicians and/or Scientists)

Grant Number:

5U24DK132746-04

Activity Code:

U24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

7/15/2022

End Date:

5/31/2027

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

UCLA LIFT-UP (Leveraging Institutional support For Talented, Upcoming Physicians and/or Scientists), proposes to develop a research and mentoring program that will contribute to strengthening the scientific workforce pursuing research careers aligned with the NIDDK mission. Our leadership team has a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rena Hiren Yadlapati

UNIVERSITY OF CALIFORNIA, SAN DIEGO, LA JOLLA, CA

Exploratory lead · 36/100

Training-friendly

Active award

Career award

$192,365

FY 2025

Project Title

Mechanism Guided Therapy for Laryngopharyngeal Reflux

Grant Number:

5K23DK125266-05

Activity Code:

K23

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/7/2021

End Date:

9/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY/ABSTRACT Generalized approaches for laryngopharyngeal reflux (LPR), a prevalent and heterogeneous syndrome in which laryngeal symptoms are attributed to gastroesophageal reflux, have led to poor health outcomes, inappropriate resource utilization, and tremendous healthcare costs. As ...

Research Terms

<21+ years old><Accounting><Acid Reflux><Address><Adult><Adult Human><Assistive Technology><Bioinformatics><Biological Markers><CRC screening><California><Caring><Chronic><Clinical><Clinical Data><Clinical Management><Clinical Trials><Controlled Clinical Trials><Data><Deglutition Disorders><Devices><Diagnosis><Diagnostic><Diagnostic Findings><Diagnostic Method><Diagnostic Procedure><Diagnostic Technique><Digestive Diseases><Digestive System Diseases><Digestive System Disorders><Disease><Disorder><Double-Blind Method><Double-Blind Study><Double-Blinded><Double-Masked Method><Double-Masked Study><Dysphagia><Dysphonia><Electrical Impedance><Ensure><Environment><Esophageal Diseases><Esophageal Disorder><Esophageal Reflux><Esophagus><Expenditure><Fluoroscopy><Functional Metagenomics><Future><GERD><GI microbiome><GI tract disorder><Gastro-oesophageal Reflux><Gastroesophageal Reflux><Gastroesophageal reflux disease><Generations><Goals><Grant><Health><Health Care Costs><Health Costs><Impedance><Inferior esophageal sphincter structure><Inflammation><Infrastructure><Institution><International><Investigators><K23 Award><K23 Mechanism><K23 Program><Knowledge><Laryngeal><Larynx><Larynx Head and Neck><Lower Esophageal Sphincter><Manometry><Manometry Biochemistry><Measures><Mentored Patient-Oriented Research Career Development Award><Mentored Patient-Oriented Research Career Development Award (K23)><Mentors><Mentorship><Metagenomics><Methods><Microbiomics><Modernization><Mouth microbiome><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Observation research><Observation study><Observational Study><Observational research><Operative Procedures><Operative Surgical Procedures><Oral><Oral Characters><Outcomes Research><Pathway interactions><Patient Care><Patient Care Delivery><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Pepsin><Pepsin A><Pharyngeal structure><Pharynx><Phenotype><Phonation Disorders><Physicians><Physiologic><Physiological><Physiology><Proton Pump Inhibitors><Randomized><Randomized, Controlled Trials><Reflux><Research><Research Design><Research Institute><Research Personnel><Research Resources><Research Training><Researchers><Resources><Salivary><Scientist><Screening procedure><Self-Help Devices><Seminal><Shotgun Sequencing><Signs and Symptoms><Source><Study Type><Surgical><Surgical Interventions><Surgical Procedure><Swallowing Disorders><Symptoms><Syndrome><Techniques><Testing><Therapeutic><Throat><Training><Translational Research><Translational Science><Treatment outcome><United States National Institutes of Health><Universities><Upper Esophageal Sphincter><Visit><Voice Disorders><Work><adulthood><arm><assisted device><assistive device><authority><bio-markers><biologic marker><biomarker><cardiac sphincter><care for patients><care of patients><care resource use><care resource utilization><career><career development><caring for patients><clinical translation><clinically translatable><colorectal cancer detection><colorectal cancer early detection><colorectal cancer screening><constriction><cost><design><designing><detect colorectal cancer><diagnostic biomarker><diagnostic marker><digestive disorder><digestive tract disease><digestive tract microbiome><diseases of esophagus><electric impedance><enteric microbiome><enthusiastic atmosphere><enthusiastic environment><esophagus disorder><experience><extraesophageal reflux disease><gastrointestinal microbiome><gastrointestinal tract disease><gastrointestinal tract disorder><gut microbiome><gut-associated microbiome><health care burden><health care resource use><health care resource utilization><improved><indexing><innovate><innovation><innovative><intestinal biome><intestinal microbiome><laryngopharyngeal reflux><microbial><microbiome><microbiome research><microbiome science><microbiome sequencing><microbiome studies><microbiota community><multidisciplinary><new diagnostics><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation diagnostics><next generation therapeutics><novel><novel diagnostics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><oral microbial community><oral microbiome><oral microbiota><oral microflora><pathway><patient oriented outcomes><poor health outcome><primary outcome><randomisation><randomization><randomized control trial><randomly assigned><recruit><reduced health outcome><research facility><response><screening tools><secondary outcome><skill acquisition><skill development><skills><study design><supportive atmosphere><supportive environment><surgery><targeted biomarker><tool><translation research><translational investigation><treatment strategy><trial design><validation studies><voice box><worse health outcome>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PAUL M STEMMER

WAYNE STATE UNIVERSITY, DETROIT, MI

Exploratory lead · 34/100

Large award

Active award

$1,953,966

FY 2025

Project Title

Orbitrap Astral for Wayne State Proteomics

Grant Number:

1S10OD038157-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2025

End Date:

7/1/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Project Summary/Abstract The goal of this proposal is to bring a Thermo Fisher Scientific Orbitrap Astral mass spectrometer with a High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS Pro Duo) devise, an Ardia Instrument Control and Data Management system plus a nano-LC to the Proteomics ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Stephanie M Cologna

UNIVERSITY OF ILLINOIS AT CHICAGO, Chicago, IL

Exploratory lead · 34/100

Large award

Active award

$1,481,999

FY 2025

Project Title

A dual-source ion mobility mass spectrometry system

Grant Number:

1S10OD036311-01A1

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/15/2025

End Date:

5/14/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

Abstract The enclosed application seeks to add a dual source ion mobility hybrid mass spectrometry system for biomedical research at the University of Illinois Chicago (UIC), a federally designated minority serving institution. This instrumentation would enable state-of-the art measurements for rese...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Terry L. Bowlin

MICROBIOTIX, INC, WORCESTER, MA

Exploratory lead · 34/100

Above-average budget

Active award

$669,859

FY 2026

Project Title

Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitis

Grant Number:

5R33EY036947-02

Activity Code:

R33

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

2/1/2025

End Date:

1/31/2028

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract The long-term goal of this project, to develop filociclovir (FCV) for the safe and effective treatment of human adenovirus (HAdV) ocular infections, especially HAdV-related epidemic keratoconjunctivitis (EKC), a stated National Eye Institute (NEI) research priority. There a...

Research Terms

<2-Pyrrolidinone, 1-ethenyl-, homopolymer><Accounting><Active Follow-up><Acute><Adenoviridae><Adenoviridae Infections><Adenovirus Infections><Adenoviruses><Adverse effects><Animals><Artificial Tears><Australia><Behavioral><Blindness><CMV infection><Canine Species><Canis familiaris><Cardiovascular><Cardiovascular Body System><Cardiovascular Organ System><Cardiovascular system><Chemistry><Chronic><Cidofovir><Clinical><Clinical Research><Clinical Study><Clinical Trials><Clinical Trials Design><Common Rat Strains><Communication><Conjunctivitis><Cornea><Cytomegalic Inclusion Disease><Cytomegalovirus Infections><Data><Devices><Disease><Disorder><Dogs><Dogs Mammals><Domestic Rabbit><Dose><Drug Kinetics><Drug Therapy><Early-Stage Clinical Trials><Economic Burden><Enzyme Gene><Enzymes><Epidemic Keratoconjunctivitis><Exhibits><Eye><Eye Drops><Eye Infections><Eyeball><Eyedrops><FDA licensed drugs><FDA-approved agents><FDA-approved drug><FDA-approved medications><FDA-approved pharmaceuticals><FDA-approved therapeutic agent><Food and Drug Administration approved drug><Food and Drug Administration approved medications><Food and Drug Administration approved pharmaceuticals><Formulation><Gel><Goals><HPMPC><Heart Vascular><Human><IND Filing><IND application><IND package><IND submission><Inclusion Disease><India><Infection><Investigational Drugs><Investigational New Drug Application><Investigational New Drugs><Iodine><Keratitis><Keratoconjunctivitis><Medical><Modeling><Modern Man><NOAEL><NSAIDs><National Eye Institute><Neurologic><Neurological><No-Observed-Adverse-Effect Level><Non-Steroidal Anti-Inflammatory Agents><Ocular Infections><Oryctolagus cuniculus><P-30 Protein><P30 Protein><Pancreatic RNase><Pancreatic ribonuclease><Pathology><Patients><Pharmacokinetics><Pharmacological Treatment><Pharmacology><Pharmacology and Toxicology><Pharmacotherapy><Phase><Phase 1 Clinical Trials><Phase 2 Clinical Trials><Phase I Clinical Trials><Phase II Clinical Trials><Polvidone><Polyvidon><Polyvinylpyrrolidone><Position><Positioning Attribute><Povidone><Pre IND FDA meeting><Pre-IND mtg><Preclinical data><Primary Care Physician><RNase A><RNase I><Rabbits><Rabbits Mammals><Rat><Rats Mammals><Rattus><Reaction><Regimen><Research Design><Research Priority><Ribonuclease A><Ribonuclease I><Safety><Salivary Gland Virus Disease><Solid><Specific qualifier value><Specified><Study Type><Supportive Therapy><Supportive care><Topical Corticosteroids><Toxicology><United States><Viral Activity><Viral Burden><Viral Function><Viral Load><Viral Load result><Viral Physiology><Viral Shedding><Virus Shedding><Visit><Visual><Work><active followup><anti-microbial><antimicrobial><canine><carcinogenicity><circulatory system><conjunctiva><corneal><decreased income><domestic dog><drug intervention><drug treatment><effective therapy><effective treatment><effectiveness testing><efficacy study><follow up><follow-up><followed up><followup><genotoxicity><improve symptom><income loss><inhibitor><lost earning><lost income><lost wage><manufacture><meeting><meetings><meter><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><non-steroidal anti-inflammatory drugs><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><nucleoside analog><organ transplant patient><organ transplant recipient><pharmaceutical intervention><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><phase 2 study><phase I protocol><phase II protocol><phase II study><pre-IND consultation><pre-IND discussion><pre-IND meeting><pre-Investigational New Drug meeting><pre-clinical><pre-clinical development><pre-clinical study><preclinical><preclinical development><preclinical findings><preclinical information><preclinical study><programs><ranpirnase><reduced income><respiratory><safety study><socio-economic><socio-economically><socioeconomically><socioeconomics><study design><symptom improvement><symptomatic improvement><translational study><vision loss><visual loss>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rosalind J Wright

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY

Exploratory lead · 34/100

Solid budget

Active award

Career award

$481,564

FY 2026

Project Title

Scholars in Environmental Pediatrics, Reproductive Health, and Life Course Science

Grant Number:

5K12ES033594-05

Activity Code:

K12

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/1/2021

End Date:

10/31/2026

Project Abstract

The need to develop children's environmental health (CEH) clinician-scientists focused on the translation of pediatric and reproductive environmental health is critical. In parallel to the rise of developmental origins of health and disease (DOHaD) principles, precision medicine (PM) has emerged as ...

Research Terms

<0-11 years old><Address><Caring><Child><Child Health><Child Youth><Childhood><Children (0-21)><Chronic Disease><Chronic Illness><Clinical><Country><Development><Development and Research><Discipline><Disease><Disorder><Ecologic Systems><Ecological Systems><Ecosystem><Environment><Environmental Health><Environmental Health Science><Environmental Science><Fellowship Program><Genetic><Health><Health Care><Health Care Professional><Health Professional><Human><Individual><Infrastructure><Institution><Investments><K12><K12 Award><K12 Mechanism><K12 Program><Lead><Learning><Life><Life Cycle><Life Cycle Stages><Medical><Mentored Clinical Scientist Development Program><Methods><Modern Man><Molecular><Outcome><Pb element><Pediatrics><Perinatal><Peripartum><Physicians><Physiologic><Physiological><Precision Medicine Initiative><R & D><R&D><Reproductive Health><Research><Role><Running><Scholars Program><Science><Scientist><Shapes><Sight><Specialty><System><Toxin><Training><Translating><Translations><Vision><Workforce Development><child health care><chronic disorder><clinical center><developmental><disease prevention><disease risk><disorder prevention><disorder risk><early childhood><exposomics><fetal><heavy metal Pb><heavy metal lead><kids><life course><medical specialties><microbial><new approaches><next generation><novel approaches><novel strategies><novel strategy><pediatric><pediatric care><pediatric health care><precision medicine><precision-based medicine><programs><reproductive><research and development><social><social role><translation><visual function><workforce needs><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Mohsen Bahrami

WAKE FOREST UNIVERSITY HEALTH SCIENCES, WINSTON-SALEM, NC

Exploratory lead · 30/100

Recent

Active award

Career award

$136,244

FY 2026

Project Title

Cerebral Small Vessel Disease and Dementia: Defining Global Resilience and Disruption in Brain Networks

Grant Number:

5K25AG090707-02

Activity Code:

K25

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

11/15/2024

End Date:

10/31/2029

Project Abstract

My goal is to establish myself as an independent biomedical researcher in brain aging and Alzheimer’s disease (AD) and AD related dementias (ADRD). My passion to build a career in aging stems from my profound desire to help older people to maintain their functionality and quality of life. AD/ADRD ar...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jonathan D Cherry

VA BOSTON HEALTH CARE SYSTEM, BOSTON, MA

Exploratory lead · 30/100

Very recent

Active award

$0

FY 2026

Project Title

Repetitive head injury alters the neurodegenerative response and pathologic progression in Alzheimer's disease

Grant Number:

1I01RD001320-01A2

Activity Code:

I01

Mechanism:

Non-SBIR/STTR

Agency:

VA

Start Date:

1/1/2026

End Date:

12/31/2029

Why this may be worth a closer look

• Award timing is recent enough to matter for outreach and opportunity scanning.

Project Abstract

Each year, millions of individuals receive repetitive head injuries (RHI) from playing contact sports or through military service. RHIs are a type of traumatic brain injury characterized by mild, mostly non-concussive injuries that, in the context of a sport like American football, can occur dozens ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rachelle Hope Crosbie

UNIVERSITY OF CALIFORNIA LOS ANGELES, LOS ANGELES, CA

Exploratory lead · 28/100

Training-friendly

Solid budget

$442,297

FY 2025

Project Title

Muscle Cell Biology, Pathophysiology, and Therapeutics

Grant Number:

5T32AR065972-10

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2016

End Date:

4/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Abstract This proposal is a competitive renewal application for a multidisciplinary training program in basic and translational research in muscle cell biology at UCLA from a group of highly engaged faculty mentors. The program in Muscle Cell Biology, Pathophysiology, and Therapeutics is focused on ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID O MELTZER

UNIVERSITY OF CHICAGO, CHICAGO, IL

Exploratory lead · 28/100

Training-friendly

Solid budget

$430,073

FY 2025

Project Title

Specialized Training: Demography and Economics of Aging - Renewal 01 - Renewal

Grant Number:

5T32AG000243-30

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/30/1994

End Date:

4/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

The University of Chicago (UC) proposes to continue the UC Specialized Training Program in the Demography and Economics of Aging program, that began in 1994, and requests funded trainee positions for 4 predoctoral fellows and 3 postdoctoral fellows per year. Housed in the interdisciplinary Center fo...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Dennis Michael Feehan

UNIVERSITY OF CALIFORNIA BERKELEY, BERKELEY, CA

Exploratory lead · 28/100

Training-friendly

Solid budget

$311,343

FY 2025

Project Title

Interdisciplinary Training in Demography

Grant Number:

5T32HD007275-40

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/1984

End Date:

4/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This project seeks to continue providing high quality, interdisciplinary training in demography, with a focus on the relationships between population dynamics, socio-cultural systems, and human health and welfare. Our objective is to continue with our successful recruiting, training, and placement o...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Machelle T. Pardue

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 28/100

Training-friendly

Active award

$248,459

FY 2025

Project Title

VIsion Science Training in Atlanta

Grant Number:

2T32EY007092-39

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/28/1984

End Date:

7/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT This T32 program, entitled “VIsion Science Training in Atlanta”: (VISTA), is an interdisciplinary predoctoral and postdoctoral training program. The goal of VISTA is to deliver a comprehensive, translational training program focused on development, health, and disease of the visual system, ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

JOHN Y KAO

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 28/100

Training-friendly

Active award

$232,710

FY 2025

Project Title

Training in Basic and Translational Digestive Sciences

Grant Number:

5T32DK094775-13

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2012

End Date:

6/30/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT This application seeks to renew the NIH T32 Training in Basic and Translational Digestive Sciences that is currently in its 10th year. The University of Michigan has a superb history of training in gastrointestinal sciences over the last several decades, including both physician and non-phy...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

LINDA C. SAMUELSON

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 28/100

Training-friendly

Active award

$232,710

FY 2025

Project Title

Training in Basic and Translational Digestive Sciences

Grant Number:

5T32DK094775-13

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/2012

End Date:

6/30/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT This application seeks to renew the NIH T32 Training in Basic and Translational Digestive Sciences that is currently in its 10th year. The University of Michigan has a superb history of training in gastrointestinal sciences over the last several decades, including both physician and non-phy...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Jose E Cavazos

UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, SAN ANTONIO, TX

Exploratory lead · 28/100

Training-friendly

Active award

$178,080

FY 2025

Project Title

South Texas Alzheimer’s and Neurodegenerative Disorders Training Program

Grant Number:

5T32AG082661-03

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2023

End Date:

8/31/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

A predoctoral T32 training program is proposed to augment the research workforce in Alzheimer’s Disease (AD), related dementias (RD) and other neurodegenerative disorders (ND). The training initiative is named the South Texas Alzheimer’s and Neurodegenerative Disorders Training Program: STAND TP. ST...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

PETER Thornton FOX

UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, SAN ANTONIO, TX

Exploratory lead · 28/100

Training-friendly

Active award

$178,080

FY 2025

Project Title

South Texas Alzheimer’s and Neurodegenerative Disorders Training Program

Grant Number:

5T32AG082661-03

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

9/1/2023

End Date:

8/31/2028

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

A predoctoral T32 training program is proposed to augment the research workforce in Alzheimer’s Disease (AD), related dementias (RD) and other neurodegenerative disorders (ND). The training initiative is named the South Texas Alzheimer’s and Neurodegenerative Disorders Training Program: STAND TP. ST...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lindsay C Kobayashi

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 28/100

Training-friendly

Active award

$162,093

FY 2025

Project Title

Interdisciplinary Research Training in Health and Aging

Grant Number:

2T32AG027708-16

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2008

End Date:

7/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Project Summary/Abstract The proposed program, “Interdisciplinary Research Training on Public Health and Aging” (IRTHA) seeks a five- year continuation of the current award, which was originally funded in 2008 and renewed most recently in May 2020. The IRTHA program provides interdisciplinary resear...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Briana Mezuk

UNIVERSITY OF MICHIGAN AT ANN ARBOR, ANN ARBOR, MI

Exploratory lead · 28/100

Training-friendly

Active award

$162,093

FY 2025

Project Title

Interdisciplinary Research Training in Health and Aging

Grant Number:

2T32AG027708-16

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2008

End Date:

7/31/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Project Summary/Abstract The proposed program, “Interdisciplinary Research Training on Public Health and Aging” (IRTHA) seeks a five- year continuation of the current award, which was originally funded in 2008 and renewed most recently in May 2020. The IRTHA program provides interdisciplinary resear...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

ALEXEI A GROM

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Exploratory lead · 28/100

Training-friendly

Active award

$154,832

FY 2025

Project Title

Cincinnati Training Program in Pediatric Rheumatology

Grant Number:

2T32AR069512-10

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2016

End Date:

4/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This T32 application for the Research Training Program (RTP) for Pediatric Rheumatic Diseases seeks to equip pediatric rheumatology fellows with the investigative skills necessary to succeed in meaningful scientific careers in academic pediatric rheumatology. The program is based in a large Division...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Grant Sanford Schulert

CINCINNATI CHILDRENS HOSP MED CTR, CINCINNATI, OH

Exploratory lead · 28/100

Training-friendly

Active award

$154,832

FY 2025

Project Title

Cincinnati Training Program in Pediatric Rheumatology

Grant Number:

2T32AR069512-10

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2016

End Date:

4/30/2030

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

This T32 application for the Research Training Program (RTP) for Pediatric Rheumatic Diseases seeks to equip pediatric rheumatology fellows with the investigative skills necessary to succeed in meaningful scientific careers in academic pediatric rheumatology. The program is based in a large Division...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Seth William Kullman

NORTH CAROLINA STATE UNIVERSITY RALEIGH, RALEIGH, NC

Exploratory lead · 28/100

Training-friendly

Active award

$121,060

FY 2025

Project Title

Molecular Pathways to Pathogenesis in Toxicology

Grant Number:

5T32ES007046-45

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

7/1/1977

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

PROJECT SUMMARY/ABSTRACT The North Carolina State University “Molecular Pathways to Pathogenesis in Toxicology” NIEHS T32 training grant is a long-standing, impactful and multidisciplinary initiative that has supported 130 pre-doctoral trainees and 18 post-doctoral researchers over the past 41 years...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

SHEHZAD Z. SHEIKH

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC

Exploratory lead · 28/100

Training-friendly

Active award

$96,269

FY 2025

Project Title

Gastroenterology Research Training

Grant Number:

3T32DK007737-30S1

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

8/1/1996

End Date:

6/30/2026

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

ABSTRACT This is a competitive renewal application for years 25-30 of a program to train postdoctoral investigators in basic and translational gastrointestinal research. An interdisciplinary faculty of 17 established mentors and 3 mentors-in-training is drawn from the Center for Gastrointestinal Bio...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

STEPHEN B. KRITCHEVSKY

WAKE FOREST UNIVERSITY HEALTH SCIENCES, WINSTON-SALEM, NC

Exploratory lead · 28/100

Training-friendly

Active award

$1

FY 2025

Project Title

Translational Training in Aging and Alzheimer’s Disease Related Disorders

Grant Number:

5T32AG033534-16

Activity Code:

T32

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2009

End Date:

8/31/2027

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Translational Training in Aging and Alzheimer’s Disease Related Disorders This renewal application seeks to sustain our T32-supported Training Program to continue training postdoctoral fellows in the conduct of translational research focused on optimizing cognitive and physical function with aging a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID A GELLER

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 26/100

Solid budget

Active award

$463,978

FY 2026

Project Title

Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)

Grant Number:

5R24DK139775-03

Activity Code:

R24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2024

End Date:

1/31/2029

Project Abstract

PROJECT SUMMARY/ABSTRACT The overall goal of the Human Liver Tissue & Hepatocytes Research Resource (HLTHRR) program is to provide normal human liver tissue and normal human hepatocytes (HC) and non-parenchymal cells (NPC) including NPC sub-fractions (Kupffer cells, sinusoidal endothelial cells, cho...

Research Terms

<21+ years old><Abscission><Acceleration><Administrative Supplement><Adult><Adult Human><Alcohol associated hepatitis><Alcohol hepatitis><Alcohol induced hepatitis><Alcohol related hepatitis><Alcoholic><Alcoholic Hepatitis><American><Animals><Biliary><Biomedical Research><Body Tissues><Boozer><Cell Body><Cell Culture Techniques><Cell Fraction><Cell Isolation><Cell Segregation><Cell Separation><Cell Separation Technology><Cells><Cessation of life><Communities><Contracting Opportunities><Contracts><Country><Data><Death><Dependent drinker><Diagnosis><Disease><Disorder><Drug or chemical Tissue Distribution><Endothelial Cells><Enzyme Gene><Enzymes><Ethanol-induced hepatitis><Excision><Extirpation><Fatty Liver><Feedback><Foundations><Funding><Goals><Hepatic Cells><Hepatic Disorder><Hepatic Neoplasms><Hepatic Parenchymal Cell><Hepatic Transplantation><Hepatocyte><Human><Human Resources><Inflammatory><Injury to Liver><Investigators><Ischemia-Reperfusion Injury><Knowledge><Kupffer Cells><Label><Leadership><Liver><Liver Cells><Liver Grafting><Liver Steatosis><Liver Transplant><Liver diseases><Liver neoplasms><Manpower><Metabolic><Modeling><Modern Man><NASH><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Normal Cell><Operative Procedures><Operative Surgical Procedures><Organization Charts><Pathology><Patients><Physiology><Population><Process><Public Health><Publications><R24><Regenerative capacity><Removal><Reperfusion Damage><Reperfusion Injury><Research><Research Personnel><Research Resources><Researchers><Resected><Resources><Scientific Publication><Scientist><Sepsis><Services><Shipping><Source><Stellate Sinusoidal Macrophage><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Survey Instrument><Surveys><Suspension substance><Suspensions><System><Tissue Distribution><Tissues><Toxicology><Translational Research><Translational Science><Tumor Cell Line><United States National Institutes of Health><Universities><Viral><Viral hepatitis><acute hepatic disease><acute liver disease><adulthood><biomedical resource><cell culture><cell cultures><cell sorting><cholangiocyte><chronic hepatic disease><chronic hepatic disorder><chronic liver disease><chronic liver disorder><drug discovery><experience><hepatic body system><hepatic damage><hepatic disease><hepatic injury><hepatic ischemia><hepatic neoplasia><hepatic neoplasm><hepatic organ system><hepatic steatosis><hepatic tumor><hepatitis virus infection><hepatopathy><hepatosteatosis><improved><innovate><innovation><innovative><liver damage><liver disorder><liver function><liver injury><liver ischemia><liver macrophage><liver transplantation><liver tumor><non-alcohol induced steatohepatitis><non-alcoholic steato-hepatitis><non-alcoholic steatohepatitis><nonalcoholic steato-hepatitis><nonalcoholic steatohepatitis><organizational structure><personnel><problem drinker><programs><regeneration ability><regeneration capacity><resection><response><stellate cell><success><surgery><translation research><translational investigation><tumor><web site><website>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Satdarshan Singh Monga

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 26/100

Solid budget

Active award

$463,978

FY 2026

Project Title

Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)

Grant Number:

5R24DK139775-03

Activity Code:

R24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2024

End Date:

1/31/2029

Project Abstract

PROJECT SUMMARY/ABSTRACT The overall goal of the Human Liver Tissue & Hepatocytes Research Resource (HLTHRR) program is to provide normal human liver tissue and normal human hepatocytes (HC) and non-parenchymal cells (NPC) including NPC sub-fractions (Kupffer cells, sinusoidal endothelial cells, cho...

Research Terms

<21+ years old><Abscission><Acceleration><Administrative Supplement><Adult><Adult Human><Alcohol associated hepatitis><Alcohol hepatitis><Alcohol induced hepatitis><Alcohol related hepatitis><Alcoholic><Alcoholic Hepatitis><American><Animals><Biliary><Biomedical Research><Body Tissues><Boozer><Cell Body><Cell Culture Techniques><Cell Fraction><Cell Isolation><Cell Segregation><Cell Separation><Cell Separation Technology><Cells><Cessation of life><Communities><Contracting Opportunities><Contracts><Country><Data><Death><Dependent drinker><Diagnosis><Disease><Disorder><Drug or chemical Tissue Distribution><Endothelial Cells><Enzyme Gene><Enzymes><Ethanol-induced hepatitis><Excision><Extirpation><Fatty Liver><Feedback><Foundations><Funding><Goals><Hepatic Cells><Hepatic Disorder><Hepatic Neoplasms><Hepatic Parenchymal Cell><Hepatic Transplantation><Hepatocyte><Human><Human Resources><Inflammatory><Injury to Liver><Investigators><Ischemia-Reperfusion Injury><Knowledge><Kupffer Cells><Label><Leadership><Liver><Liver Cells><Liver Grafting><Liver Steatosis><Liver Transplant><Liver diseases><Liver neoplasms><Manpower><Metabolic><Modeling><Modern Man><NASH><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Normal Cell><Operative Procedures><Operative Surgical Procedures><Organization Charts><Pathology><Patients><Physiology><Population><Process><Public Health><Publications><R24><Regenerative capacity><Removal><Reperfusion Damage><Reperfusion Injury><Research><Research Personnel><Research Resources><Researchers><Resected><Resources><Scientific Publication><Scientist><Sepsis><Services><Shipping><Source><Stellate Sinusoidal Macrophage><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Survey Instrument><Surveys><Suspension substance><Suspensions><System><Tissue Distribution><Tissues><Toxicology><Translational Research><Translational Science><Tumor Cell Line><United States National Institutes of Health><Universities><Viral><Viral hepatitis><acute hepatic disease><acute liver disease><adulthood><biomedical resource><cell culture><cell cultures><cell sorting><cholangiocyte><chronic hepatic disease><chronic hepatic disorder><chronic liver disease><chronic liver disorder><drug discovery><experience><hepatic body system><hepatic damage><hepatic disease><hepatic injury><hepatic ischemia><hepatic neoplasia><hepatic neoplasm><hepatic organ system><hepatic steatosis><hepatic tumor><hepatitis virus infection><hepatopathy><hepatosteatosis><improved><innovate><innovation><innovative><liver damage><liver disorder><liver function><liver injury><liver ischemia><liver macrophage><liver transplantation><liver tumor><non-alcohol induced steatohepatitis><non-alcoholic steato-hepatitis><non-alcoholic steatohepatitis><nonalcoholic steato-hepatitis><nonalcoholic steatohepatitis><organizational structure><personnel><problem drinker><programs><regeneration ability><regeneration capacity><resection><response><stellate cell><success><surgery><translation research><translational investigation><tumor><web site><website>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Alejandro Soto-Gutierrez

UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PITTSBURGH, PA

Exploratory lead · 26/100

Solid budget

Active award

$463,978

FY 2026

Project Title

Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)

Grant Number:

5R24DK139775-03

Activity Code:

R24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2024

End Date:

1/31/2029

Project Abstract

PROJECT SUMMARY/ABSTRACT The overall goal of the Human Liver Tissue & Hepatocytes Research Resource (HLTHRR) program is to provide normal human liver tissue and normal human hepatocytes (HC) and non-parenchymal cells (NPC) including NPC sub-fractions (Kupffer cells, sinusoidal endothelial cells, cho...

Research Terms

<21+ years old><Abscission><Acceleration><Administrative Supplement><Adult><Adult Human><Alcohol associated hepatitis><Alcohol hepatitis><Alcohol induced hepatitis><Alcohol related hepatitis><Alcoholic><Alcoholic Hepatitis><American><Animals><Biliary><Biomedical Research><Body Tissues><Boozer><Cell Body><Cell Culture Techniques><Cell Fraction><Cell Isolation><Cell Segregation><Cell Separation><Cell Separation Technology><Cells><Cessation of life><Communities><Contracting Opportunities><Contracts><Country><Data><Death><Dependent drinker><Diagnosis><Disease><Disorder><Drug or chemical Tissue Distribution><Endothelial Cells><Enzyme Gene><Enzymes><Ethanol-induced hepatitis><Excision><Extirpation><Fatty Liver><Feedback><Foundations><Funding><Goals><Hepatic Cells><Hepatic Disorder><Hepatic Neoplasms><Hepatic Parenchymal Cell><Hepatic Transplantation><Hepatocyte><Human><Human Resources><Inflammatory><Injury to Liver><Investigators><Ischemia-Reperfusion Injury><Knowledge><Kupffer Cells><Label><Leadership><Liver><Liver Cells><Liver Grafting><Liver Steatosis><Liver Transplant><Liver diseases><Liver neoplasms><Manpower><Metabolic><Modeling><Modern Man><NASH><NIDDK><NIH><National Institute of Diabetes and Digestive and Kidney Diseases><National Institutes of Health><Normal Cell><Operative Procedures><Operative Surgical Procedures><Organization Charts><Pathology><Patients><Physiology><Population><Process><Public Health><Publications><R24><Regenerative capacity><Removal><Reperfusion Damage><Reperfusion Injury><Research><Research Personnel><Research Resources><Researchers><Resected><Resources><Scientific Publication><Scientist><Sepsis><Services><Shipping><Source><Stellate Sinusoidal Macrophage><Surgical><Surgical Interventions><Surgical Procedure><Surgical Removal><Survey Instrument><Surveys><Suspension substance><Suspensions><System><Tissue Distribution><Tissues><Toxicology><Translational Research><Translational Science><Tumor Cell Line><United States National Institutes of Health><Universities><Viral><Viral hepatitis><acute hepatic disease><acute liver disease><adulthood><biomedical resource><cell culture><cell cultures><cell sorting><cholangiocyte><chronic hepatic disease><chronic hepatic disorder><chronic liver disease><chronic liver disorder><drug discovery><experience><hepatic body system><hepatic damage><hepatic disease><hepatic injury><hepatic ischemia><hepatic neoplasia><hepatic neoplasm><hepatic organ system><hepatic steatosis><hepatic tumor><hepatitis virus infection><hepatopathy><hepatosteatosis><improved><innovate><innovation><innovative><liver damage><liver disorder><liver function><liver injury><liver ischemia><liver macrophage><liver transplantation><liver tumor><non-alcohol induced steatohepatitis><non-alcoholic steato-hepatitis><non-alcoholic steatohepatitis><nonalcoholic steato-hepatitis><nonalcoholic steatohepatitis><organizational structure><personnel><problem drinker><programs><regeneration ability><regeneration capacity><resection><response><stellate cell><success><surgery><translation research><translational investigation><tumor><web site><website>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Leo Le Wang

UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA

Exploratory lead · 26/100

Training-friendly

Career award

$174,420

FY 2025

Project Title

Hydrogel Therapies for Alopecia Areata

Grant Number:

1K08AR084610-01A1

Activity Code:

K08

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/1/2025

End Date:

7/31/2025

Why this may be worth a closer look

• Activity code is useful for trainees, fellows, or mentored roles.

Project Abstract

Proposal Summary/Abstract Candidate: Dr. Leo Wang holds a BA, MS, MD, and PhD from the University of Pennsylvania, where he is currently completing dermatology residency and a postdoctoral fellowship. Since 2018, Dr. Wang has been working with Dr. George Cotsarelis, MD, with a primary focus on bioma...

Research Terms

<(IFN) α><(IFN)-α><(IFN)α><Address><Aldara><Alferon><Alopecia><Alopecia Areata><Animal Model><Animal Models and Related Studies><Animals><Area><Assay><Autoimmune Diseases><Award><Baldness><Behavior><Binding><Bioassay><Bioavailability><Biocompatible Materials><Biological Assay><Biological Availability><Biology><Biomaterials><Biometrics><Biometry><Biostatistics><Blood><Blood Plasma><Blood Reticuloendothelial System><Blood Serum><Body Tissues><Cancers><Cardiac><Cardiac infarction><Cell Body><Cell Communication and Signaling><Cell Line><Cell Signaling><Cell-Mediated Lympholytic Cells><CellLine><Cells><Cellular biology><Chemicals><Chemistry><Clinical><Clinical Trials><Clotting><Coagulation><Coagulation Process><Collaborations><Core Facility><Cutaneous Disorder><Cytolytic T-Cell><Cytotoxic T Cell><Cytotoxic T-Lymphocytes><Dermatologist><Dermatology><Dermatoses><Development><Disease><Disorder><Disulfides><Doctor of Philosophy><Drug Delivery><Drug Delivery Systems><Drug Kinetics><Drugs><Effectiveness><Engineering><Ensure><Environment><Epidemiology><Event><FDA approved><Faculty><Fellowship><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Formulation><Fostering><Funding><Future><Generalized Growth><Growth><Hair><Hair Bulb><Hair Diseases><Hair Disorder><Hair bulb structure><Health Care Providers><Health Personnel><Histologic><Histologically><Human><Hyaluronic Acid><Hydrogels><Hydrogen Oxide><IFN Alpha><IFN α><IFN-α><IFNa><IFNα><Imaging Procedures><Imaging Technics><Imaging Techniques><Imiquimod><Immune><Immunes><Immunochemical Immunologic><Immunologic><Immunological><Immunologically><Immunologics><Immunology><In Vitro><Infection><Inflammation><Inflammatory><Inflammatory Response><Injectable><Injections><Interferon Alfa-n3><Interferon-α><International><Intracellular Communication and Signaling><Investigators><JAK kinase><Janus kinase><LC/MS><Leukocyte Interferon><Luciferase Immunologic><Luciferases><Lymphoblast Interferon><Lymphoblastoid Interferon><MALD-MS><MALDI><MALDI-MS><Malignant Neoplasms><Malignant Tumor><Measurement><Measures><Mediating><Medication><Mentors><Mentorship><Mercaptans><Mercapto Compounds><Methacrylates><Methods><Mice><Mice Mammals><Modeling><Modern Man><Molecular Interaction><Murine><Mus><Myocardial Infarct><Myocardial Infarction><NIAMS><National Institute of Arthritis, and Musculoskeletal, and Skin Diseases><Nitriles><Nuclear Magnetic Resonance><Oral><Pathogenesis><Patients><Penetrance><Pennsylvania><Performance><Ph.D.><PhD><Pharmaceutical Preparations><Pharmacokinetics><Pharmacology><Physiologic Availability><Plasma><Plasma Serum><Polymers><Population><Position><Positioning Attribute><Postdoc><Postdoctoral Fellow><Property><QOL><Quality of life><Reaction><Research><Research Associate><Research Personnel><Research Proposals><Researchers><Residencies><Reticuloendothelial System, Serum, Plasma><Risk><STAT protein><Serum><Signal Pathway><Signal Transducer and Activator of Transcription><Signal Transduction><Signal Transduction Systems><Signaling><Skin><Skin Diseases><Skin Diseases and Manifestations><Specialist><Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization><Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization><Strains Cell Lines><Sulfhydryl Compounds><Swelling><System><T-Cells><T-Lymphocyte><Technology><Testing><Thiols><Time><Tissue Grafts><Tissue Growth><Tissues><Topical Drug Administration><Topical application><Toxic effect><Toxicities><Training><Universities><Water><absorption><adduct><alopecia circumscripta><apply topically><authority><autoimmune condition><autoimmune cutaneous disease><autoimmune dermatologic disease><autoimmune dermatologic disorder><autoimmune dermatoses><autoimmune disorder><autoimmune skin condition><autoimmune skin disease><autoimmune skin disorder><autoimmunity disease><biological material><biological signal transduction><biomaterial development><cardiac infarct><career preparation><career readiness><cell biology><clinical translation><clinically translatable><co-morbid><co-morbidity><comorbidity><compare to control><comparison control><coronary attack><coronary infarct><coronary infarction><crosslink><cultured cell line><cutaneous disease><deliver topically><dermal disease><dermal disorder><developmental><disease model><disorder model><draining lymph node><drug distribution><drug/agent><epidemiologic><epidemiological><flow cytophotometry><health care personnel><health care worker><health provider><health workforce><heart attack><heart infarct><heart infarction><human tissue><imaging mass spectrometry><improved><in vivo><in vivo Model><innovate><innovation><innovative><intradermal injection><job readiness><killer T cell><kinase inhibitor><liquid chromatography mass spectrometry><malignancy><mass spectrometric imaging><materials science><matrix assisted laser desorption ionization><mechanical properties><medical personnel><model of animal><mouse model><murine model><neoplasm/cancer><novel><ontogeny><patchy loss of hair><pelade><polymer><polymeric><post-doc><post-doctoral><post-doctoral trainee><prevent><preventing><professor><regional lymph node><research associates><self assembly><skin disorder><skin heterograft><skin xenograft><sulfhydryl group><systemic toxicity><therapeutic agent development><therapeutic development><thymus derived lymphocyte><tissue grafting><topical administration><topical delivery><topical drug application><topical drug delivery><topical instillation><topical treatment><translational opportunities><translational potential><translational therapeutics><translational therapy><treat topically><treatment provider><venous thromboembolism><work readiness><workforce readiness><workplace readiness>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Birgit Schilling

BUCK INSTITUTE FOR RESEARCH ON AGING, NOVATO, CA

Exploratory lead · 24/100

Large award

$1,759,412

FY 2025

Project Title

timsTOF fleX MALDI-2 for Spatial Molecular Imaging

Grant Number:

1S10OD038264-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

4/1/2025

End Date:

3/31/2026

Why this may be worth a closer look

• Large budget suggests more room for personnel or project growth.

Project Abstract

PROJECT SUMMARY/ABSTRACT This shared instrumentation proposal seeks funding for the purchase of a Bruker ‘timsTOF fleX MALDI-2 for Spatial Molecular Imaging’ including a bundled HTX M3+ sprayer. This new mass spectrometry (MS) platform will facilitate ongoing and future scientific research to spatia...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Yvonne Claire Lee

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 24/100

Active award

Career award

$188,809

FY 2026

Project Title

Mentored Patient-Oriented Research of Novel Mechanisms Linking Pain, Sleep-Wake Patterns, and Autonomic Activity in Rheumatic Diseases

Grant Number:

5K24AR080840-04

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

2/24/2023

End Date:

1/31/2028

Project Abstract

PROJECT SUMMARY/ABSTRACT This K24 application seeks to provide protected time for the applicant, Yvonne Lee, MD, MMSc, to mentor trainees in patient-oriented research (POR) and grow her research program. Dr. Lee is the Solovy/Arthritis Research Society Professor in the Division of Rheumatology at No...

Research Terms

<0-11 years old><Accelerometer><Acoustics><Acute><Anesthesiology><Area><Arthritis><Atrophic Arthritis><Autonomic Dysfunction><Behavioral Sciences><Biosensor><Brain imaging><CNS Nervous System><Central Nervous System><Child><Child Youth><Children (0-21)><Clinical Research><Clinical Study><Cognition Therapy><Cognitive Psychotherapy><Cognitive Therapy><Cognitive treatment><Collaborations><Data><Data Collection><Data Set><Development><Enrollment><Fostering><Frequencies><Funding><Future><Health Care Providers><Health Care Visit><Health Personnel><Heart><History><IMiD><Immune modulatory therapeutic><Immunosuppressants><Immunosuppressive Agents><Immunosuppressive drug><Immunosuppressive treatment><Individual><Inflammation><Inflammatory Arthritis><Infrastructure><Insomnia><Insomnia Disorder><Interdisciplinary Research><Interdisciplinary Study><Intervention><Intervention Studies><Investigators><Kinesiology><Link><Literature><MR Imaging><MR Tomography><MRI><MRIs><Magnetic Resonance Imaging><Maintenance><Measurement><Measures><Mediating><Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance><Medicine><Mentors><Methodology><Mission><Movement science><Multidisciplinary Collaboration><Multidisciplinary Research><Musculoskeletal Pain><Musculoskeletal Pain Disorder><NIH><NMR Imaging><NMR Tomography><National Institutes of Health><Neuraxis><Neurobiology><Neurosciences><Nuclear Magnetic Resonance Imaging><Operative Procedures><Operative Surgical Procedures><Pain><Pain intensity><Painful><Parents><Participant><Pathogenesis><Pathway interactions><Patient Outcomes Assessments><Patient Recruitments><Patient Reported Measures><Patient Reported Outcomes><Patient Self-Report><Patients><Peripheral><Phenotype><Physical activity><Play><Polysomnography><Postdoc><Postdoctoral Fellow><Process><Productivity><R-Series Research Projects><R01 Mechanism><R01 Program><Recording of previous events><Regulation><Regulatory Pathway><Reporting><Research><Research Associate><Research Grants><Research Personnel><Research Project Grants><Research Projects><Research Resources><Research Support><Researchers><Resources><Rest><Rheumatic Diseases><Rheumatism><Rheumatoid Arthritis><Rheumatologic Diseases><Rheumatologic Disorder><Rheumatology><Scientist><Sedentary behavior><Sedentary life-style><Self-Report><Sensory><Site><Sleep><Sleep Deprivation><Sleep Disorders><Sleep Monitoring><Sleep disturbances><Sleeplessness><Societies><Somnography><Subgroup><Surgical><Surgical Interventions><Surgical Procedure><Symptoms><Testing><Therapeutic><Time><Training><Training Programs><United States National Institutes of Health><Universities><Work><Wrist><Zeugmatography><aberrant sleep><accelerometry><activity monitor><activity tracker><arthritic><biological sensor><brain visualization><career><central pain><chronic pain><circadian><clinical center><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><cohort><cortical pain><cost><deficient sleep><developmental><diaries><disability><disrupted sleep><disturbed sleep><enroll><fibromyalgia patients><health care personnel><health care worker><health provider><health staff><health workers><health workforce><healthcare employees><healthcare staff><healthcare workforce><heart rate variability><histories><immune modulating agents><immune modulating drug><immune modulating therapeutics><immune modulatory agents><immune modulatory drugs><immune suppressive agent><immune suppressor><immunomodulating agents><immunomodulating drugs><immunomodulator agent><immunomodulator drug><immunomodulator medication><immunomodulator prodrug><immunomodulator therapeutic><immunomodulatory agents><immunomodulatory drugs><immunomodulatory therapeutics><immunosuppressive substance><immunosuppressor><impaired sleep><improved><inadequate sleep><innovate><innovation><innovative><insufficient sleep><interdisciplinary collaboration><intervention research><interventional research><interventional study><interventions research><investigator training><irregular sleep><joint damage><joint injury><joint trauma><kids><medical care providers><medical college><medical personnel><medical schools><neural><neural imaging><neuro-imaging><neurobiological><neurobiological mechanism><neuroimaging><neurological imaging><next generation><non-narcotic analgesic><non-opiate analgesic><non-opioid><non-opioid analgesic><non-opioid therapeutics><nonnarcotic analgesics><nonopiate analgesic><nonopioid><nonopioid analgesics><novel><pain sensitivity><parent><participant recruitment><pathway><patient oriented research><patient oriented study><patients with fibromyalgia><post-doc><post-doctoral><post-doctoral trainee><pre-doc><pre-doctoral><prevent><preventing><professor><programs><prospective><research associates><rheumatic arthritis><school of medicine><sedentary lifestyle><skills><sleep abnormalities><sleep debt><sleep deficiency><sleep deficit><sleep diseases><sleep disruption><sleep dysfunction><sleep dysregulation><sleep illness><sleep insufficiency><sleep loss><sleep measurement><sleep pattern><sleep polysomnography><sleep problem><sleep routine><sleep schedule><sleep/wake disruption><sleep/wake disturbance><sleep/wake patterns><surgery><training opportunity><transdisciplinary collaboration><treatment provider><youngster>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Victoria Alice Macht

UNIVERSITY OF NORTH CAROLINA WILMINGTON, WILMINGTON, NC

Exploratory lead · 22/100

Recent

Active award

$249,000

FY 2026

Project Title

Adolescent intermittent ethanol induction of neuroimmune signaling disrupts the mature phenotype of surviving hippocampal neuroprogenitors

Grant Number:

5R00AA030089-04

Activity Code:

R00

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

3/10/2025

End Date:

2/29/2028

Project Abstract

PROJECT SUMMARY Adolescent binge drinking hijacks the developing brain, resulting in long-lasting increases in neuroinflammation which are paralleled by decreases in hippocampal neurogenesis and deficits in learning and memory-related tasks. Unlike adult alcohol exposure, the cellular and behavioral...

Research Terms

<0-4 weeks old><12-20 years old><21+ years old><Absolute ethanol><Abstinence><Address><Adolescence><Adolescent><Adolescent Youth><Adult><Adult Human><Alcohol Chemical Class><Alcohols><Ammon Horn><Amphoterin><Amphoterin Gene><Anti-Inflammatories><Anti-Inflammatory Agents><Anti-inflammatory><Anticholinesterase Agents><Anticholinesterase Drugs><Anticholinesterases><Antiphosphodiesterases><Astrocytes><Astrocytus><Astroglia><Astroprotein><Automobile Driving><Behavior><Behavioral><Brain><Brain Nervous System><CCL2><CCL2 gene><CNS plasticity><COX-2><COX2><Cell Body><Cell Communication and Signaling><Cell Growth in Number><Cell Multiplication><Cell Proliferation><Cell Signaling><Cells><Cellular Proliferation><Chemokine, CC Motif, Ligand 2><Cholinesterase Inhibitors><Chromosomal Protein, Nonhistone, HMG1><Chromosomal Protein, Nonhistone, HMG1 Gene><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Cornu Ammonis><Data><Deoxyuridine><Development><Disturbance in cognition><Dominance Hierarchy><Drug Therapy><ETOH><Electrophysiology><Electrophysiology (science)><Encephalon><Equilibrium><Ethanol><Ethyl Alcohol><Euthanasia><FBJ osteosarcoma oncogene><FM1 Gene Product><FOS gene><Female><Functional impairment><Future><G0S7><GFA-Protein><GFAP><Galantamin><Galantamine><Galanthamine><Gatekeeping><Gene Expression><Glia><Glial Cells><Glial Fibrillary Acid Protein><Glial Fibrillary Acidic Protein><Glial Intermediate Filament Protein><Glycyrrhizic Acid><Glycyrrhizin><Glycyrrhizinic Acid><Grain Alcohol><HMG-1><HMG-1 Gene><HMG-1 Protein><HMG1><HMG1 Gene><HMG3><HMG3 Gene><HMGB1><HMGB1 Protein><HMGB1 gene><Heparin-Binding Protein p30><High Mobility Group Box Protein 1><High Mobility Group Protein 1><High Mobility Group Protein 1 Gene><High-Mobility Group (Nonhistone Chromosomal) Protein 1><High-Mobility Group (Nonhistone Chromosomal) Protein 1 Gene><High-Mobility Group Box 1><High-Mobility Group Box 1 Gene><Hippocampus><Histologic><Histologically><Homolog of Drosophila TOLL><Hortega cell><Immediate-Early Genes><Immune><Immunes><Immunofluorescence><Immunofluorescence Immunologic><Impaired cognition><Impairment><Indocin><Indometacin><Indomethacin><Inflammatory><Intervention><Intracellular Communication and Signaling><Knowledge><Kolliker's reticulum><Label><Learning><Link><Lycoremine><MCAF><MCP-1><MCP1><Maps><Mediating><Memory><Mercy Killing><Methylcarbinol><Mice><Mice Mammals><Microglia><Monocyte Chemoattractant Protein-1><Monocyte Chemotactic Protein-1><Monocyte Chemotactic and Activating Factor><Monocyte Chemotactic and Activating Protein><Monocyte Chemotactive and Activating Factor><Monocyte Secretory Protein JE><Morphology><Murine><Mus><N Methyl D aspartic Acid><N methyl D aspartate><N-Methyl-D-aspartate><N-Methylaspartate><NMDA><Nerve Cells><Nerve Unit><Neural Cell><Neural Stem Cell><Neurocyte><Neuroglia><Neuroglial Cells><Neuroimmune><Neuronal Differentiation><Neuronal Plasticity><Neurons><Neurophysiology / Electrophysiology><Newborn Infant><Newborns><Non-neuronal cell><Nonhistone Chromosomal Protein HGM1><Nonhistone Chromosomal Protein HGM1 Gene><Nonneuronal cell><PGHS-2><PHS-2><PTGS2><PTGS2 gene><Performance><Pharmacological Treatment><Pharmacotherapy><Phenotype><Phosphodiesterase Antagonists><Phosphodiesterase Inhibitors><Phosphoric Diester Hydrolase Inhibitors><Physiologic><Physiological><Population><Predisposition><Property><Protooncogene FOS><Regulation><Reporter><Research><Research Training><Reversal Learning><SBP-1><SBP-1 Gene><SCYA2><Signal Transduction><Signal Transduction Systems><Signaling><Social Dominance><Stress><Sulfoglucuronyl Carbohydrate Binding Protein><Sulfoglucuronyl Carbohydrate Binding Protein Gene><Susceptibility><TLR4><TLR4 gene><Tamoxifen><Techniques><Testing><Toll Homologue><Training><Transgenic Mice><Transgenic Model><Transgenic Organisms><Trees><Tube><adolescence (12-20)><adolescent alcohol binge exposure><adolescent alcohol exposure><adolescent binge alcohol drinking><adolescent binge drinking><adolescent ethanol exposure><adolescent exposure to alcohol><adolescent exposure to ethanol><adolescent intermittent ethanol exposure><adolescent onset binge drinking><adult neurogenesis><adulthood><alcohol exposed><alcohol exposure><alcohol exposure during adolescence><antagonism><antagonist><astrocytic glia><balance><balance function><biological signal transduction><brain circuitry><c fos><c-fos Gene><c-fos Proto-Oncogenes><central nervous system plasticity><cognitive dysfunction><cognitive loss><developmental><driving><drug intervention><drug treatment><electrophysiological><ethanol exposed><ethanol exposure><ethanol exposure during adolescence><experiment><experimental research><experimental study><experiments><exposed to alcohol><exposed to ethanol><exposure to alcohol><exposure to ethanol><flexibility><flexible><gatekeeper><gitter cell><hCOX-2><hippocampal><inflammation marker><inflammatory marker><insight><intraperitoneal><juvenile><juvenile human><life span><lifespan><male><memory recognition><mesoglia><microglial cell><microgliocyte><morris water maze><morris watermaze><nerve cement><nerve stem cell><neural circuit><neural circuitry><neural inflammation><neural plasticity><neural precursor><neural precursor cell><neural progenitor><neural progenitor cells><neural stem and progenitor cells><neurocircuitry><neurogenesis><neurogenic progenitors><neurogenic stem cell><neuroinflammation><neuroinflammatory><neuron progenitors><neuronal><neuronal excitability><neuronal progenitor><neuronal progenitor cells><neuronal stem cells><neuronal survival><neuroplastic><neuroplasticity><neuroprogenitor><newborn child><newborn children><newborn neuron><novel><object recognition><optogenetics><p65><perivascular glial cell><pharmaceutical intervention><pharmacologic><pharmacological intervention><pharmacological therapy><pharmacology intervention><pharmacology treatment><pharmacotherapeutics><postnatal><postsynaptic><progenitor and neural stem cells><programs><restoration><sex><social stress><socially stressed><synaptic circuit><synaptic circuitry><therapeutic target><toll-like receptor 4><tool><transgenic><transgenic trait><v-FOS FBJ Murine Osteosarcoma Viral Oncogene Homolog><♀><♂>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Molishree Umesh Joshi

UNIVERSITY OF COLORADO DENVER, Aurora, CO

Exploratory lead · 20/100

Solid budget

Active award

$491,315

FY 2025

Project Title

Catalyzing cancer research through the use of advanced functional genomics and cell engineering technologies

Grant Number:

1R50CA293856-01A1

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/12/2025

End Date:

8/31/2029

Project Abstract

Project Summary Technological advances like genome sequencing, RNA interference (RNAi), and CRISPR have transformed functional genomics by speeding up genetic discoveries and enhancing our understanding of diseases and personalized medicine. Dr. Molishree Joshi, the PI of the proposal and the Associ...

Research Terms

<3D cell culture><3D culture><Automation><Award><CAR T cells><CAR modified T cells><CAR-T><CAR-Ts><CRISPR><CRISPR approach><CRISPR based approach><CRISPR editing screen><CRISPR library><CRISPR method><CRISPR methodology><CRISPR screen><CRISPR technique><CRISPR technology><CRISPR tools><CRISPR-CAS-9><CRISPR-based library><CRISPR-based method><CRISPR-based screen><CRISPR-based technique><CRISPR-based technology><CRISPR-based tool><CRISPR/CAS approach><CRISPR/Cas method><CRISPR/Cas system><CRISPR/Cas technology><CRISPR/Cas9><CRISPR/Cas9 library><CRISPR/Cas9 screen><CRISPR/Cas9 technology><Cancer Center><Cancer cell line><Cancers><Cas nuclease technology><Cell Body><Cell Isolation><Cell Segregation><Cell Separation><Cell Separation Technology><Cells><Clinical Trials><Clustered Regularly Interspaced Short Palindromic Repeats><Clustered Regularly Interspaced Short Palindromic Repeats approach><Clustered Regularly Interspaced Short Palindromic Repeats library><Clustered Regularly Interspaced Short Palindromic Repeats method><Clustered Regularly Interspaced Short Palindromic Repeats methodology><Clustered Regularly Interspaced Short Palindromic Repeats technique><Clustered Regularly Interspaced Short Palindromic Repeats technology><Colorado><Complex><Comprehensive Cancer Center><Core Facility><Custom><Development><Disease><Disorder><Drug Combinations><Education><Educational aspects><Educational process of instructing><Employee><Ensure><Evolution><Funding><Future><Genes><Genetic><Genomics><Genomics Shared Resource><Grant><Heterozygote><Immune mediated therapy><Immunologically Directed Therapy><Immunotherapy><Interdisciplinary Research><Interdisciplinary Study><Libraries><Malignant Cell><Malignant Neoplasms><Malignant Tumor><Measurement><Multidisciplinary Collaboration><Multidisciplinary Research><Mutation Detection><NIH><National Institutes of Health><Non-Polyadenylated RNA><ORFs><Open Reading Frames><Patients><Peer Review><Post-Transcriptional Gene Silencing><Protein Coding Region><Protocol><Protocols documentation><Publications><RNA><RNA Gene Products><RNA Interference><RNA Silencing><RNAi><Reagent><Research Resources><Resource Sharing><Resources><Ribonucleic Acid><Scientific Publication><Scientist><Secure><Sequence-Specific Posttranscriptional Gene Silencing><Services><Speed><T cells for CAR><Teaching><Technology><The University of Colorado Cancer Center><United States National Institutes of Health><Universities><Work><anti-cancer research><cancer cell><cancer research><career><cell engineering><cell sorting><cellular engineering><chimeric antigen T cell receptor><chimeric antigen receptor (CAR) T cells><chimeric antigen receptor T><chimeric antigen receptor T cells><chimeric antigen receptor fusion protein T-cells><chimeric antigen receptor modified T cells><clustered regularly interspaced short palindromic repeats screen><customs><depository><developmental><digital><empowerment><functional genomics><genome editing><genome sequencing><genomic editing><heterozygosity><iPS><iPSC><iPSCs><immune therapeutic approach><immune therapeutic interventions><immune therapeutic regimens><immune therapeutic strategy><immune therapy><immune-based therapies><immune-based treatments><immuno therapy><induced pluripotent cell><induced pluripotent stem cell><inducible pluripotent cell><inducible pluripotent stem cell><innovate><innovation><innovative><instrumentation><malignancy><neoplasm/cancer><novel><personalization of treatment><personalized medicine><personalized therapy><personalized treatment><precision medicine><precision-based medicine><programs><protocol development><repository><shRNA><short hairpin RNA><success><three dimensional cell culture><tumor>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Harshani R Lawrence

H. LEE MOFFITT CANCER CTR & RES INST, TAMPA, FL

Exploratory lead · 20/100

Solid budget

Active award

$293,933

FY 2025

Project Title

Developing chemical probes for oncogenic signaling pathways

Grant Number:

5R50CA211447-08

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/19/2017

End Date:

8/31/2028

Project Abstract

Abstract: The goal of the NCI Research Specialist Award prepared by Dr. Harshani Lawrence “Developing chemical probes for oncogenic signaling pathways” will promote identification of small molecules/chemical probes for cancer targets to elucidate underlying molecular mechanisms driving cancer and dr...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Michael Stafford

VANDERBILT UNIVERSITY MEDICAL CENTER, NASHVILLE, TN

Exploratory lead · 20/100

Solid budget

Active award

$289,768

FY 2025

Project Title

Vanderbilt Student Research Training Program

Grant Number:

5T35DK007383-46

Activity Code:

T35

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/1980

End Date:

4/30/2028

Project Abstract

Project Summary This T35 grant application from the Vanderbilt Student Research and Training Program (SRTP) requests continued support for medical student research training in the areas of diabetes, obesity, digestive diseases, and kidney diseases. The SRTP started in 1975, and NIH-funded since 1980...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Maarit Inkeri Tiirikainen

UNIVERSITY OF HAWAII AT MANOA, HONOLULU, HI

Exploratory lead · 18/100

Above-average budget

$518,494

FY 2025

Project Title

Genomic BeadChip Analysis System Upgrade for Diversity Research

Grant Number:

1S10OD038215-01

Activity Code:

S10

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

5/1/2025

End Date:

4/30/2026

Why this may be worth a closer look

• Award size is strong enough to merit immediate review.

Project Abstract

Project Summary/Abstract Funds are requested for an Illumina iScan System Upgrade with automation including these main components: Scientific instrument: the Illumina iScan System, and Main Accessories: Infinium Automated Pipetting System with ILASS, an Autoloader and the Infinium Water Circulator a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Nippie Sarita Shah

EMORY UNIVERSITY, ATLANTA, GA

Exploratory lead · 18/100

Active award

Career award

$195,347

FY 2025

Project Title

Mentoring Multidisciplinary Patient-Oriented Research in TB, HIV, and Global Health

Grant Number:

5K24AI165099-03

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

6/23/2023

End Date:

5/31/2028

Project Abstract

Dr. Shah is a physician-scientist with 15 years of experience leading patient-oriented research (POR) on diagnosis, treatment, and prevention of tuberculosis (TB) globally, including drug-resistant TB and TB/HIV co- infection. Her experience with U.S. and international public health programs, includ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Manney Carrington Reid

WEILL MEDICAL COLL OF CORNELL UNIV, NEW YORK, NY

Exploratory lead · 18/100

Active award

Career award

$187,308

FY 2025

Project Title

Reid Aging and Pain Research Training Program

Grant Number:

5K24AG053462-10

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2016

End Date:

5/31/2027

Project Abstract

Summary/Abstract My patient-oriented research program focuses on addressing key knowledge gaps related to the problem of later-life pain, a common, morbid, and costly disorder. I seek renewal of my National Institute on Aging (NIA) K24 Award to expand a robust program of mentorship established over ...

Research Terms

<21+ years old><AIDS Virus><Achievement><Achievement Attainment><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Address><Adult><Adult Human><Affect><Age><Aging><Agreement><Amentia><American><Analgesia Tests><Analgesic Agents><Analgesic Drugs><Analgesic Preparation><Analgesics><Anodynes><Antinociceptive Agents><Antinociceptive Drugs><Anxiety><Arthritis><Award><Behavior Conditioning Therapy><Behavior Modification><Behavior Therapy><Behavior Treatment><Behavioral><Behavioral Conditioning Therapy><Behavioral Modification><Behavioral Therapy><Behavioral Treatment><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Care Givers><Career Mobility><Caregivers><Caring><Center Core Grants><Chronic Disease><Chronic Illness><Cognition Therapy><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive Psychotherapy><Cognitive Therapy><Cognitive decline><Cognitive function abnormal><Cognitive treatment><Collaborations><Communication><Communication Tools><Conditioning Therapy><Decline in mobility><Decrease in mobility><Decreased mobility><Dementia><Dementia caregivers><Depressed mood><Development><Development Plans><Devices><Dimensions><Diminished mobility><Disease><Disorder><Distress><Disturbance in cognition><Drugs><Early-Stage Clinical Trials><Education><Educational aspects><Educational process of instructing><Emotional Depression><Emotions><Ensure><Environment><Ethnic Origin><Ethnicity><Evaluation><Excretory function><Exercise><Family Care Giver><Family Caregiver><Family Relations><Family Relationship><Fear><Fostering><Fright><Funding><Geriatrics><Goals><Guidelines><HIV><Health><Heart failure><High Prevalence><Home><Human Immunodeficiency Viruses><Impaired cognition><Individual><Institute of Medicine><Institute of Medicine (U.S.)><Intervention><Intervention Strategies><Investigators><Journals><K24 Award><Knowledge><LAV-HTLV-III><Life><Lung Diseases><Lymphadenopathy-Associated Virus><Magazine><Measurable><Medication><Mental Depression><Mentors><Mentorship><Meta-Analysis><Methods><Mid-Career Clinical Scientist Award (K24)><Mobility decline><Mobility impairment><NAS/IOM><National Institute of Aging><National Institute on Aging><Nociception Tests><Non-pharmacologic Therapy><Nonpharmacologic Intervention><Nonpharmacologic Therapy><Nonpharmacologic approach><Nonpharmacologic treatment><Older Population><P30 Award><P30 Grant><P30 Mechanism><P30 Program><Pain><Pain Assessment><Pain Assessment Tool><Pain Control><Pain Measurement><Pain Research><Pain Therapy><Pain interference><Pain management><Pain measure><Painful><Participant><Patients><Peer Review><Personal Satisfaction><Pharmaceutical Preparations><Phase 1 Clinical Trials><Phase I Clinical Trials><Physical Performance><Play><Population><Prevalence><Prevention><Productivity><Provider><Publishing><Pulmonary Diseases><Pulmonary Disorder><QOL><Quality of life><Race><Races><Randomized><Randomized, Controlled Trials><Reduced mobility><Reduction in mobility><Reporting><Research><Research Personnel><Research Resources><Research Support><Researchers><Resources><Role><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><Schedule><Self Efficacy><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Structure><Symptoms><T'ai Chi><Tai Chi><Tai Chi Chih><Tai Chi Chuan><Tai Ji><Tai Ji Quan><Tai Qi><TaiChi><Taiji><Taijiquan><Teaching><Techniques><Testing><Text Messaging><Time><Training><Training Programs><Virus-HIV><Woman><Work><active method><active technique><active treatment><adulthood><age associated alterations><age associated changes><age associated disease><age associated disorder><age associated impairment><age correlated alterations><age correlated changes><age dependent alterations><age dependent changes><age dependent disease><age dependent disorder><age dependent impairment><age induced alterations><age induced changes><age related alterations><age related changes><age related human disease><age specific alterations><age specific changes><age-related disease><age-related disorder><age-related impairment><ages><aging associated alterations><aging associated changes><aging correlated alterations><aging correlated changes><aging dependent alterations><aging dependent changes><aging induced alterations><aging induced changes><aging related alterations><aging related changes><aging specific alterations><aging specific changes><alterations with age><arm><arthritic><behavior intervention><behavioral intervention><cardiac failure><care as usual><care giver stress><care outcomes><care receiver><care recipients><career><career advancement><career development><career transition><caregiver distress><caregiver stress><caregivers for persons living with dementia><caregivers for persons with dementia><caregivers of individuals with dementia><caregivers of patients with dementia><changes with age><chronic disorder><chronic pain><co-morbid><co-morbidity><cognitive behavior intervention><cognitive behavior modification><cognitive behavior therapy><cognitive behavioral intervention><cognitive behavioral modification><cognitive behavioral therapy><cognitive behavioral treatment><cognitive dysfunction><cognitive loss><comorbidity><comparable efficacy><comparative efficacy><compare efficacy><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><dementia care><dementia care giver><depressed><depression><depression symptom><depressive><depressive symptoms><developmental><disabling pain><disease of the lung><disorder of the lung><drug/agent><emotion regulation><emotional regulation><evidence base><excretion><experience><falls><forging><frailty><functional improvement><geriatric medicine><health care outcomes><homes><improve function><improved><improved functional outcomes><innovate><innovation><innovative><interest><lung disorder><manage symptom><mindfulness meditation><minority trainee><neuropathic pain><new technology><non-drug><non-drug therapy><non-drug treatment><nondrug><nondrug therapy><nondrug treatment><novel technologies><older adult><older adulthood><older groups><older individuals><older person><opiate consumption><opiate crisis><opiate drug use><opiate intake><opiate use><opioid consumption><opioid crisis><opioid drug use><opioid epidemic><opioid intake><opioid use><pain assay><pain intervention><pain killer><pain medication><pain outcome><pain reduction><pain relief><pain reliever><pain treatment><pain-related disability><pain-related outcome><painful neuropathy><painkiller><patient barriers><patient oriented research><patient oriented study><patient-level barriers><phase I protocol><pilot test><post-doctoral training><programs><provider barriers><provider-level barriers><psychologic><psychological><racial><racial background><racial origin><randomisation><randomization><randomized control trial><randomly assigned><recruit><reduce pain><relieve pain><sadness><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><short message service><side effect><sms messaging><sms messaging intervention><social relationships><social role><stress among caregiver><stress in caregiver><stress on caregiver><substance use><substance using><success><symptom management><text based intervention><text intervention><text messaging based intervention><text messaging intervention><texting><tool><transcranial direct current stimulation><treatment as usual><treatment effect><usual care><well-being><wellbeing>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Katrina Walsemann

UNIV OF MARYLAND, COLLEGE PARK, COLLEGE PARK, MD

Exploratory lead · 18/100

Active award

Career award

$144,755

FY 2025

Project Title

The role of early educational contexts in differential genetic susceptibility to cognitive impairment and dementia

Grant Number:

5K02AG075237-04

Activity Code:

K02

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

8/1/2022

End Date:

7/31/2027

Project Abstract

PROJECT SUMMARY Although education is often cited as the most important protective factor against Alzheimer’s Disease and related dementias (ADRD), most research in this area ignores the educational contexts in which that schooling took place. Moreover, it has yet to consider whether and how early e...

Research Terms

<12-20 years old><21+ years old><AD related dementia><ADRD><Acceleration><Adolescence><Adult><Adult Human><African ancestry><African descent><Age><Aging><Alzheimer risk factor><Alzheimer's and related dementias><Alzheimer's dementia and related dementia><Alzheimer's dementia or related dementia><Alzheimer's disease and related dementia><Alzheimer's disease and related disorders><Alzheimer's disease or a related dementia><Alzheimer's disease or a related disorder><Alzheimer's disease or related dementia><Alzheimer's disease related dementia><Alzheimer's disease risk><Amentia><Area><Award><Biological><Black><Black race><Cognition><Cognitive><Cognitive Disturbance><Cognitive Impairment><Cognitive decline><Cognitive function abnormal><Collaborations><D.C. Washington><DC Washington><Data><Dementia><Development><Diagnosis><District of Columbia><Disturbance in cognition><Early identification><Education><Educational Achievement><Educational Status><Educational aspects><Environment><Environmental Factor><Environmental Risk Factor><Episodic memory><Ethnic Origin><Ethnicity><European ancestry><Foundations><Funding><Future><Generalized Growth><Genes><Genetic><Genetic Markers><Genetic Predisposition><Genetic Predisposition to Disease><Genetic Risk><Genetic Susceptibility><Genetic propensity><Goals><Growth><Health><Health and Retirement Study><Immediate Memory><Impaired cognition><Impairment><Independent Scientist Award><Individual><Inherited Predisposition><Inherited Susceptibility><Institution><International><Investigators><K02 Award><Knowledge><Length><Life><Life Cycle><Life Cycle Stages><Link><Local Government><Maryland><Measurement><Measures><Medicare claim><Memory><Mentors><Methods><Modeling><Play><Policies><Population Study><Prevalence><Provincial Government><Pupil><Race><Races><Research><Research Personnel><Research Priority><Researchers><Risk><Risk Factors><Role><Sampling><Schools><Scientific Advances and Accomplishments><Scientist><Secure><Shapes><Short-Term Memory><Specific qualifier value><Specified><State Government><Subgroup><System><Time><Tissue Growth><Training><Translating><United States><Universities><Variant><Variation><Work><adolescence (12-20)><adulthood><advanced analytics><ages><alzheimer risk><ancestry analysis><biologic><brain health><career><cognitive dysfunction><cognitive function><cognitive loss><cohort><college><collegiate><computer based prediction><demented><dementia risk><developmental><educational level><environmental risk><experience><gene biomarker><gene expression biomarker><gene marker><gene signature biomarker><genetic biomarker><genetic etiology><genetic mechanism of disease><genetic vulnerability><genetically predisposed><innovate><innovation><innovative><insight><institutional capacity><life course><model building><older adult><older adulthood><ontogeny><polygenetic risk scores><polygenic predictors><polygenic risk score><polygenic scores><population-based study><population-level study><predictive modeling><programs><prospective><protective factors><racial><racial background><racial origin><risk factor for dementia><risk for dementia><scientific accomplishments><scientific advances><segregation><skills><social><social role><studies of populations><study of the population><success><teacher><training achievement><training level><training status><working memory>

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Carol A. Feghali-Bostwick

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Exploratory lead · 18/100

Active award

Career award

$130,189

FY 2025

Project Title

Scleroderma Twin Study and analysis of Estrogen in patients with dcSSc

Grant Number:

5K24AR060297-11

Activity Code:

K24

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

12/24/2012

End Date:

6/30/2026

Project Abstract

ABSTRACT Systemic sclerosis (SSc; Scleroderma) is a connective tissue disease of unknown etiology that is associated with significant morbidity and mortality. It has long been presumed that SSc likely results from environmental triggers, although these environmental insults have not been identified....

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Pradeep Yammanuru Ramulu

JOHNS HOPKINS UNIVERSITY, BALTIMORE, MD

Exploratory lead · 10/100

Active award

$239,250

FY 2025

Project Title

Wilmer Eye Institute Stimulating Access to Research in Residency Program

Grant Number:

1R38EY037088-01

Activity Code:

R38

Mechanism:

Other Research-Related

Agency:

NIH

Start Date:

9/15/2025

End Date:

6/30/2030

Project Abstract

PROJECT SUMMARY The Johns Hopkins Wilmer Eye Institute StARR (Stimulating Access to Research in Residency) Program seeks to extend its goal of training clinician-scientists in the areas of clinical and laboratory vision research. The program has 4 goals: 1) recruitment of qualified resident-research...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Elizabeth Thomas Bartom

NORTHWESTERN UNIVERSITY, CHICAGO, IL

Exploratory lead · 10/100

Active award

$229,792

FY 2025

Project Title

Bioinformatics Analysis of Next Generation Sequencing Data from Cancer Cells

Grant Number:

5R50CA221848-08

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/19/2017

End Date:

8/31/2028

Project Abstract

Project Summary This proposal is a renewal of a prior R50 grant that supported the bioinformatics needs of cancer researchers at Northwestern University. The initial award primarily supported two NCI funded Outstanding Investigators, Dr. Marcus Peter and Dr. Ali Shilatifard, with a small fraction of...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Andrew B Lassman

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 10/100

Active award

$193,926

FY 2025

Project Title

Clinical Trials Specialist in NCI Clinical Trials Research

Grant Number:

1R50CA288588-01A1

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/1/2025

End Date:

8/31/2030

Project Abstract

The planned activities describe a set of efforts that will build upon my primary interest in brain tumors, leveraging my experience and leadership roles to develop national clinical trials, implement NCI-sponsored trials at the NCI-designated P30 Herbert Irving Comprehensive Cancer Center (HICCC), a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

John Lanier Pearce

MEDICAL UNIVERSITY OF SOUTH CAROLINA, CHARLESTON, SC

Exploratory lead · 10/100

Active award

$192,001

FY 2025

Project Title

Administrative Supplement to Expand Enhancement of the IMHRD Cohort in EXACT-PLAN

Grant Number:

3R21AR084039-01S1

Activity Code:

R21

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

7/1/2025

End Date:

8/31/2026

Project Abstract

TITLE: Administrative Supplement to Expand Enhancement of the IMHRD Cohort in EXACT-PLAN ABSTRACT. The NIAMS funded parent project planning award entitled: “Enhancing the IMHRD cohort to support study of the exposome in autoimmune disease” seeks to develop resources and strategies needed to examine ...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Rajesh Kumar Soni

COLUMBIA UNIVERSITY HEALTH SCIENCES, NEW YORK, NY

Exploratory lead · 10/100

Active award

$169,932

FY 2025

Project Title

Advancing Proteomics Technologies for Cancer Research

Grant Number:

5R50CA293857-02

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/4/2024

End Date:

7/31/2029

Project Abstract

Project Summary I am the Technical Director of the Proteomics and Macromolecular Crystallography Shared Resource (PMCSR) at the Herbert Irving Comprehensive Cancer Center (HICCC), Columbia University Irving Medical Center (CUIMC). I joined PMCSR in 2018 and established and expanded the service portf...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Lan Liao

BAYLOR COLLEGE OF MEDICINE, HOUSTON, TX

Exploratory lead · 10/100

Active award

$143,443

FY 2025

Project Title

Supporting Cancer Research as a Core-based Scientist by Providing Comprehensive Genetically Engineered Rodent Model Services

Grant Number:

5R50CA283804-02

Activity Code:

R50

Mechanism:

Non-SBIR/STTR

Agency:

NIH

Start Date:

9/6/2024

End Date:

8/31/2029

Project Abstract

Project Summary/Abstract To conquer cancer, researchers with diverse backgrounds and expertise must work together to discover molecular targets and develop therapeutics. Many investigators are unable to accomplish their research goals without access to specialized expertise, sophisticated technologi...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Vineet Arora

UNIVERSITY OF CHICAGO, CHICAGO, IL

Exploratory lead · 10/100

Active award

$90,553

FY 2025

Project Title

Short Term Aging-Related Research Program

Grant Number:

5T35AG029795-18

Activity Code:

T35

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2008

End Date:

4/30/2028

Project Abstract

PROJECT SUMMARY/ABSTRACT Given the aging of the population and concerns over the physician-scientist workforce, it is imperative to inculcate the next generation of physicians with the desire to understand and improve care for older adults through pursuit of scientific discovery in the basic, clinic...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

DAVID O MELTZER

UNIVERSITY OF CHICAGO, CHICAGO, IL

Exploratory lead · 10/100

Active award

$90,553

FY 2025

Project Title

Short Term Aging-Related Research Program

Grant Number:

5T35AG029795-18

Activity Code:

T35

Mechanism:

Training, Institutional

Agency:

NIH

Start Date:

5/1/2008

End Date:

4/30/2028

Project Abstract

PROJECT SUMMARY/ABSTRACT Given the aging of the population and concerns over the physician-scientist workforce, it is imperative to inculcate the next generation of physicians with the desire to understand and improve care for older adults through pursuit of scientific discovery in the basic, clinic...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Pedro L Vera

VA MEDICAL CENTER - LEXINGTON, KY, LEXINGTON, KY

Exploratory lead · 10/100

Active award

$0

FY 2026

Project Title

Spinal targets to treat persistent bladder pain

Grant Number:

5I01BX006646-02

Activity Code:

I01

Mechanism:

Non-SBIR/STTR

Agency:

VA

Start Date:

10/1/2024

End Date:

9/30/2028

Project Abstract

Interstitial cystitis/Bladder pain syndrome (IC/BPS) is a painful condition of unknown etiology. IC/BPS often results in poor quality of life and affects approximately 1.08% and 0.66% in female and male veterans and corresponding to 22134 female veterans and 109183 male veterans, respectively. are a...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

VICTORIA P WERTH

PHILADELPHIA VA MEDICAL CENTER, PHILADELPHIA, PA

Exploratory lead · 10/100

Active award

$0

FY 2026

Project Title

Extracellular vesicles as a novel mediator for ultraviolet-B light induced photoaging and skin inflammation.

Grant Number:

5I01BX005921-03

Activity Code:

I01

Mechanism:

Non-SBIR/STTR

Agency:

VA

Start Date:

10/1/2023

End Date:

9/30/2027

Project Abstract

Ultraviolet B (UVB) irradiation causes skin inflammation, photodamage, and photoaging, all major medical problems for Armed Forces personnel and veterans. Because UVB is absorbed mostly by the epidermis, with just 10% reaching the dermis, we seek to investigate likely signals from epidermis to media...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

Hongjun Wang

RALPH H JOHNSON VA MEDICAL CENTER, CHARLESTON, SC

Exploratory lead · 10/100

Active award

$0

FY 2026

Project Title

hAAT-engineered Mesenchymal Stem Cells for the Treatment of Chronic Pain

Grant Number:

5I01BX004536-06

Activity Code:

I01

Mechanism:

Non-SBIR/STTR

Agency:

VA

Start Date:

10/1/2019

End Date:

9/30/2028

Project Abstract

One-third of the veterans (~20 million) are suffering from chronic pain. This grant studies chronic pancreatitis (CP)-associated chronic pain in which pain is common and leads to morbidity, poor quality of life, and loss of workdays. Our current VA-funded BLR&D grant is focused on novel stem cell th...

Research Terms

View Full Project Details on NIH Reporter

Public NIH records usually do not include a direct email address. For outreach, verify the investigator through their institution profile, lab website, recent publications, or official NIH project page.

NIH Grant Search by PI — Funded Principal Investigator Finder

Search NIH grants by research area to find funded PIs

Search Results

Opportunity Digest

Gil Dan Rabinovici

Project Title

Project Abstract

Research Terms

JAMES B BREWER

Project Title

Project Abstract

Research Terms

Xin Zhang

Project Title

Project Abstract

Research Terms

Samuel M Wu

Project Title

Project Abstract

Research Terms

Xingjun Fan

Project Title

Project Abstract

Research Terms

JONATHAN W FRIEDBERG

Project Title

Project Abstract

Research Terms

Denes V. Agoston

Project Title

Project Abstract

Research Terms

LISA D COLES

Project Title

Project Abstract

Research Terms

Dominique Duncan

Project Title

Project Abstract

Research Terms

Aristea S Galanopoulou

Project Title

Project Abstract

Research Terms

ANDREY M MAZARATI

Project Title

Project Abstract

Research Terms

Terence John O'Brien

Project Title

Project Abstract

Research Terms

Richard Staba

Project Title

Project Abstract

Research Terms

Judy Lieberman

Project Title

Project Abstract

Research Terms

Hao Wu

Project Title

Project Abstract

Research Terms

Ryan Peter Vetreno

Project Title

Project Abstract

Research Terms

Ju Chen

Project Title

Project Abstract

Research Terms

MICHELE CARBONE

Project Title

Project Abstract

Research Terms

Robert Taylor Ripley

Project Title

Project Abstract

Research Terms